Warning: this site contains 0% fragrance

Myths we won’t tell you

Plenty of scary fragrance “facts” online go further than the research does. Every claim on this site comes from a graded evidence base, built by reading more than 200 papers in full and checking them against their original sources.

This page is the other half: the claims that evidence base says we can’t make, and why. Some come from activists, some from the fragrance industry, and some from misread studies. If we never overstate, nobody can use an overstatement to dismiss the rest.

824 graded claims, 762 claims we won't make. Last updated 2026-09-27.

How we grade evidence

  • Strong evidence: replicated, or one large, well-controlled study
  • Moderate evidence: a single study, a small sample, or a review
  • Weak evidence: thin, unreplicated, indirect or contested

The grade says how reliable a finding is for its kind of evidence. Each fact also says what kind that is, such as a survey, a lab test or an animal study, so a well-done lab result can be moderate but is still a lab result.

The ones we hear most

We won’t say

“One in three people are allergic to fragrance / fragrance sensitivity is an epidemic.”

Why not: 32% = any self-reported symptom from any product; patch-test fragrance allergy is ~4.5%. Source: Steinemann 2019, Air Quality, Atmosphere & Health

What the evidence does support

  • In national surveys of 4,435 adults in the US, Australia, the UK and Sweden, about 1 in 3 (32%) said fragranced products such as air fresheners, scented cleaners or other people's perfume cause them health problems.

    Moderate evidence: Self-report; any symptom from any product counts; pooled re-analysis of previously published surveys; the US arm (34.7%) is the same dataset as four US papers. Source: Steinemann 2019, Air Quality, Atmosphere & Health

  • About 1 in 22 European adults (4.5%) tested positive to at least one of six fragrance-related patch-test markers (2008-2011); single fragrance markers pick up 1-3%, and up to 16% of patients referred for patch testing react.

    Strong evidence: The 4.5% is a six-marker union including non-fragrance markers (colophonium, sesquiterpene lactones), with no clinical-relevance criterion. Source: Sukakul 2024, Acta Dermato-Venereologica Industry-funded

We won’t say

“Fragrance allergy affects 42% of people.”

Why not: Symptoms not associated with atopy; irritation/sensitivity, not allergy. Source: Elberling 2005, Clinical and Experimental Allergy

What the evidence does support

  • In a random-based sample of 946 Danish adults, 42% said fragranced products gave them eye, nose or breathing symptoms in the past year (50% of women, 30% of men).

    Moderate evidence: Self-attributed symptoms; sample enriched for allergy at baseline. Source: Elberling 2005, Clinical and Experimental Allergy

We won’t say

“Baby products emit 228 toxic chemicals.”

Why not: 228 is all distinct compounds detected incl. ethanol/acetone; threshold-dependent. Source: Nematollahi 2018, Air Quality, Atmosphere & Health

What the evidence does support

  • In a test of 42 fragranced baby products (shampoos, lotions, oils, sprays), 95% of the chemicals they released into the air were not listed on the label, safety data sheet or company website.

    Moderate evidence: Headspace presence only; Australian products. Source: Nematollahi 2018, Air Quality, Atmosphere & Health

We won’t say

“Natural or essential-oil cleaners are a safe, low-emission alternative.”

Why not: The same review warns essential-oil cleaners emit formaldehyde and fragrance chemicals (Milhem 2021); essential oils are ozone-reactive terpenes. Source: Salonen 2024, Environment International

What the evidence does support

  • Scent chemicals such as limonene and pine oil react with ozone indoors to make new pollutants, including formaldehyde and fine particles, that keep forming for hours after cleaning ends.

    Strong evidence: Size of the effect depends on dose and indoor ozone; confirmed by later chamber and field studies. Source: Nazaroff & Weschler 2004, Atmospheric Environment

We won’t say

“Citrus and lavender scents are allergens.”

Why not: The fresh parent terpenes are weak; the oxidation products sensitize. Source: Karlberg & Lepoittevin 2021, Contact Dermatitis

What the evidence does support

  • 'Natural' is no protection: lavender oil's own components form skin allergens when exposed to air.

    Strong evidence: Primary is Hagvall 2008 (lab open-flask air exposure, 10-45 weeks): the oil oxidized at the same rate as a synthetic mix of its terpenes; 3.3% linalyl acetate-OOH + 0.48% Lin-OOH at 10 weeks; mouse LLNA EC3 36% fresh -> 4.4% at 45 weeks (weak -> moderate); 4/4 oxidized-linalool-allergic patients reacted to oxidized oil (elicitation only, no fresh-oil control). Real-bottle oxidation rates not measured. Lavender oil ~40% linalool (Klaschka 2016). Source: Bråred Christensson 2016, Contact Dermatitis Industry-funded

  • In patch tests of 2,900 dermatitis patients in six countries, 5.2% were allergic to oxidized limonene and 6.9% to oxidized linalool, two of the most common fragrance chemicals.

    Strong evidence: Clinic population, not general public. Source: Bråred Christensson 2016, Contact Dermatitis Industry-funded

We won’t say

“Lavender and tea tree oils cause breast growth or early puberty in children.”

Why not: Uncontrolled case reports, no exposure measurement; only 2 of 12 cases used tea tree oil. Source: Braunstein & Braunstein 2023, touchREVIEWS in Endocrinology Industry-funded

We won’t say

“Lavender has been proven safe for children, or the link has been debunked.”

Why not: The reviews undercount (they omit about 20 exposed children in clinic tallies) and misread lab data; the null survey (RR 2.8, 95% CI 0.35–22) had about 5% power. The honest statement is 'not ruled out'. Source: Hawkins 2020, Complementary Therapies in Medicine Industry-funded

What the evidence does support

  • As of 2019, the evidence that lavender or tea tree oil causes breast growth in young children consisted only of case reports: 11 children described in detail in 4 papers, with no controlled study.

    Moderate evidence: Systematic review of case reports; undercounts (one included paper reports ~20 more cases in clinic tallies). Source: Hawkins 2020, Complementary Therapies in Medicine Industry-funded

  • Even a review that found little evidence of harm from lavender and tea tree oil in children warned that 'a lack of evidence of harm cannot be interpreted as evidence of safety' for essential oils in children's products.

    Moderate evidence: Direct quote; the review's own conclusion is that the link is unsupported. Source: Hawkins 2020, Complementary Therapies in Medicine Industry-funded

We won’t say

“Perfume causes autism / perfume use in pregnancy raises autism risk.”

Why not: No human or epidemiological data; unreplicated speculative hypothesis. Source: Bagasra 2013, Medical Hypotheses

We won’t say

“Fragrance causes asthma.”

Why not: The toxicology review says fragrances are not considered to cause asthma; our evidence supports exacerbation and non-allergic reactivity, and surveillance new-onset cases are unconfirmed by challenge. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

What the evidence does support

  • 27.9% of US adults with asthma said fragranced products had triggered asthma attacks.

    Moderate evidence: Self-report. Corroborated but not strengthened by an independent 1986 clinic/inpatient survey (Shim & Williams, n=60, unselected for fragrance sensitivity): 72% named perfume/cologne as worsening their asthma, well above this 27.9% attack-specific representative-survey rate, consistent with our clinic-ceiling-above-population-rate pattern. Source: Steinemann 2018, Air Quality, Atmosphere & Health

We won’t say

“Fragrance chemicals are proven neurotoxins.”

Why not: Terpene data mostly show drug-like or protective effects at high doses; chronic low-dose effects unknown. Source: Pinkas 2017, Environmental Research

What the evidence does support

  • Older synthetic musks (musk ambrette, AETT) caused nerve damage in animal studies and were later restricted.

    Moderate evidence: Both primaries now read directly (2026-09-26): Spencer 1979 (AETT, N=16, single lab, single route) and Spencer 1984 (musk ambrette, N=220, dual route, dose-ranging). The musk-ambrette evidence alone is large and well-controlled enough to support 'strong', but the claim bundles it with the smaller AETT study, which keeps the combined claim at moderate under the grading rule. Source: Pinkas 2017, Environmental Research

We won’t say

“All 'unscented' products contain fragrance.”

Why not: The review says 'numerous' products do but gives no survey or count. Source: Rodriguez 2024, Cutis

What the evidence does support

  • In the US, "fragrance free", "unscented" and "free and clear" have no legal definition, so each company picks its own meaning; some "unscented" products contain a masking fragrance added to hide the product's smell.

    Strong evidence: Expert review; the legal-definition point is not itself quantified, but the practical consequence now is: Hamann 2015 found 42 of 52 (80.8%) US pediatric products labeled 'fragrance free' contained >=1 NACDG-tray contact allergen, converging with Xu 2017's 45% (18/40) for adult moisturizers (narrower CAMP cross-reactor definition). Two independent, systematically screened surveys across different age populations now confirm the practical failure of the 'fragrance free' label; masking fragrance specifically remains unmeasured (see Scheinman 1999 for the one documented case). Strong because the absence of a legal definition is a regulatory fact. Hamann's 80.8% counts any NACDG allergen (mostly preservatives), not fragrance; use Xu 2017's 45% for fragrance-related allergens. Source: Rodriguez 2024, Cutis

We won’t say

“Using an app like EWG Skin Deep lowers your chemical exposure.”

Why not: Barrett 2025 measured product hazard ratings, not exposure; ratings come from ingredient lists that omit undisclosed fragrance constituents. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

What the evidence does support

  • About a third of the personal care products people actually used were not in EWG's Skin Deep database at all, including 39% of perfumes and nearly all intimate-care products, so their hazards could not be rated.

    Moderate evidence: Database coverage as of July 2022; EWG has since added products. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

We won’t say

“Phthalates are easily avoided by reading labels.”

Why not: No label among 213 products listed any phthalate (Dodson 2012) Source: Crinnion 2010, Alternative Medicine Review

What the evidence does support

  • In lab tests of 213 US household and personal-care products, not one label listed a phthalate, yet the phthalate DEP, a common fragrance solvent, turned up in half of the pooled conventional product samples.

    Strong evidence: Products bought 2007-08; composited samples; content not dose. Source: Dodson 2012, Environmental Health Perspectives

We won’t say

“Air fresheners fill rooms with dangerous levels of chemicals.”

Why not: 12 mg/m3 limonene is a 3 m3 chamber peak (~700x typical personal exposure); modeled formaldehyde worst case is below WHO guideline. Source: Steinemann 2017, Building and Environment

What the evidence does support

  • In a US national survey, about 1 in 5 adults (20.4%) said air fresheners gave them health problems such as breathing difficulty, migraine or asthma attacks.

    Moderate evidence: Restated from Steinemann 2016 survey; cite the primary; self-report. Source: Steinemann 2017, Building and Environment

Every claim we won’t make

The complete list, grouped by topic. Open a topic to see each claim, why the evidence doesn’t support it, and the source.

Fragrance is everywhere (81)
  • “Limonene in 78% of household products means most products cause skin allergy.”

    Why not: Parent limonene/linalool nearly inert; oxidized limonene allergy <1% in hand-eczema patients (Heydorn 2003) Source: Rastogi 2001, Contact Dermatitis Industry-funded

  • “Household products today contain these fragrance levels (average 827 ppm limonene).”

    Why not: C. 2000 EU products; mean driven by one product at 0.94%; reported SD is likely an SEM. Source: Rastogi 2001, Contact Dermatitis Industry-funded

  • “75% of people with asthma have attacks triggered by perfume.”

    Why not: Clinic ceiling; population samples show 34-43% airway symptoms among asthmatics. Source: Kazemi 2022, Journal of Environmental Health Science and Engineering

  • “Perfume causes breast cancer, autism or infertility.”

    Why not: Cited studies measured phthalates/parabens/antiperspirants, not perfume use; authors call links unproven. Source: Kazemi 2022, Journal of Environmental Health Science and Engineering

  • “Chemistry and statistics quoted from this review are reliable without checking primary sources.”

    Why not: Review contains factual errors (DEP evaporation, triclosan status) Source: Kazemi 2022, Journal of Environmental Health Science and Engineering

  • “Perfume exposes women to hormone-disrupting phthalates that harm babies.”

    Why not: DEP not antiandrogenic in animal studies; MEP may mark other fragrance chemicals. Source: Parlett 2013, Journal of Exposure Science and Environmental Epidemiology

  • “Switching to fragrance-free products cuts phthalate exposure by two-thirds.”

    Why not: Observational users vs non-users; switching not tested here. Source: Parlett 2013, Journal of Exposure Science and Environmental Epidemiology

  • “Fragrance now pollutes city air more than cars.”

    Why not: Fragrance not quantified separately; terpenes ~17% of VCP SOA potential. Source: McDonald 2018, Science

  • “Consumer products cause most urban particle pollution.”

    Why not: Fossil-only share, one city, modeled yields; traffic-side studies not in our evidence base. Source: McDonald 2018, Science

  • “Phthalates are easily avoided by reading labels.”

    Why not: No label among 213 products listed any phthalate (Dodson 2012) Source: Crinnion 2010, Alternative Medicine Review

  • “The phthalate in perfume doubles breast cancer risk.”

    Why not: Single case-control study; MEP may mark fragrance mixture. Source: Crinnion 2010, Alternative Medicine Review

  • “Parabens cause breast cancer.”

    Why not: Tumor-tissue detection and cell tests, not causation. Source: Crinnion 2010, Alternative Medicine Review

  • “US products didn't contain limonene, so Korean products are chemically different.”

    Why not: US survey's method couldn't detect fragrance-level limonene. Source: Kwon 2007, Journal of Hazardous Materials

  • “Chemicals found in the vapor above a product (chloroform, benzene) are what people breathe.”

    Why not: Headspace is not exposure; single library matches; likely base-formula by-products. Source: Kwon 2007, Journal of Hazardous Materials

  • “Product A releases more chemicals than product B, based on counts of VOCs detected.”

    Why not: Counts are set by detection thresholds. Source: Kwon 2007, Journal of Hazardous Materials

  • “Consumer products cause more smog than cars.”

    Why not: Mobile sources were 7 of top 10 reactivity-weighted sources; McDonald 2018 disagrees on ratio. Source: Chen & Luo 2012, Atmospheric Environment

  • “Air fresheners are a leading source of air pollution.”

    Why not: Air fresheners absent from 2005 SoCAB consumer-product top 10 (<2.5 t/d) Source: Chen & Luo 2012, Atmospheric Environment

  • “Household products don't contain limonene / fragrance chemicals weren't in 1980s products.”

    Why not: Only 67 products covered limonene, at a 0.1% w/w limit; method artifact. Source: Sack 1992, Atmospheric Environment. Part A. General Topics

  • “Benzene and 1,4-dioxane are rare in products (or: are in most products), compared across studies.”

    Why not: Detection frequency depends on detection limit. Source: Sack 1992, Atmospheric Environment. Part A. General Topics

  • “Today's household products contain these chlorinated solvents at tens of per cent.”

    Why not: 1,1,1-TCA and CFC-113 phased out in the 1990s; data are historical. Source: Sack 1992, Atmospheric Environment. Part A. General Topics

  • “Fragranced cleaning products cause breast cancer in immigrant women.”

    Why not: Neither exposure nor cancer measured. Source: Knox 2026, Journal of Exposure Science & Environmental Epidemiology

  • “Fragrances are breast carcinogens.”

    Why not: Fragrance grouped as a 'breast-cancer-relevant' class; no causal evidence for fragrance as a group. Source: Knox 2026, Journal of Exposure Science & Environmental Epidemiology

  • “Perth homes are full of fragrance chemicals at harmful levels.”

    Why not: Levels low (mostly <=5 µg/m³); limonene 4-20x below Europe/California. Source: Maisey 2013, Atmospheric Environment

  • “Opening windows is why Perth homes have low indoor chemical levels.”

    Why not: Authors' explanation; air exchange not measured. Source: Maisey 2013, Atmospheric Environment

  • “Homes reach the terpene levels used in lab studies of scent-ozone chemistry.”

    Why not: Max limonene ~9x below lowest chamber condition. Source: Maisey 2013, Atmospheric Environment

  • “Perfume doesn't cover body odor, so wearing it is pointless.”

    Why not: Study did not measure odor strength or pleasantness with vs without perfume; cited work finds perfumed BO rated more pleasant. Source: Gaby & Dalton 2019, Perception

  • “Perfume has no effect on body-odor discrimination.”

    Why not: 'Unaffected' is an equivalence claim never tested; Allen 2015 reports dampening; supports 'not abolished' only. Source: Gaby & Dalton 2019, Perception

  • “Perfume smells better on women taking the pill.”

    Why not: N=9 per arm on one anti-androgenic pill; no p-value printed; the paper's own Discussion says attractiveness is independent of contraception. Source: Chróst 2021, Journal of Cosmetic Dermatology

  • “Women are more sensitive to fragrance at certain points of their menstrual cycle.”

    Why not: Only men rated; women were the odor source, their own sensitivity was not tested. Source: Chróst 2021, Journal of Cosmetic Dermatology

  • “Musk ketone causes cancer.”

    Why not: Never had a carcinogenicity bioassay; musk xylene is IARC group 3 (mouse liver tumors only) Source: Schmeiser 2001, International Journal of Hygiene and Environmental Health

  • “Nitro musks like musk ketone damage nerves.”

    Why not: Demyelination is documented for musk ambrette and AETT; MK and MX were negative in the rat 90-day neurotoxicity study (RIFM, Ford 1990) Source: Schmeiser 2001, International Journal of Hygiene and Environmental Health

  • “Musk ketone in breast milk harms babies.”

    Why not: No infant outcome data; 'not acceptable' is the authors' precautionary judgment. Source: Schmeiser 2001, International Journal of Hygiene and Environmental Health

  • “Over 220 hazardous chemicals came out of fragranced baby products.”

    Why not: Misquote. Nematollahi 2018 found 207 hazardous detections of 43 different chemicals across 42 products; 228 is the count of distinct VOCs of any kind. Source: Rádis-Baptista 2023, Journal of Xenobiotics

  • “Dozens of green, natural or organic products emitted over 100 VOCs.”

    Why not: Misquote of Steinemann 2011: 25 mostly conventional best-sellers, 11 with green claims; green and regular did not differ. Source: Rádis-Baptista 2023, Journal of Xenobiotics

  • “Fragrance chemicals cause cancer and atherosclerosis through olfactory receptors.”

    Why not: Mouse xenograft (OR51E2, ionones) and mouse macrophage data at pharmacological doses; no indoor-exposure link. Source: Rádis-Baptista 2023, Journal of Xenobiotics

  • “EPA says indoor air is 2-5 (or 10) times more polluted than outdoor air.”

    Why not: The page gives both numbers; both are 1980s class averages for about a dozen organics. Real ratios range from ~1 (benzene) to hundreds (limonene). Use compound-specific figures. Source: US EPA 2026

  • “EPA says air fresheners cause liver damage, cancer or memory loss.”

    Why not: EPA lists these effects for VOCs as a class, ranging from highly toxic to no known effect; it attributes no specific effect to air fresheners or fragrance. Source: US EPA 2026

  • “EPA says the VOC levels in ordinary homes are harmful.”

    Why not: EPA states that not much is known about health effects at the levels usually found in homes. Source: US EPA 2026

  • “EPA warns against fragrance.”

    Why not: The page never mentions fragrance, perfume or terpenes; it names air fresheners and cosmetics only as VOC sources. Source: US EPA 2026

  • “Teflon in makeup causes cancer.”

    Why not: Tumors were seen only when PTFE discs, films or mesh were implanted under the skin of rodents, a foreign-body effect also seen with glass and other plastics; there are no dermal carcinogenicity data. Source: Jomaa 2024, Journal of the Netherlands Society of Toxicology (JNST) Industry-funded

  • “PTFE in cosmetics has been proven safe.”

    Why not: Only acute, irritation, sensitization and two genotoxicity tests exist, on test materials that are not cosmetic-grade PTFE; ADME, endocrine and impurity data are missing, by the review's own account. Source: Jomaa 2024, Journal of the Netherlands Society of Toxicology (JNST) Industry-funded

  • “Makeup containing PTFE gives off toxic fumes.”

    Why not: Polymer fume fever requires PTFE heated to roughly 300–450 °C (fumes from ~260 °C); no study shows this from a cosmetic. Source: Jomaa 2024, Journal of the Netherlands Society of Toxicology (JNST) Industry-funded

  • “PTFE cosmetics contain PFOA.”

    Why not: Plausible because irradiated PTFE micropowder can contain PFOA (EU cap 1 mg/kg), but no evidence base source has measured PFOA in a cosmetic. Source: Jomaa 2024, Journal of the Netherlands Society of Toxicology (JNST) Industry-funded

  • “An EPA study found fragrance chemicals cause cancer, brain damage and death.”

    Why not: The EPA study identified chemicals in products; the health effects are MSDS warnings for the pure chemicals at high doses, attached later by an advocate. Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “Limonene and benzyl acetate are carcinogens.”

    Why not: Both IARC Group 3 (external to evidence base, verify); limonene's rat kidney tumors are male-rat specific. The defensible limonene hazard is its oxidation products (allergy) and ozone chemistry (formaldehyde). Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “In the Anderson mouse study, toilet water was harmless and only cologne hurt the mice.”

    Why not: Toilet water was one of the five test products compared with sham air; there was no toilet-water control. Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “One in five people react to fragrance and 72% of asthmatics react to perfume (2008 brochure figures).”

    Why not: No sources given; use the representative surveys (27.8-34.7% any effect; 55.6-64.3% of asthmatics). Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “Fragrance contributes to hypothyroidism, infertility, pregnancy loss, autism or ADHD (the brochure's 'consider how much they contribute' statistics).”

    Why not: The panel lists general disease-burden statistics (some wrong, e.g. '40% hypothyroid') with no fragrance data at all. Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “Halifax declared the whole city fragrance free.”

    Why not: Unsourced in this document; our evidence base has no source on Halifax's policy scope. Source: DONTSPRAYCALIFORNIA 2008 (DOJ ADA docket)

  • “Perfume and scented products in New York emit as many terpenes as a forest.”

    Why not: The forest-sized flux (14.7-24.4 kg/d/km2) is ALL anthropogenic monoterpenes; fragranced products explain ~220 +/- 170 of 520-860 mg/person/day (~26-42%) Source: Coggon 2021

  • “Fragrance chemicals cause half of consumer-product smog.”

    Why not: Fragranced PRODUCT categories make ~half of VCP ozone; the fragrance compound class is ~6%, ethanol and glycol/oxygenate solvents carry most of it. Source: Coggon 2021

  • “24 million New Yorkers breathed unhealthy air because of scented products.”

    Why not: The 24 M includes 13.5 M in the 'unhealthy for sensitive groups' AQI band, and most of the ozone came from NOx plus natural isoprene; fragranced products are a minority share. Source: Coggon 2021

  • “This proves fragrance pollutes city air as much as cars.”

    Why not: The comparison is for one compound class (monoterpenes) reaching a similar ambient enhancement to benzene in one city, one season, not a claim about total organic mass, ozone, or particle formation from fragranced products versus vehicles. Source: Gkatzelis 2021, Environmental Science & Technology

  • “This study measured how much fragrance people are actually exposed to.”

    Why not: The paper measures outdoor city air, not indoor air or personal exposure, and its own monoterpene emission estimate is explicitly a lower limit because the compound reacts away within hours of being emitted. Source: Gkatzelis 2021, Environmental Science & Technology

  • “Limonene detected in city air always means fragranced consumer products are the source.”

    Why not: Monoterpenes are only a reliable fragrance-VCP tracer close to the emission source (city centers); pine forests and other biogenic sources also emit monoterpenes, dominated by pinenes rather than limonene. Source: Gkatzelis 2021, Environmental Science & Technology

  • “Musk ketone and musk xylene blood levels track how much perfume, lotion or deodorant someone uses.”

    Why not: Only body surface area, not any cosmetics-use frequency variable, significantly predicted nitro-musk (musk ketone, musk xylene) blood levels in this study (n=100); the significant lotion/perfume link was for the polycyclic musks (galaxolide, tonalide) only. Source: Hutter 2009, Science of the Total Environment

  • “Synthetic nitro musk exposure has clearly declined since the 1990s phase-outs.”

    Why not: This paper's own 79% Austrian blood detection of musk xylene is far higher than the 12% reported in a German study from 1998 that it also cites as reflecting the phase-out; the paper instead compares itself to an earlier, higher German benchmark from 1994-96. Source: Hutter 2009, Science of the Total Environment

  • “This study proves Black women's hair products are more hazardous than White women's hair products.”

    Why not: No matched comparison group of White women's hair products was tested; the racial-disparity argument combines a differential-use survey, this study's own product measurements against a non-race-stratified 2012 baseline, and separate biomonitoring papers. Source: Helm 2018, Environmental Research

  • “Hair relaxers are proven to cause the diseases linked to Black women's higher rates of fibroids, early menarche or breast cancer.”

    Why not: This paper measured chemical content only; it cites but does not test that disease literature. Source: Helm 2018, Environmental Research

  • “These measurements show current, nationwide chemical exposure levels for Black women's hair products.”

    Why not: Products were purchased in 2008 based on a 2004-5 New York City usage survey; the Black-women's hair-product market has since shifted toward natural/unstraightened styling, with a roughly 20% decline in the relaxer market between 2008 and 2012 (Mintel 2013, cited in the paper) Source: Helm 2018, Environmental Research

  • “Personal-care products emit as much VOC as cars.”

    Why not: The paper's own 24-hour city-wide D5 total (3-5.5 kg/day) is about a fifth to a third of its benzene comparison total (15.6 kg/day); only the peak-commute enhancement ratio exceeds 0.3, not the full-day integrated mass. Source: Coggon 2018, Environmental Science & Technology

  • “This proves fragrance pollutes outdoor air more than cars.”

    Why not: D5 is a silicone base ingredient, not a fragrance compound, and this study measured neither fragrance chemicals nor home/building indoor air; it has no bearing on fragrance-specific claims. Source: Coggon 2018, Environmental Science & Technology

  • “This study measured how exposed people are to D5.”

    Why not: The paper measures outdoor ambient air, a vehicle cabin, and infers a city-wide emission rate; it is not a personal-exposure or home/building indoor-air study. Source: Coggon 2018, Environmental Science & Technology

  • “Deodorant completely covers your natural body scent.”

    Why not: Discrimination stayed above chance in every condition except one narrow subgroup (female donor odor + assigned fragrance); this paper does not support a general masking claim. Source: Allen, Havlíček & Roberts 2015, Frontiers in Psychology

  • “Deodorant has no effect at all on how individually recognizable your body odor is.”

    Why not: Discrimination rate fell significantly and stepwise with fragrance (chi-squared p<0.001); 'not abolished' is not the same as 'no effect'. Source: Allen, Havlíček & Roberts 2015, Frontiers in Psychology

  • “This study proves deodorant makes everyone smell the same.”

    Why not: Only one of six condition-by-donor-sex cells (female donor odor + assigned fragrance) reached chance-level indistinguishability; every other combination stayed above chance. Source: Allen, Havlíček & Roberts 2015, Frontiers in Psychology

  • “This finding about deodorant also applies to perfumes and body sprays.”

    Why not: The study deliberately used deodorants (fragrance plus antiperspirant/antimicrobial action), not fragrance-only perfumes, and says nothing about perfume-only products at typical spray doses. Source: Allen, Havlíček & Roberts 2015, Frontiers in Psychology

  • “The cosmetics industry's own safety panel proved Teflon (PTFE) in cosmetics is completely safe.”

    Why not: The panel's conclusion covers only the endpoints actually tested (acute toxicity, irritation, sensitization, two genotoxicity assays) at reported use concentrations; it explicitly could not assess dermal absorption, distribution, metabolism, excretion, or impurity levels in any finished product, because none of that data exists. Source: CIR 2018 Industry-funded

  • “The industry's own report shows it measured PFOA in Teflon-containing cosmetics.”

    Why not: It did not — the <25 ppb figure is a chemical supplier's own claim about raw PTFE material before formulation, not a measurement of any finished cosmetic product. Source: CIR 2018 Industry-funded

  • “Teflon in cosmetics causes cancer, according to the industry's own safety data.”

    Why not: The only cancer signal in this report is from PTFE surgically implanted under the skin of rodents — a foreign-body effect also seen with glass and other plastics, not a topical-use finding — which the panel itself judged not relevant to cosmetic use. The one confirmed carcinogen in this report, tetrafluoroethylene monomer, was undetected in finished PTFE at a 75 ppb detection limit — 'undetected' meaning below that limit, not proven absent. Source: CIR 2018 Industry-funded

  • “This confirms the 2005 California CARB numbers or shows that perfume/cologne pollutes Los Angeles air more than cars.”

    Why not: This paper has no Los Angeles data of any kind and reports no perfume/cologne-specific product category; it cannot confirm or refute Chen & Luo 2012's or DONTSPRAYCALIFORNIA 2008's LA-basin figures. Source: Gkatzelis 2021b, Environmental Science & Technology

  • “This measures indoor air or personal exposure to chemical products.”

    Why not: Both ground sites are outdoor rooftop/building-exterior inlets; the paper reports no indoor concentrations or indoor/outdoor ratio, so it cannot move McDonald 2018's 'indoor ~7x outdoor' claim. Source: Gkatzelis 2021b, Environmental Science & Technology

  • “'Mobile sources' in this cluster of papers means cars and trucks.”

    Why not: In dense city cores like Manhattan, up to 90% of the PMF-derived 'mobile source' signal was off-road engines (food trucks, generators, small gasoline equipment), not on-road vehicles. Source: Gkatzelis 2021b, Environmental Science & Technology

  • “Musk levels in German milk in the 1990s were only 11 (or only 40) micrograms per kilogram of fat, so exposure was low.”

    Why not: This paper's own 5-sample average (11) and a separate larger Bavarian survey's average (40) are two different, non-overlapping German cohorts; this paper's individual values already ranged up to 108 micrograms per kilogram, nearly matching later, larger studies' means. Source: Rimkus & Wolf 1996, Chemosphere

  • “This 1996 German data plus the 2004 US data prove musk exposure is rising over time.”

    Why not: Comparing this paper's small 1990s German cohort to a later, different-country, different-laboratory study is a cross-country/cross-lab comparison, not a validated time trend; a same-population repeated series (Lignell 2008) found no significant HHCB trend. Source: Rimkus & Wolf 1996, Chemosphere

  • “This study shows ADBI, AHDI, ATII and DPMI are reliably present in most people's body fat.”

    Why not: ADBI, AHDI and ATII were detected in only a minority of the 19 samples, and DPMI could not be quantified in any of them due to an analytical interference. Source: Rimkus & Wolf 1996, Chemosphere

  • “Limonene or linalool appearing on 20-23% of detergent labels means those products cause skin allergy.”

    Why not: The parent chemicals measured here are largely non-allergenic; their air-oxidation products (hydroperoxides), not measured in this study, are the potent sensitizers — see C60. Source: Wieck 2018, Regulatory Toxicology and Pharmacology

  • “This study shows detergents are a bigger fragrance-allergen source than cosmetics.”

    Why not: No direct comparison was made in this study; Klaschka 2016 found higher average allergen counts and higher per-substance declaration rates in natural cosmetics (3.8/product) than this paper found in detergents (1.4/product) Source: Wieck 2018, Regulatory Toxicology and Pharmacology

  • “This study shows dryer sheets and fabric softener fragrance pollute the air or water with hazardous chemicals.”

    Why not: The paper measured plain cotton and polyester textile fiber mass only; it did not test for fragrance, VOCs, or any chemical, and never identifies which products (if any) used in the real consumer loads were fragranced. Source: Cummins 2023, PLOS ONE Industry-funded

  • “Switching to a condenser or 'sealed' non-vented dryer solves the microfiber pollution problem.”

    Why not: The study found condenser dryers released a comparable total quantity of fiber to vented dryers (341.5 vs 256.0 ppm); the fiber that doesn't go to air goes to the condenser and drain water instead, so the pollution is relocated, not eliminated. Source: Cummins 2023, PLOS ONE Industry-funded

  • “This study measured what a neighbor or household member actually breathes from a dryer vent.”

    Why not: The vented-dryer 'airborne' figure (33.3 ppm) is total fiber mass captured by a fine mesh sieve mounted directly on the exhaust vent pipe, not an ambient air concentration at any distance from the house; no receptor-side measurement exists for microfibers, matching the same gap already noted for dryer-vent VOCs. Source: Cummins 2023, PLOS ONE Industry-funded

Hidden ingredients (61)
  • “5 of 6 fragranced products emitted hazardous air pollutants / 10 regulated chemicals.”

    Why not: The paper's own tables show 4 of 6 and 11. Source: Steinemann 2009, Environmental Impact Assessment Review

  • “The fragrance in these products contains hazardous air pollutants.”

    Why not: 1,4-dioxane and chloromethane come from the base formulation; fragrance vs base not attributed. Source: Steinemann 2009, Environmental Impact Assessment Review

  • “These products expose you to toxic levels of chemicals.”

    Why not: Headspace above neat product, not room air; no exposure or health measurement. Source: Steinemann 2009, Environmental Impact Assessment Review

  • “Green or natural products are chemical-free.”

    Why not: Alternatives held unlabeled parabens, 2.4% DEA, siloxanes, terpenes and substitute phthalates found only in alternatives. Source: Dodson 2012, Environmental Health Perspectives

  • “DEP from fragrance disrupts hormones or causes birth defects.”

    Why not: No health data; paper argues DEP may only mark fragrance use; DEP not antiandrogenic in animals. Source: Dodson 2012, Environmental Health Perspectives

  • “These products expose people to harmful doses of hormone disruptors.”

    Why not: Product content is not dose; 2007-08 products. Source: Dodson 2012, Environmental Health Perspectives

  • “Every fragranced product emits toxic chemicals.”

    Why not: 'Hazardous' list includes ethanol, alpha-pinene, camphor via FIFRA/OSHA; headspace is not exposure. Source: Steinemann 2011, Environmental Impact Assessment Review

  • “The fragrance in these products contains carcinogens.”

    Why not: 1,4-dioxane, formaldehyde, methylene chloride likely base-derived; only acetaldehyde plausibly fragrance-linked. Source: Steinemann 2011, Environmental Impact Assessment Review

  • “Green products are proven to be no better than regular products.”

    Why not: Null result from 11 vs 14 products rules out only a large difference. Source: Steinemann 2011, Environmental Impact Assessment Review

  • “95% of baby products expose babies to hazardous chemicals.”

    Why not: Hazard classification of headspace presence, not measured exposure. Source: Nematollahi 2018, Air Quality, Atmosphere & Health

  • “Baby products emit 228 toxic chemicals.”

    Why not: 228 is all distinct compounds detected incl. ethanol/acetone; threshold-dependent. Source: Nematollahi 2018, Air Quality, Atmosphere & Health

  • “Fragranced baby products give babies cancer.”

    Why not: No concentrations or risk estimate. Source: Nematollahi 2018, Air Quality, Atmosphere & Health

  • “A major review in Environment International links fragrance to autism.”

    Why not: Written by the group that proposed the hypothesis; no new data; not independent of Bagasra 2013/Sealey 2015. Source: Sealey 2016, Environment International

  • “98 perfumes caused mutations in fetal brain cells even at 1:50,000 dilution.”

    Why not: Primary (Bagasra 2013): 91 perfumes, bacterial Ames test, 1:15,000; the correct version is also on the avoid list. Source: Sealey 2016, Environment International

  • “Autism is highest where people use the most perfume and lowest in Saudi Arabia, where perfume is banned.”

    Why not: Ecological map with no perfume-use data; premise false (perfume widely used in Saudi Arabia) Source: Sealey 2016, Environment International

  • “Autism rose 10-fold because of synthetic chemicals such as fragrances.”

    Why not: Paper's own numbers do not give 10-fold; ascertainment changes explain much of the rise; no exposure data. Source: Sealey 2016, Environment International

  • “Fragrance chemicals like DEP cause genital defects and ADHD in babies exposed in the womb.”

    Why not: DEP as a fragrance marker and DEP's own toxicity are disputed; citations include a musk-in-milk study that measured no phthalates. Source: Sealey 2016, Environment International

  • “Just for Me shampoo (or JLo Glow) is the most toxic product on the market.”

    Why not: BCPP ranked 32 hand-picked products by number of hazard-flagged chemicals detected, with no concentrations, and its printed order does not follow its own counts. Source: BCPP 2018

  • “Three-quarters of the toxic chemicals in your products come from fragrance.”

    Why not: BCPP defined 'fragrance' as membership of the IFRA list (which includes solvents/preservatives) and counted chemicals, not dose; independent studies trace the worst carcinogens to the base formulation. Source: BCPP 2018

  • “Personal care products are more toxic than cleaning products.”

    Why not: 9.2 vs 8.4 hazard-flagged chemicals per product, 25 vs 7 non-random products, no concentrations. Source: BCPP 2018

  • “A single shampoo or perfume contains up to 229 toxic chemicals.”

    Why not: 229 was the maximum number of compounds of any kind detected by a very sensitive non-targeted method; the report says counts are not ingredient counts; the hazard-flagged maximum was 24. Source: BCPP 2018

  • “Independent laboratory testing proved these products are harmful.”

    Why not: The labs were contractors to an advocacy group that designed, selected and interpreted the study; it measured presence, not harm, and was not peer reviewed. Source: BCPP 2018

  • “80% of cosmetics contain toxic chemicals.”

    Why not: The 80% is products with at least one of 12 listed ingredient groups chosen by an advocacy group, reported by volunteers; not measured toxicity, dose or a market sample; 2010 formulations. Source: David Suzuki Foundation 2010

  • “57% of personal-care products contain carcinogens.”

    Why not: The share counts ingredients that might carry 1,4-dioxane or release formaldehyde; nothing was measured, and the report's carcinogen footnotes are miscited. Source: David Suzuki Foundation 2010

  • “Reading ingredient labels doesn't help you avoid harmful chemicals.”

    Why not: An unquantified aside from a self-selected sample; Barrett 2025 found label readers used products with lower EWG hazard scores. Neither measured exposure. Source: David Suzuki Foundation 2010

  • “98% of Canadians want stronger cosmetic laws.”

    Why not: 98% of people who chose to take an advocacy group's online survey, not a population sample. Source: David Suzuki Foundation 2010

  • “Fragrance ingredients cause cancer and neurotoxicity.”

    Why not: The report's sources are an unreplicated acute mouse assay with no cancer endpoint (Anderson 1998) and one NTP bioassay of a single compound. Source: David Suzuki Foundation 2010

  • “Name the 'most loaded' brands from the 2010 survey as current toxic products.”

    Why not: Volunteer-reported 2010 formulations, many since reformulated; brand-level naming needs current label or lab data. Source: David Suzuki Foundation 2010

  • “Every perfume contains carcinogens, mutagens and reproductive toxicants.”

    Why not: Lee 2015 applied pure-substance SDS categories to unconfirmed, unnamed GC/MS library hits with no concentrations; a trace of a classified substance does not make a product Category 1 under GHS mixture rules. Source: Lee 2015, Young Scientist Journal (Vanderbilt University)

  • “Perfumes contain chemicals as acutely toxic as poisons (oral LD50 of 5 mg/kg or less).”

    Why not: Lee 2015's nine such hits in one body mist are chemically implausible for fragrance materials and cannot be checked because no compound is named. Source: Lee 2015, Young Scientist Journal (Vanderbilt University)

  • “A study found parabens and triclosan in perfume, and that they drive cancer and thyroid disease (Lee 2015, as cited by Kazemi 2022).”

    Why not: Lee 2015 never mentions parabens or triclosan and predates the 2016 FDA triclosan rule; Kazemi's ref. 5 is a miscitation. Source: Kazemi 2022 citing Lee 2015, Young Scientist Journal (Vanderbilt University)

  • “Phthalates in breast milk lower SHBG and LH in baby boys.”

    Why not: The primary found both HIGHER (mEP/mBP-SHBG r=0.27-0.32; miNP-LH r=0.24); the thesis inverted the direction. Source: Gilton 2011 (misrelaying Main 2006)

  • “Fragrance chemicals cause preterm birth, lower IQ and childhood asthma.”

    Why not: Those studies measured plasticizer phthalates (DEHP/MEHP, BBzP) from all sources, not fragrance, and are associations only. Source: Gilton 2011

  • “Europe bans over 1,000 chemicals from cosmetics while the US bans only 11.”

    Why not: No source given in the thesis; the lists are of different kinds (many EU entries were never cosmetic ingredients); needs a current primary regulatory source. Source: Gilton 2011

  • “Plug-in air fresheners contain hexane, a neurotoxin, at harmful levels.”

    Why not: One dollar-store product, library identification only, no amount; the authors say plug-in vapors are unlikely to reach neurotoxic levels. Source: Pino-Delgado 2021, Journal of Student Research

  • “A plug-in air freshener measurably pollutes your home air (citing Pino-Delgado 2021).”

    Why not: In the one home tested the plug-in made no clear difference against background; use Singer 2006 chamber data for the increment. Source: Pino-Delgado 2021, Journal of Student Research

  • “Car air fresheners react with ozone to make formaldehyde in your car (citing Pino-Delgado 2021).”

    Why not: The authors looked for new compounds and found none; SPME-GC/MS could not detect formaldehyde and ozone was not measured. Use Singer 2006 for ozone chemistry. Source: Pino-Delgado 2021, Journal of Student Research

  • “The esters in air fresheners are safe to breathe.”

    Why not: The paper's support is EWG Skin Deep (label-based, absence of listed hazard) and a RIFM skin-irritation review; no inhalation data. Source: Pino-Delgado 2021, Journal of Student Research

  • “4.1% of Europeans are allergic to fragrance.”

    Why not: 4.1% is real but it is EDEN's raw patch-test positive rate to at least one fragrance marker (Diepgen 2015, n=3,119, five EU countries), before the clinical-relevance filter. Only 1.9% had clinically relevant fragrance allergy (0.8% by a stricter contact-dermatitis criterion). Say '1.9% had clinically relevant fragrance allergy', or give the 4.1% with that explanation. Note: EDEN was funded by RIFM. Source: Pastor-Nieto 2021, Current Treatment Options in Allergy

  • “Chemically intolerant, fragrance-sensitive mothers are three times more likely to have an autistic child.”

    Why not: Miscited: the ~3x figure is parental chemical intolerance (QEESI, either parent), not fragrance sensitivity in mothers, and is a self-report association. Source: Pastor-Nieto 2021, Current Treatment Options in Allergy

  • “83.7% of autistic adults are disabled by fragranced products.”

    Why not: 83.7% reported any adverse effect; about 62% reported potentially disabling effects; self-report. Source: Pastor-Nieto 2021, Current Treatment Options in Allergy

  • “Breathing problems from fragrance are all in the mind.”

    Why not: The review relays this from an industry-authored summit paper; blinded studies show partial expectation effects for airway symptoms only, while skin allergy is immunological. Source: Pastor-Nieto 2021, Current Treatment Options in Allergy

  • “About 5% of patients are allergic to oxidized limonene or linalool.”

    Why not: Depends on test concentration: 1.3-5.1% across doses in the same Spanish study; one major network says the top doses over-call. Source: Pastor-Nieto 2021, Current Treatment Options in Allergy

  • “Diethyl phthalate caused the boy's breast growth.”

    Why not: One uncontrolled case, DEP unquantified in the product and never measured in the child; DEP's own anti-androgenicity is disputed. Source: Giroux & Orjubin 2020 (JCEM letter; Consortium Huiles Essentielles), The Journal of Clinical Endocrinology & Metabolism Industry-funded

  • “Lab tests showed there was no lavender in any of the products the children used.”

    Why not: The industry letter found lavender oil ('very low') in the Baby Magic bath, did not report Mi Tesoro, and reported nothing on linalool for any product. Source: Giroux & Orjubin 2020 (JCEM letter; Consortium Huiles Essentielles), The Journal of Clinical Endocrinology & Metabolism Industry-funded

  • “The essential-oil industry proved the lavender breast-growth cases were misclassified.”

    Why not: The letter disputes one product (Crusellas), by an interested party, without numbers, and never says 'misclassified'; Hawkins 2021's 'more than one' overstates it. Source: Giroux & Orjubin 2020 (JCEM letter; Consortium Huiles Essentielles), The Journal of Clinical Endocrinology & Metabolism Industry-funded

  • “Scented tampons cause allergic reactions.”

    Why not: No user data; published pad dermatitis cases mostly blame colophonium, a preservative or acrylates; the allergens found at the highest levels are weak sensitizers at 0.001-0.01%. Source: Desmedt 2020, Contact Dermatitis

  • “Tampons are loaded with limonene, linalool and geraniol.”

    Why not: All three were trace (<10 µg/g) in Desmedt 2020; the quantified allergens were α-isomethyl ionone, hexyl cinnamal and benzyl salicylate. Source: Desmedt 2020, Contact Dermatitis

  • “The US protects women better because tampons are regulated as medical devices.”

    Why not: Device status means pre-market review, not ingredient or allergen disclosure; neither the US nor the EU required fragrance-allergen labeling on tampons in 2020. Source: Desmedt 2020, Contact Dermatitis

  • “Scented tampons contain only about 0.7 µg/g of fragrance.”

    Why not: Lin 2020's 692 ng/g counts limonene and α-pinene only; Desmedt found 25-39 µg/g of two non-terpene allergens per tampon. Source: Desmedt 2020, Contact Dermatitis

  • “Reading the ingredient label tells you whether a cosmetic has PFAS impurities.”

    Why not: This study found unlabeled PFCA impurities in almost every PFAS-containing product tested, more dermally bioaccessible than the labeled ingredient itself, and found 2 of 6 INCI names were themselves ambiguous or inaccurate. Source: Namazkar 2024, Environmental Science: Processes & Impacts

  • “This study shows PTFE/Teflon-containing cosmetics contain PFOA.”

    Why not: No product in this study contained PTFE; it tested a different family of PFAS ingredients (silanes, cyclic perfluorocarbons, ethers, phosphate esters). PFOA/GenX levels in PTFE-containing cosmetics remain unmeasured (still open). Source: Namazkar 2024, Environmental Science: Processes & Impacts

  • “10% of Belgian medicines cause allergic reactions.”

    Why not: 10% is the share of products that merely list a fragrance ingredient, not a reaction rate. Confirmed fragrance-allergic reactions were 127/3,378 (3.8%) of iatrogenic-ACD patients, or 0.67% of all 18,960 patients tested in this clinic — not 10% of anything about people. Source: Nardelli 2009, Contact Dermatitis

  • “This study shows most people react to fragranced medicines.”

    Why not: The 127 reactors are drawn from patients already referred to a specialist contact-allergy clinic for suspected allergy, not a general-population sample; this is a clinic-selected group, not a population prevalence estimate. Source: Nardelli 2009, Contact Dermatitis

  • “FDA found that phthalates in cosmetics are unsafe.”

    Why not: The opposite is true — FDA concluded there was insufficient data to establish a hazard and took no regulatory action; this is a content-testing study, not a safety verdict either way. Source: Hubinger & Havery 2006, Journal of Cosmetic Science

  • “DEHP is not a cosmetics phthalate.”

    Why not: This 2006 survey of 48 products (bought ~2003-05) found no DEHP, but later surveys of different products found it (nail polish composite, Dodson 2012; children's hair-relaxer kits, Helm 2018) — the absence here is specific to this sample, not proof DEHP is absent from cosmetics generally. Source: Hubinger & Havery 2006, Journal of Cosmetic Science

  • “You can avoid phthalates in cosmetics by reading the ingredient label.”

    Why not: Phthalate esters were named on the ingredient list of only some nail products in this survey; fragrance and every other category hid DEP/DBP inside the single word 'fragrance', exactly the gap Dodson 2012 and the David Suzuki Foundation 2010 later measured directly. Source: Hubinger & Havery 2006, Journal of Cosmetic Science

  • “This study measured PFAS in real cosmetics.”

    Why not: It modeled an estimate from ingredient databases, reported industry use-concentration ranges, and retail sales data; no product was chemically tested. A different evidence base source (Namazkar 2024) did test real products. Source: Balan 2024, Environmental Science & Technology

  • “PFAS in cosmetics is mainly a makeup problem.”

    Why not: By this paper's mass estimate, the opposite is true: makeup (where PTFE is concentrated) is under 3% of total estimated PFAS mass; shaving cream, hair care, facial cleanser, sun care, and lotions dominate the estimated mass. Source: Balan 2024, Environmental Science & Technology

  • “Cosmetics are a major, precisely quantified source of PFAS pollution.”

    Why not: The paper's own uncertainty ranges span roughly two orders of magnitude (e.g., 650-56,000 kg/year total PFAS), driven mainly by unreliable, patent/website-sourced use-concentration data; the authors explicitly say a central (mean/median) estimate would be unreliable. Source: Balan 2024, Environmental Science & Technology

  • “PTFE cosmetics are now proven to contain more PFOA or GenX than previously thought.”

    Why not: This paper does not measure PFOA or GenX in any product; it notes PTFE is not classified as a PFAA precursor, and its higher reported PTFE use-concentration ceiling (30% vs. 13% cited from CIR) is about how much PTFE is used, not about impurity levels within it. Source: Balan 2024, Environmental Science & Technology

Health effects (160)
  • “17% of Australians are disabled by fragrance.”

    Why not: The MCS re-cut of the same data shows the DDA item was computed over the fragrance-affected only (55.4% = 36/65, not of 71), so '17.1% of the population' is most likely 17.1% of the 33% affected = 5.6% of adults. Source: Steinemann 2017, Preventive Medicine Reports

  • “7.7% of Australians lost their job because of fragrance.”

    Why not: Combined workdays/job item, possibly including 'became sick'; upper bound. Source: Steinemann 2017, Preventive Medicine Reports

  • “The Australian survey independently confirms the US and international fragrance-sensitivity figures.”

    Why not: Same dataset as the 2018 AU asthmatics paper and 2019 AU arm; count as one study. Source: Steinemann 2017, Preventive Medicine Reports

  • “One in three people are allergic to fragrance / fragrance sensitivity is an epidemic.”

    Why not: 32% = any self-reported symptom from any product; patch-test fragrance allergy is ~4.5%. Source: Steinemann 2019, Air Quality, Atmosphere & Health

  • “Fragrance costs $146 billion a year in lost work; 9% of people lose work to fragrance.”

    Why not: Self-estimated costs, 90% US, implausible implied wages; work item also counted 'became sick'; upper bounds. Source: Steinemann 2019, Air Quality, Atmosphere & Health

  • “22.7% of people are kept out of places by fragrance; four countries independently confirm the earlier surveys.”

    Why not: 22.7% is an averaging error (correct ~16%); pooled paper reuses the same national datasets. Source: Steinemann 2019, Air Quality, Atmosphere & Health

  • “75% of asthmatics react to perfume.”

    Why not: The 75% figure is a citation error: Shim & Williams 1986 reports 72% (43/60) of its clinic asthma sample naming perfume/cologne as an asthma-worsening odor; 75% (45/60) in the same table is for cigarette smoke. Population surveys (this one included) put perfume-triggered breathing problems at ~34-43% of people with asthma. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “35% of asthmatics lost their job over fragrance.”

    Why not: Item is 'became sick, lost workdays, or lost a job'; upper bound. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “A separate 2018 study confirmed the US fragrance-sensitivity findings.”

    Why not: Same respondents as the 2016 US survey. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “Fragrance causes asthma / fragrance caused these symptoms.”

    Why not: Self-attributed, cross-sectional; authors disclaim causation. Source: Elberling 2005, Clinical and Experimental Allergy

  • “Fragrance allergy affects 42% of people.”

    Why not: Symptoms not associated with atopy; irritation/sensitivity, not allergy. Source: Elberling 2005, Clinical and Experimental Allergy

  • “75% of asthmatics are affected by perfume.”

    Why not: Population figure is 34-38% lung symptoms; 75% is a clinic-sample ceiling. Source: Elberling 2005, Clinical and Experimental Allergy

  • “Sweden provides independent confirmation of the four-country fragrance-sensitivity findings.”

    Why not: Same dataset as the 2019 pooled SE arm. Source: Steinemann 2018 (Sweden), Air Quality, Atmosphere & Health

  • “Fragranced products cause immune problems in 7.8% of Swedes.”

    Why not: Mislabeled Table 3 row; immune is 1.5% for all exposures. Source: Steinemann 2018 (Sweden), Air Quality, Atmosphere & Health

  • “Women's fragrance sensitivity peaks at menopause.”

    Why not: Swedish female rates plateau at 43-47% from age 25 to 65. Source: Steinemann 2018 (Sweden), Air Quality, Atmosphere & Health

  • “Fragrance sensitivity affects one in three people (as a diagnosis).”

    Why not: 34.7% is any self-reported symptom from any product, not MCS or allergy, not clinically confirmed. Source: Steinemann 2016, Air Quality, Atmosphere & Health

  • “Fragranced products typically emit formaldehyde.”

    Why not: Primary formaldehyde found in 2/25 products; mostly a secondary ozone-terpene product. Source: Steinemann 2016, Air Quality, Atmosphere & Health

  • “15% of Americans lost their job over fragrance.”

    Why not: Item also counts becoming sick or losing workdays; upper bound. Source: Steinemann 2016, Air Quality, Atmosphere & Health

  • “Fragrance causes asthma, or fragrance-triggered asthma is an allergy.”

    Why not: Survey measures triggering in existing asthma; cannot separate allergic from irritant. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “Asthmatics react to fragrance the same way in every country.”

    Why not: US asthmatics report up to 2x AU migraine and work loss with the same instrument. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “18% of asthmatics lost their jobs because of fragrance.”

    Why not: Item combines lost workdays and job loss; upper bound. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “Even 'organic' air fresheners were shown to release cancer-causing chemicals (using the review's organic example).”

    Why not: The primary product made no organic claim; review swapped label and MSDS. Source: Steinemann 2017, Building and Environment

  • “Air fresheners fill rooms with dangerous levels of chemicals.”

    Why not: 12 mg/m3 limonene is a 3 m3 chamber peak (~700x typical personal exposure); modeled formaldehyde worst case is below WHO guideline. Source: Steinemann 2017, Building and Environment

  • “US and Australian surveys independently confirm air-freshener health effects.”

    Why not: Same datasets restated by the same author, not replications. Source: Steinemann 2017, Building and Environment

  • “6.3% of UK adults have lost workdays or a job because of fragrance.”

    Why not: Item also counts 'became sick'; upper bound. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “The UK survey independently confirms the US results.”

    Why not: Same instrument/program; UK severity about half the US. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “Fragrance sensitivity is mainly a women's or menopausal problem.”

    Why not: UK highest band is men 25-34; F:M 1.17. Source: Steinemann 2018, Air Quality, Atmosphere & Health

  • “Fragrance causes autism, or perfume in pregnancy causes autism in boys.”

    Why not: No animal or human evidence; hypothesis from cell-line data. Source: Sealey 2015, Environmental Research

  • “Fragrance is toxic to nerves at femtomolar doses.”

    Why not: Nominal dilution of unidentified mixtures; no link to real exposure. Source: Sealey 2015, Environmental Research

  • “Male brain cells are more vulnerable to fragrance.”

    Why not: Only one male and one female cancer cell line (BE(2)-M17 vs SH-SY5Y; sexes correctly assigned in the paper), so a cell-line difference cannot be told apart from a sex difference; no fetal neurons, animals or people studied. Source: Sealey 2015, Environmental Research

  • “Science has proven chemical sensitivity is biological, not psychological.”

    Why not: Mechanism does not exclude other contributors; either/or framing rejected. Source: Molot 2023, Neuroscience and Biobehavioral Reviews

  • “Indoor air is 4 times more polluted than outdoor air.”

    Why not: Unreferenced average; I/O ratios range ~1 to ~60 by compound. Source: Molot 2023, Neuroscience and Biobehavioral Reviews

  • “Everyday low-level exposure at home sensitizes your nerves and causes chemical sensitivity (9-16% have MCS).”

    Why not: No dose comparison; prevalence self-reported and definition-dependent. Source: Molot 2023, Neuroscience and Biobehavioral Reviews

  • “This shows fragrance chemicals harm people by irritating nerves.”

    Why not: The review proposes these compounds as anti-allergic treatments; no human exposure measured. Source: Mihara & Shibamoto 2015, Allergy, Asthma & Clinical Immunology

  • “Fragrance reactions are an allergy.”

    Why not: TRPA1 is a sensory-irritant route, not immune allergy; human data link symptoms to airway reactivity, not atopy. Source: Mihara & Shibamoto 2015, Allergy, Asthma & Clinical Immunology

  • “A double-blind study proved perfume triggers breathing problems.”

    Why not: In that study airway symptoms were as common on placebo (5/11) as on perfume (6/11); eye-only, sub-olfactory, 15 min, no spirometry. Source: Elberling 2006, Indoor Air

  • “Fragrance sensitivity is purely physical, not psychological; blinded tests prove it.”

    Why not: Patients also reported more nose, throat, headache and fatigue symptoms under placebo; the design cannot separate expectation from a hyper-reactive baseline. Source: Elberling 2006, Indoor Air

  • “The smell of gas, or any added odorant, causes COPD.”

    Why not: Uncontrolled occupational handling of the liquid at ppm levels with splashing, far above a leak or household exposure. Source: Baur & Bittner 2009, American Journal of Industrial Medicine

  • “Humans are harmed by tetrahydrothiophene at 3 ppm.”

    Why not: 3-4 ppm was an estimate transferred from similar conditions; the authors themselves say 'intermittently high' exposures. Source: Baur & Bittner 2009, American Journal of Industrial Medicine

  • “Perfume is the main cause of work-related irritable larynx syndrome / 10% of workers have it.”

    Why not: Perfume named by 5/30; general fumes/odors and 'other' more common; 10% is of specialist-clinic referrals. Source: Hoy 2010, Occupational Medicine

  • “Olfactory-bulb differences in autism show that perfume exposure damages the developing brain.”

    Why not: The OB phenotype appears in autism-gene mice with no fragrance exposure and is reversible in adults; OB abnormality is not evidence for a fragrance cause. Source: Sturm 2025, eNeuro

  • “Perfume is neurotoxic / causes brain damage.”

    Why not: FOB scored by unblinded technicians, no ethanol-vehicle control although colognes are mostly ethanol; the authors themselves say mouse neurotoxicity data cannot be extrapolated to humans. Source: Anderson & Anderson 1998, Archives of Environmental Health

  • “Mice were exposed to moderate, real-world levels of fragrance.”

    Why not: No airborne concentration was measured; estimated ~5,500 mg/m3 per gram in the source chamber, 3-5 orders of magnitude above measured indoor fragrance exposure. The 'moderate levels' wording comes from Curtis 2004, not from the study. Source: Anderson & Anderson 1998, Archives of Environmental Health

  • “Perfume killed laboratory mice.”

    Why not: 5 deaths in ~744 exposed animals at the highest product loads, not analyzed statistically; the authors explicitly refuse to extrapolate the deaths to humans. Source: Anderson & Anderson 1998, Archives of Environmental Health

  • “Fragrance causes new-onset asthma as often as other workplace chemicals.”

    Why not: Among classifiable cases fragrance cases were less often new-onset (38% vs 55%); surveillance NOA needs no objective test. Source: Weinberg 2017, Journal of Asthma

  • “3.8% of asthma is caused by fragrance.”

    Why not: It is 3.8% of confirmed work-related asthma cases in one state's surveillance system, not of all asthma. Source: Weinberg 2017, Journal of Asthma

  • “Toxicologists say people with asthma need a 10-fold safety margin for indoor chemicals.”

    Why not: This review explicitly rejects AF 10 for asthmatics (Johansson 2016) and AF 20 for the general population; the accurate claim is that data to set any factor are missing. Source: Kleinbeck & Wolkoff 2024, Archives of Toxicology Industry-funded

  • “Studies prove people with MCS are physically more sensitive to chemicals.”

    Why not: 12 controlled studies: symptom ratings higher in 8/10, objective markers in 0/5 (blink, breathing, nasal cytokines); none tested capsaicin cough threshold or brain markers. Source: Kleinbeck & Wolkoff 2024, Archives of Toxicology Industry-funded

  • “Everyday indoor fragrance levels irritate everyone's eyes and airways.”

    Why not: The review (citing Nielsen & Wolkoff 2017) and the exposure data put typical indoor fragrance below sensory-irritation thresholds for healthy adults; effects in susceptible groups are a separate question. Source: Kleinbeck & Wolkoff 2024, Archives of Toxicology Industry-funded

  • “Household cleaning products have been clearly shown to cause asthma in children.”

    Why not: The review's own body text says evidence is consistent for wheeze but not asthma, cross-sectional studies are inconclusive, and adolescents show no association. Source: Salonen 2024, Environment International

  • “Natural or essential-oil cleaners are a safe, low-emission alternative.”

    Why not: The same review warns essential-oil cleaners emit formaldehyde and fragrance chemicals (Milhem 2021); essential oils are ozone-reactive terpenes. Source: Salonen 2024, Environment International

  • “Cleaning products make fewer particles than cooking.”

    Why not: Based on instruments that miss particles below ~10 nm; Rosales 2022 measured ~10^6/cm3 sub-3-nm clusters during terpene-cleaner mopping. Source: Salonen 2024, Environment International

  • “Lavender and tea tree oils cause breast growth or early puberty in children.”

    Why not: Uncontrolled case reports, no exposure measurement; only 2 of 12 cases used tea tree oil. Source: Braunstein & Braunstein 2023, touchREVIEWS in Endocrinology Industry-funded

  • “Tea tree oil causes gynecomastia.”

    Why not: Only 2 of 12 detailed cases used a tea tree oil product; most involved lavender. Source: Braunstein & Braunstein 2023, touchREVIEWS in Endocrinology Industry-funded

  • “Using an app like EWG Skin Deep lowers your chemical exposure.”

    Why not: Barrett 2025 measured product hazard ratings, not exposure; ratings come from ingredient lists that omit undisclosed fragrance constituents. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

  • “Perfumes are the most toxic personal care products.”

    Why not: That is EWG's label-based hazard rating, not measured toxicity or dose; 39% of perfumes used could not be rated. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

  • “Black women's hair products are more hazardous on average.”

    Why not: Mean hair-product scores did not differ by race; the difference was in the share using at least one high-rated product. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

  • “People who worry about chemicals in products buy safer products.”

    Why not: Perception results are non-monotonic (strong agreement and strong disagreement both go with lower scores), 28 uncorrected contrasts, and a key CI is misprinted. Source: Barrett 2025, Journal of Exposure Science & Environmental Epidemiology

  • “Eucalyptus oil / eucalyptol cuts your DHEA by up to 40%.”

    Why not: The '20–40%' figure is from the paper's ABSTRACT and covers three compounds together. Its Results give eucalyptol 13% — the equal weakest of eight — and its direct DHEA measurement gives ~13% at p = 0.0574, not statistically significant. A paper's abstract is a secondary source for its own findings. Source: Sharma 2024, Biomolecules

  • “Eucalyptol blocks aromatase / lowers estrogen.”

    Why not: Not reported in the paper. The six aromatase inhibitors were bisabolol, cedrol, dihydro-beta-ionone, limonene, alpha-terpineol and alpha-terpinyl acetate. Eucalyptol does not appear in that result at all; the attribution was a evidence base error inherited from the abstract. Source: Sharma 2024, Biomolecules

  • “Essential oils disrupt hormone production at everyday exposure levels.”

    Why not: Everything is at a single 10 µM (1.54 mg/L for eucalyptol). Sustained peak indoor air gives ~0.05 µM even assuming 100% absorption and zero clearance; a leave-on product at the highest measured level ~0.07 µM. Only neat undiluted oil on skin (~5.7 µM) comes close, and that route has never been measured in anyone. Source: Sharma 2024, Biomolecules

  • “This proves lavender oil disrupts steroid hormones.”

    Why not: Linalool, linalyl acetate and terpinen-4-ol — ~87% of lavender oil and 30–48% of tea tree oil — were not in the compound set. The only tested molecule that is a meaningful constituent of either oil is eucalyptol, which gave the weakest result in the paper. Source: Sharma 2024, Biomolecules

  • “Essential oils have a feminizing effect on hormone production.”

    Why not: The paper shows inhibition of BOTH androgen synthesis (feminizing) and estrogen synthesis (anti-feminizing), with dihydro-beta-ionone doing both at once, and it measured no estrogen or testosterone at all. Which way the balance moves is unknown. Source: Sharma 2024, Biomolecules

  • “Computer modeling shows terpenes bind and block the enzymes that make steroid hormones.”

    Why not: The docking found binding WITHOUT heme-iron coordination, and the authors state that strong inhibition is therefore 'not expected' — which their own assays confirmed. Cedrol, the best-predicted binder for CYP17A1, inhibited it not at all. Source: Sharma 2024, Biomolecules

  • “Terpenes kill prostate cancer cells, so essential oils help fight cancer.”

    Why not: Up to 50% loss of viability at 10 µM by 48 h in one cell line, and at least partly non-specific toxicity — the authors say so for cedrol, which does not inhibit CYP17A1. It is a drug-design lead, and the same toxicity clouds the paper's enzyme results. Source: Sharma 2024, Biomolecules

  • “One spray of perfume is 77 times (or 9,000 times) a toxic dose.”

    Why not: The multiples compare the perfume volume put on a lab plate with the volume sprayed on skin; they include no absorption, evaporation or metabolism and each rests on one perfume. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “Perfume causes cancer or DNA damage in people.”

    Why not: The genotoxicity test used bacteria without metabolic activation; no mammalian cells, no human data, no compound identified. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “Perfume disrupts your hormones or causes thyroid disease.”

    Why not: Endocrine tests were yeast and enzyme assays with no link to human doses; the aromatase assay lacked a false-positive control; thyroid function and phthalates were not measured. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “Sunlight makes perfume on your skin more toxic.”

    Why not: Only UV-C (254 nm) was tested, which does not reach the ground or come from indoor lighting; one zone got stronger, another weaker. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “Perfumes were shown to be carcinogenic and to harm fetal brain development at femtomole levels.”

    Why not: Morlock 2025 repeats this from Bagasra 2013, which ran only a bacterial Ames test, cytotoxicity at 1:100, and a neuroblastoma tumor cell line, with no compound amounts. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “Expensive or men's perfumes are safer.”

    Why not: No price or gender difference was found, but perfumes were an unsystematic convenience sample and not named. Source: Morlock & Heil 2025, Journal of Chromatography A

  • “One million Australians have MCS.”

    Why not: Extrapolates one self-reported 'ever told' item from an online panel aged 18-65; South Australia found 1% diagnosed; 15.5% of the 'diagnosed' deny chemical sensitivity. Source: Steinemann 2018, Preventive Medicine Reports

  • “Most people with MCS (55%) are disabled by fragrance.”

    Why not: 55.4% is a share of the fragrance-affected MCS respondents (36/65), about 51% of all; one self-report DDA-worded question. Source: Steinemann 2018, Preventive Medicine Reports

  • “People with MCS are 27 times more likely to react to fragrance, so fragrance causes MCS.”

    Why not: Unadjusted cross-sectional POR 26.6 (CI 11-62), partly circular because the chemical-sensitivity question names perfumes; cannot show cause. Source: Steinemann 2018, Preventive Medicine Reports

  • “Half of people with MCS lost their job because of fragrance.”

    Why not: 52.1% is 'lost workdays or a job' combined, n = 71; upper bound. Source: Steinemann 2018, Preventive Medicine Reports

  • “The Australian MCS survey is new evidence alongside the 2017, 2018 and 2019 Australian fragrance papers.”

    Why not: Same June 2016 survey; count once. Source: Steinemann 2018, Preventive Medicine Reports

  • “Multiple chemical sensitivity has tripled in the US in a decade.”

    Why not: Compares telephone surveys (2.5-3.9%) with an opt-in online panel (12.8%); the excess is confined to men under 45. Source: Steinemann 2018 (JOEM), Journal of Occupational and Environmental Medicine

  • “1 in 8 Americans (25 million) have diagnosed MCS.”

    Why not: 12.8% is 3-5x every other estimate (1-6.3%); implausible young-male skew suggests panel artifact. Source: Steinemann 2018 (JOEM), Journal of Occupational and Environmental Medicine

  • “The 2018 MCS study confirms that one in three Americans react to fragrance.”

    Why not: Same June 2016 respondents as Steinemann 2016; counts identical; not a replication. Source: Steinemann 2018 (JOEM), Journal of Occupational and Environmental Medicine

  • “22 million Americans lost work because of fragrance.”

    Why not: Upper-bound item (sibling papers include 'became sick') extrapolated from one online survey. Source: Steinemann 2018 (JOEM), Journal of Occupational and Environmental Medicine

  • “76% of people with MCS are disabled by fragrance.”

    Why not: 76% is of the fragrance-affected MCS; 65.5% of all diagnosed MCS; self-reported ADA wording. Source: Steinemann 2018 (JOEM), Journal of Occupational and Environmental Medicine

  • “Perfume in your eyes can trigger asthma attacks.”

    Why not: The patients did not have asthma, and FEV1 did not change (e.g. 100% -> 99% predicted); symptoms were self-rated and single-blind. Source: Millqvist 1999, Allergy

  • “A placebo-controlled study ruled out psychological causes of fragrance sensitivity.”

    Why not: Millqvist 1999 was single-blind with only self-rated outcomes and no objective change; the authors' 'psychological explanations can be excluded' is not supported, and the airway symptoms did not replicate double-blind. Source: Millqvist 1999, Allergy

  • “Perfume vapor entering through the eyes causes breathing problems.”

    Why not: Shown only single-blind in 11 people; the double-blind repeat (Elberling 2006) found lower-airway symptoms as often on placebo (5/11) as on perfume (6/11) Source: Millqvist 1999, Allergy

  • “This 2012 review proves fragrance causes asthma below safety limits.”

    Why not: The review covers occupational irritants in general (solvents, isocyanates, dusts, gases) and never analyses fragrance or consumer-product exposure; extending it to fragrance is an inference, not a finding of this paper. Source: Baur, Bakehe & Vellguth 2012, Journal of Occupational Medicine and Toxicology

  • “Toxicologists have proven with strong evidence that irritants worsen asthma below workplace exposure limits.”

    Why not: No agent anywhere in this review's 474-study evidence base reached its own top evidence-strength grade; the below-OEL pattern rests on 3 older cited sources plus compiled case-series-level examples, not a high-quality dose-response study. Source: Baur, Bakehe & Vellguth 2012, Journal of Occupational Medicine and Toxicology

  • “Asthmatics are about 3 times more sensitive to indoor/airborne chemicals in general.”

    Why not: This paper reports no single overall multiplier; sensitivity varies hugely by chemical, from no evidence of increased sensitivity (formaldehyde, diesel particles) to an EDRF of 9 for sulfur dioxide specifically. The '~3x overall' figure traces to a evidence base/review paraphrase, not to a number in this paper. Source: Johansson 2016, Critical Reviews in Toxicology

  • “This 2016 study proves current safety limits for asthmatics are too weak and should be tightened.”

    Why not: The paper's own conclusion is the opposite: it presents its findings as support for the existing default assessment factor of 10 being adequate, not as evidence the default should be raised. Source: Johansson 2016, Critical Reviews in Toxicology

  • “Ozone and nitrogen dioxide affect asthmatics more severely than healthy people.”

    Why not: This paper's own concentration-response analysis (Part 2) could not confirm a differential effect for either gas, even though an earlier same-conditions study tally (Part 1) had suggested one; for nitrogen dioxide the apparent asthmatic effect appeared even in filtered-air controls, consistent with an exercise artifact. Source: Johansson 2016, Critical Reviews in Toxicology

  • “This proves multiple chemical sensitivity is caused by nerve damage or hypersensitivity, not psychological factors.”

    Why not: A real, objectively measured physiological difference in one small study does not establish causation for the whole condition or rule out contributing psychological/expectation factors. Source: Ternesten-Hasséus 2002, Journal of Occupational and Environmental Medicine

  • “This has been proven in large clinical trials.”

    Why not: Single 12-vs-12-patient study from one research group (Gothenburg/Sahlgrenska) that has authored nearly every paper in this specific evidence line; not independently replicated by an unrelated group. Source: Ternesten-Hasséus 2002, Journal of Occupational and Environmental Medicine

  • “This NHANES biomarker study proves tampons raise blood VOC levels.”

    Why not: It found no significant association between tampon (or pad) use and any of the 7 VOCs measured; the significant biomarker links were with douching and feminine powder, not tampons or pads. Source: Ding 2020, Journal of Women's Health

  • “Douching causes higher 1,4-DCB levels in the body.”

    Why not: Cross-sectional, self-reported association only; the authors themselves note mothballs and toilet/room deodorizer blocks are DCB's dominant known sources and could not be ruled out as confounders shared with douching behavior. Source: Ding 2020, Journal of Women's Health

  • “Citronellol from fragranced products protects the brain against Parkinson's disease, or could be used to treat it.”

    Why not: The tested dose (25 mg/kg/day oral, rat) is 10^4-10^5x above real-world human citronellol exposure and was given as prevention before neurotoxin exposure, not as treatment of existing disease; no human data exist for citronellol and Parkinson's disease at any dose. Source: Jayaraj 2022, Heliyon

  • “Cleaning products cause 12% of all work-related asthma.”

    Why not: 12% is a share of cases a surveillance system in four states happened to confirm and report in one five-year window, not a validated population-attributable fraction. The same authors estimate the system misses 53-87% of true cases (Michigan capture-recapture) and that up to 37% of confirmed cases in such systems may not be truly work-related. Source: Rosenman 2003, Journal of Occupational and Environmental Medicine

  • “This surveillance study shows fragrance in cleaning products causes occupational asthma.”

    Why not: Limonene (the only fragrance-type agent recorded) was named in just 2 of 300 exposure-agent counts. The dominant named agents were bleach, unspecified disinfectants, acids/oxidizers and quaternary ammonium compounds – general cleaning-product chemistry, not fragrance. Source: Rosenman 2003, Journal of Occupational and Environmental Medicine

  • “75% of asthmatics have asthma attacks triggered by perfume, per Shim 1986.”

    Why not: Citation error: Shim & Williams 1986's actual perfume/cologne figure is 72% (43/60); 75% (45/60) in the same table is for cigarette smoke, not perfume. The 75% figure propagated through Lee 2015 and Kazemi 2022. Source: Shim & Williams 1986, The American Journal of Medicine

  • “Spraying cleaning products 4-7 days a week doubles your asthma risk, with a clear dose-response, per Weinmann 2017.”

    Why not: Overstates the paper: the significant, dose-response-flavored result was for disinfectant use generally (mostly non-spray methods), not sprays; spray use alone had the same point estimate but a non-significant confidence interval (OR 2.79, 95% CI 0.84-9.20) and no monotonic dose-response across low/medium/high spray categories. Source: Weinmann 2017, Occupational and Environmental Medicine

  • “This study proves cleaning products cause asthma in adults.”

    Why not: One observational cohort with self-reported exposure and outcome; authors explicitly state no causal conclusion can be drawn; low/medium disinfectant use was also linked to remittent (improving) asthma, an unexplained result the authors attribute tentatively to reverse causation rather than any causal model. Source: Weinmann 2017, Occupational and Environmental Medicine

  • “AETT is still used in fragrances today.”

    Why not: AETT was withdrawn from cosmetic formulations by the fragrance industry in 1978 and has not been a fragrance ingredient since; cite this paper only as history. Source: Spencer 1979, Science Industry-funded

  • “This proves modern synthetic musks (galaxolide, tonalide, etc.) are neurotoxic.”

    Why not: AETT and musk ambrette are structurally distinct, discontinued nitro-musk compounds; the polycyclic musks that replaced them have a different toxicological profile (see synthetic-musks concept page). Source: Spencer 1979, Science Industry-funded

  • “The FDA banned AETT because of this study.”

    Why not: The FDA denied a citizen petition to formally ban AETT, reasoning that the fragrance industry's own voluntary withdrawal made a ban unnecessary; no recall was required. Source: Spencer 1979, Science Industry-funded

  • “Spraying cleaning products regularly gives you asthma, per this 10-year cohort study.”

    Why not: A persistent, spray-only exposure profile (12% of the cohort) showed point estimates at or below 1.0 for current asthma, current wheeze, incident asthma, and incident wheeze in this same study — no positive association at all. Source: Pacheco Da Silva 2025, Allergy

  • “This study confirms Weinmann 2017's disinfectant-asthma link.”

    Why not: The comparable long-term multi-DCP estimate here (OR 1.68, 95% CI 0.48-5.88, non-significant) is smaller than and not a significant replication of Weinmann 2017's disinfectant-only OR 2.79 (significant); it reuses overlapping SOLAR 2 data from the same cohort, not an independent sample. Source: Pacheco Da Silva 2025, Allergy

  • “Anderson & Anderson's 1997 air-freshener study is independent replication of their cologne study's 30-35% airflow finding.”

    Why not: Same two authors, same commercial testing laboratory, same computerised ASTM E-981 method — a within-lab consistency check on a second product, not independent replication; does not raise the cologne claim to 'strong'. Source: Anderson & Anderson 1997, Archives of Environmental Health

  • “Anderson's air-freshener study proves people are routinely exposed to hazardous fragrance concentrations in normal daily life.”

    Why not: The paper's 'real-use' evidence is an 18-22 hour test in a sealed, unventilated 760-cubic-foot room reaching a bulk methane-equivalent FID TVOC of 480-710 ppm; not comparable to the microgram-per-cubic-meter speciated exposures measured in real households elsewhere in this evidence base, and not independently validated. Source: Anderson & Anderson 1997, Archives of Environmental Health

  • “This air freshener study shows air fresheners cause brain damage or are neurotoxic to humans.”

    Why not: FOB blinding status for this study is not clearly stated, there is no solvent/vehicle-only control, the study comes from the authors' own commercial testing laboratory, and mouse behavioral data of this kind cannot be extrapolated to humans per the authors' own companion paper. Source: Anderson & Anderson 1997, Archives of Environmental Health

  • “This study tells us which brand of air freshener is more or less toxic.”

    Why not: The product and its formulation are not named in the paper; nothing here is traceable to a specific consumer product. Source: Anderson & Anderson 1997, Archives of Environmental Health

  • “This proves fragrance chemicals cause breast cancer.”

    Why not: This is an estrogen-receptor activation and proliferation assay in an existing breast cancer cell line; it says nothing about cancer initiation, only about growth-stimulating a cell line that is already cancerous, and only at concentrations far above estimated exposure. Source: Charles & Darbre 2009, Journal of Applied Toxicology

  • “Lilial was banned in the EU because of this estrogenicity finding.”

    Why not: Lilial's EU cosmetics ban (phased out from 2022) was on reproductive-toxicity (CMR) grounds from its REACH dossier — a different hazard and a much later, stronger regulatory trigger than the weak estrogen-receptor activity reported here in 2009. Don't conflate the two. Source: Charles & Darbre 2009, Journal of Applied Toxicology

  • “MCF7 proliferation results like these are unambiguous evidence of estrogenicity in general.”

    Why not: MCF7 proliferation assays are also confounded by the cell line's baseline growth response to antiestrogen/steroid withdrawal; the paper itself shows basal proliferation is partly fulvestrant-sensitive even without any added test compound. Source: Charles & Darbre 2009, Journal of Applied Toxicology

  • “This lab study proves perfume causes an allergic reaction in the body.”

    Why not: The histamine release was non-IgE-mediated and unrelated to allergy status; the authors describe a different, non-allergic reactivity of unidentified mechanism, not classic allergy. Source: Elberling 2007, Clinical and Experimental Allergy

  • “This study proves histamine causes the breathing symptoms people report from perfume.”

    Why not: The paper's own authors note antihistamines are rarely effective clinically for these patients; no airway or symptom measurement was taken in this study, which tested cells in a dish, not people breathing perfume. Source: Elberling 2007, Clinical and Experimental Allergy

  • “Everyone's basophils react to perfume the same way, so perfume is dangerous to breathe.”

    Why not: Both patients' and healthy volunteers' basophils released histamine dose-dependently; the difference was one of degree at the single highest, most concentrated dose tested, not a difference between reactive and non-reactive people. Source: Elberling 2007, Clinical and Experimental Allergy

  • “Triclosan in sunlight turns into dioxins.”

    Why not: The paper's photoproducts (P1, P2) share a dibenzo-dioxin ring skeleton but are a trichloro anionic tautomer and a non-aromatic dihydro form, not confirmed as the specific, better-characterized environmental dioxin 2,8-DCDD; their toxicity was not tested, only their (reduced) binding to a bacterial antibacterial-target enzyme. Source: Dubey 2019, Ecotoxicology and Environmental Safety

  • “This study proves triclosan causes DNA damage in people from normal sun exposure.”

    Why not: One single-lab, single-cell-line in-vitro study at a triclosan concentration not validated against measured human skin levels; no human skin, biomonitoring or in vivo data. Grading rule: one small single-lab study stays at moderate, never strong. Source: Dubey 2019, Ecotoxicology and Environmental Safety

  • “Stores intentionally stock worse hair products in Black neighborhoods.”

    Why not: The study cannot separate a race effect from a poverty/SES effect: the significant result (Roxbury) came from a mixed-race, high-poverty neighborhood, not Mattapan, the neighborhood selected specifically for high Black population share, which was not significant. The study measures association, not retailer intent. Source: Chan 2023, Environmental Health Perspectives

  • “Hair products in lower-income Boston neighborhoods are more toxic.”

    Why not: EWG's hazard score is a rating built from disclosed ingredients, not measured toxicity or exposure; nearly 40% of all cataloged products had no score, worst in the neighborhoods of color the study aimed to characterize (Chinatown 94.3% missing, excluded entirely). Source: Chan 2023, Environmental Health Perspectives

  • “This study shows what people in these Boston neighborhoods actually use or are exposed to.”

    Why not: This is a store-inventory snapshot, not a purchase, use, or biomonitoring study; residents may shop outside their home neighborhood, and no individual-level data were collected. Source: Chan 2023, Environmental Health Perspectives

  • “This double-blind PGME study proves the solvent's vapor is safe at any level.”

    Why not: The study tested only 12 men for 2.5 h at up to 150 ppm; it says nothing about longer exposures, other populations (women, children, sensitized individuals), or higher occupational or nail-salon-type continuous exposures. Source: Emmen et al. 2003, Toxicology Letters Industry-funded

  • “Emmen 2003's double-blind data disproves the older 250 ppm PGME irritation finding.”

    Why not: Emmen 2003 only tested up to 150 ppm, so it does not directly re-test the 250 ppm claim from Stewart 1970; it undermines confidence in Stewart's unblinded method, not the number itself. Source: Emmen et al. 2003, Toxicology Letters Industry-funded

  • “This paper independently confirms PGME is safe for nail and cosmetic use.”

    Why not: It is a solvent-vapor eye-irritation study only; it does not address the reproductive/developmental (beta-isomer) or systemic toxicity questions covered by the CIR 2008 review of the same chemical. Source: Emmen et al. 2003, Toxicology Letters Industry-funded

  • “This proves ozone-limonene chemistry doesn't bother people with asthma.”

    Why not: The study had no clean-air control, used only mild asthmatics, and found asthmatics reported more (not fewer) physiological symptoms and a larger (non-significant) stress-marker rise — the 'less irritated' result is about self-reported sensory perception only, and the authors themselves warn this could mean asthmatics are under-protected by symptom-based air-quality controls, not that they are unaffected. Source: Fadeyi et al. 2015, Indoor Air

  • “New air filters protect people with asthma from ozone/fragrance chemistry better than used ones.”

    Why not: This study found no measurable difference between new and about-10-month-old filters on any outcome or on the chemistry itself; the comparison is narrow (one filter grade, moderate wear only) so it cannot show filters are never protective, only that this specific new-vs-used contrast made no difference here. Source: Fadeyi et al. 2015, Indoor Air

  • “Asthmatics feeling less irritated means the ozone-limonene air was genuinely less irritating or safer.”

    Why not: Measured ozone and secondary organic aerosol concentrations in the chamber were essentially identical for both groups; only self-reported perception differed, and asthmatics' own physiological symptom ratings and a stress-hormone marker were higher, not lower. Source: Fadeyi et al. 2015, Indoor Air

  • “This proves ozone-terpene chemistry never inflames the airways.”

    Why not: Excluded asthma and chemical sensitivity, tested only one short exposure, and used a nasal-lavage technique the authors themselves say may be less sensitive than the technique used in the one earlier study that found an effect (Koren 1992) Source: Laumbach 2005, Journal of Occupational and Environmental Medicine

  • “The clean-air control proves people could not tell the exposures apart by smell.”

    Why not: The authors' own data show the masked-air control was rated significantly less odorous than the VOC and VOC+ozone conditions throughout the exposure, not just at the start. Source: Laumbach 2005, Journal of Occupational and Environmental Medicine

  • “Fresh limonene-ozone reaction mixtures do not irritate people at all.”

    Why not: A different, more direct single-eye exposure paradigm found a real, statistically robust rise in blink frequency at a comparable-or-lower terpene dose; this whole-body, steady-state nasal null does not overturn that different-route result. Source: Laumbach 2005, Journal of Occupational and Environmental Medicine

  • “Nanoplastics or microplastics from cosmetics easily soak through healthy, intact skin.”

    Why not: Every genuinely positive tissue-level penetration result this review cites used ex vivo skin restricted to well under 1 micrometer, a lab-grown 3D skin model, or skin with the outer barrier removed or bypassed by engineered surface chemistry (PEGylation) built to enhance penetration — not intact living human skin under real cosmetic use. Source: Menichetti et al. 2025, Journal of Xenobiotics

  • “If a fish or rodent cell takes up more nanoplastic than a human cell in a lab dish, that means human skin cells are just as vulnerable to harm.”

    Why not: One cited study (Peng et al. 2024) found zebrafish dermal fibroblasts took up more polystyrene nanoparticles than human dermal fibroblasts, yet the proliferation-inhibiting effect was larger in the human cells — uptake and harm did not track together across species in this study, so a high-uptake result in an animal or fish cell line cannot be assumed to predict the size of the effect in human cells. Source: Menichetti et al. 2025, Journal of Xenobiotics

  • “This study proves perfume worsens asthma.”

    Why not: The 9 patients did not have asthma by objective criteria: normal spirometry and a negative methacholine test, and no measure of airway obstruction (PEF, O2 saturation, heart rate, respiratory rate, expired CO2) changed at all in any condition. This is the exact overstatement Curtis 2004 makes citing this paper (extends C47). Source: Millqvist & Löwhagen 1996, Allergy

  • “A carbon-filter mask is useless against fragrance sensitivity in general.”

    Why not: Tested in only 9 people, for one perfume, at one unmeasured chamber concentration, in a single clinic sample; it did not test filters or masks that also shield the eyes, which the paper itself proposes as the likely entry route. Source: Millqvist & Löwhagen 1996, Allergy

  • “This was double-blind proof that fragrance sensitivity is purely physical, not psychological.”

    Why not: Only the carbon-filter-vs-dummy-filter contrast was double-blind; the primary perfume-vs-saline contrast was single-blind, all symptom outcomes were self-rated, and patients knew a provocation was underway even though they could not identify which substance was used. Source: Millqvist & Löwhagen 1996, Allergy

  • “Perfume/fragrance is the main cause of irritable larynx syndrome.”

    Why not: Perfume was named by only 10/39 (26%) of the founding ILS cohort; reflux (72%) and other airborne irritants (51%) were both more commonly named triggers. Source: Morrison 1999, Journal of Voice

  • “Gastroesophageal reflux caused irritable larynx syndrome in over 90% of patients.”

    Why not: This figure is from the paper's own abstract; its Results Table 4 gives reflux as an etiologic factor in 33/39 = 84.6% of patients, not over 90%; abstract-sourced numbers should not be quoted over the Results. Source: Morrison 1999, Journal of Voice

  • “Irritable larynx syndrome is a proven neuroplastic/neurological disease (or, conversely, that it is purely psychological).”

    Why not: The paper's central neural-plasticity mechanism is an untested hypothesis with no biomarker, imaging, or challenge data in these 39 patients; the diagnostic criteria explicitly exclude formal psychiatric diagnosis while still counting a broad, non-diagnostic "psychogenic" contribution in 41% of cases, so neither a purely biological nor a purely psychological reading is supported. Source: Morrison 1999, Journal of Voice

  • “Irritable larynx syndrome, as originally defined, is an occupational or workplace condition.”

    Why not: This founding series is a general voice-clinic population (Vancouver, 1996-97), not an occupational cohort; the occupational form (work-associated irritable larynx syndrome, WILS) is a separate, later paper (Hoy 2010) Source: Morrison 1999, Journal of Voice

  • “Lidocaine blocking capsaicin-induced cough proves multiple chemical sensitivity is purely a nerve disease and has no psychological component.”

    Why not: The same lidocaine blockade also reduces capsaicin-induced cough in healthy subjects (cited in this paper, Midgren et al. 1992), so the effect demonstrates the normal cough-reflex pathway, not a disease-specific lesion, and the study has no arm that could rule out an expectation or cueing effect. See C45 and C281. Source: Millqvist 2000, Allergy

  • “This capsaicin-lidocaine study is a large, independently replicated finding about chemical sensitivity.”

    Why not: It is a single 12-patient study from one Gothenburg clinic, the same research group behind nearly every other capsaicin-challenge paper on chemical sensitivity and sensory hyperreactivity in this evidence base (Millqvist co-authors or is the sole author of all of them). Source: Millqvist 2000, Allergy

  • “This industry-funded null study proves fragranced household products are safe for people with asthma.”

    Why not: Funded by and co-authored with SC Johnson, whose own product line was apparently the 'test aerosol'; tested only a single acute exposure to two specific products, not chronic/repeated real-world use, and did not select participants for fragrance sensitivity. Source: Opiekun 2003, Clinical and Experimental Allergy Industry-funded

  • “Because a lab test found no objective effect, self-reported fragrance-triggered asthma symptoms in population surveys aren't real.”

    Why not: Different population (unselected clinical-trial volunteers vs. self-selected survey respondents who already suspect fragrance), different exposure pattern (single 30-minute acute exposure vs. repeated real-world exposure); the study's own authors say a non-objective symptom locus does not mean symptoms are fabricated. Source: Opiekun 2003, Clinical and Experimental Allergy Industry-funded

  • “This review proves multiple chemical sensitivity and fragrance reactions are all psychological, not real.”

    Why not: The review explicitly excluded all capsaicin-provocation studies as 'not classic stimuli', so it never tested the TRPV1 capsaicin-cough-hypersensitivity mechanism at all; and its own Table I nose-clip studies (both Millqvist perfume papers) still found significant eye/airway symptoms even with smell blocked, which the review calls imperfectly blinded, not false. See C45. Source: Das-Munshi 2006, Journal of Allergy and Clinical Immunology

  • “A systematic review of multiple chemical sensitivity studies proves that banning fragrances in public places doesn't help and could make things worse.”

    Why not: This is the authors' policy opinion, drawn by analogy from lab provocation results and a single local news article about a proposed municipal scent ban; no fragrance ban or policy intervention was actually tested in this review or any study it includes. Source: Das-Munshi 2006, Journal of Allergy and Clinical Immunology

  • “This study proves that chemical intolerance, sick building syndrome, electrosensitivity and noise sensitivity share the same underlying biological mechanism.”

    Why not: The study only shows the four conditions co-occur in the same people more than chance predicts; a shared reporting style, symptom-attribution tendency, or shared exposure (e.g. a genuinely problematic building also involving chemical cleaning agents) is not ruled out. Source: Palmquist 2014, International Journal of Hygiene and Environmental Health

  • “12.2% of Swedes have multiple chemical sensitivity.”

    Why not: This is a single yes/no self-report item about symptoms from odorous/pungent chemicals, not a clinical MCS diagnosis; the physician-diagnosed rate in the same sample is 3.3%, and even that relies on self-reported diagnosis status rather than verified records. Source: Palmquist 2014, International Journal of Hygiene and Environmental Health

  • “This study proves that fragrance diffusers in cars cause contact dermatitis.”

    Why not: It is a 5-patient, single-clinic case series in a non-peer-reviewed journal section, with no denominator, no control group and no chemical testing of what was actually in the diffusers; it can only show an association plausible enough to report, not a proven or quantified risk. Source: Perper et al. 2017, Contact Dermatitis

  • “15% of Americans are at risk of car-diffuser contact dermatitis because 15% of Americans use Uber.”

    Why not: The 15% figure is a 2016 PBS News Hour estimate of general ride-hailing app usage, not a measurement of diffuser prevalence in those cars or of any exposure or health outcome; the paper uses it only as background context, not as a risk estimate. Source: Perper et al. 2017, Contact Dermatitis

  • “This 1970 study proves PGME vapor is dangerous at everyday consumer or indoor exposure levels.”

    Why not: The lowest irritating concentration tested (250 ppm, roughly 920 mg/m3) is about 500-800x higher than measured indoor glycol-ether peaks from cleaning products elsewhere in our evidence base; this study says nothing about typical consumer exposure. Source: Stewart 1970 (Arch Environ Health), Archives of Environmental Health: An International Journal Industry-funded

  • “The 250 ppm PGME irritation finding is just a two-person anecdote and can be dismissed on that basis.”

    Why not: This description, which appeared in an earlier version of our own claim bank, is itself a sample-size error: 23 subjects were exposed at approximately 250 ppm across five separate runs, not two. The genuine design weaknesses are lack of blinding and lack of objective ocular measures, not small n at this concentration. Source: Stewart 1970 (Arch Environ Health), Archives of Environmental Health: An International Journal Industry-funded

  • “A second paper from the same NIEHS lab independently confirms the lavender/tea-tree gynecomastia link.”

    Why not: Ramsey 2020 (YJBM) shares its lead author (Ramsey) and senior author (Korach) with Ramsey 2019 and Henley 2007. Its endocrine section cites only those three papers and adds no new cases, exposure measurements or constituent testing; it is a restatement in a different journal, not independent corroboration. Source: Ramsey 2020 (YJBM), Yale Journal of Biology and Medicine

  • “Essential oils' antibacterial, antiviral and anti-inflammatory activity shown in lab dish and cell-culture assays means they work as real-world treatments.”

    Why not: All antimicrobial, antiviral and cytokine-inhibition data summarized in this review are in vitro (minimum inhibitory/bactericidal concentration assays, cultured cells); no human dosing, consumer-product-use or clinical-outcome data are reported for these effects. Source: Ramsey 2020 (YJBM), Yale Journal of Biology and Medicine

  • “Reading ingredient labels means you understand fragrance safety.”

    Why not: People who read product references to learn about fragrance ingredients were actually more likely (67.3%) than the general population (55.6%) to hold the false 'natural is healthier' belief. Source: Klaschka 2020a, Environmental Sciences Europe

  • “Autistic adults are proven to react more strongly to fragrances.”

    Why not: The German subgroup is n=49, too small for statistical testing, self-reported diagnosis, and cannot separate true biological sensitivity from differences in symptom noticing or reporting. Source: Klaschka 2020a, Environmental Sciences Europe

  • “German fragrance-sensitivity data confirm the four-country US/AU/UK/SE prevalence figures.”

    Why not: Germany's 19.9% is the lowest of the five same-instrument countries, and its lower survey completion rate (83% vs 92-97%) is a plausible partial explanation; it is a different, lower data point, not a replication. Source: Klaschka 2020a, Environmental Sciences Europe

  • “This survey proves fragrance causes these symptoms.”

    Why not: Cross-sectional self-report with no exposure measurement or clinical confirmation; the author notes people may misattribute unrelated symptoms once primed by a fragrance-focused survey, and conversely under-report due to olfactory adaptation. Source: Klaschka 2020a, Environmental Sciences Europe

  • “New research measured how much fragrance pollution dryer vents release across an entire city or state.”

    Why not: No new city- or state-wide measurement was taken. The tons-per-year figures are a back-of-envelope extrapolation from 2 US households (measured in 2011, reused from Steinemann 2013) and up to 6 Australian households (reused from Goodman et al. 2019), multiplied by census and usage-rate assumptions with no stated uncertainty. Source: Goodman, Nematollahi & Steinemann 2020/2021, Air Quality, Atmosphere & Health

  • “This paper independently confirms earlier findings on fragranced-laundry dryer-vent emissions and health effects with new data.”

    Why not: This is a synthesis paper: every survey percentage, VOC panel result and dryer-vent concentration it reports was already published in earlier Steinemann/Goodman/Nematollahi papers (Steinemann 2013, 2015, 2016-2019; Nematollahi 2018/2019; Goodman et al. 2019); the only new content is a mass-balance extrapolation calculation, not new measurement or survey data. Source: Goodman, Nematollahi & Steinemann 2020/2021, Air Quality, Atmosphere & Health

  • “This review shows fabric softeners or dryer sheets containing QAC cause asthma or dermatitis in ordinary household laundry use.”

    Why not: Every hypersensitivity study the review covers involves occupational, medical or cosmetic-preservative QAC exposure (disinfectant spraying, hospital sterilization, eye/nose drops, hairdressing products), never laundered fabric or dryer-vent exposure; the review does not discuss esterquats, the actual main active ingredient in most modern fabric softeners/dryer sheets, at all. Source: Peyneau 2022, Frontiers in Toxicology

  • “Quaternary ammonium compounds detectable in the blood of 80% of a small volunteer sample (Hrubec 2020, correlated with inflammatory markers) prove that a specific consumer product caused those changes.”

    Why not: The cited biomonitoring study did not identify exposure sources for the detected QAC; correlation with inflammatory cytokines does not establish which product(s), if any, were responsible. Source: Peyneau 2022, Frontiers in Toxicology

  • “There is a settled scientific verdict on whether QAC-related occupational asthma is common or rare.”

    Why not: Two cohort studies cited by this review directly disagree: a US nurses' cohort found no QAC-asthma association while a French healthcare-worker cohort found a strong one, and neither has been read as a primary source. Source: Peyneau 2022, Frontiers in Toxicology

Children and pregnancy (90)
  • “A quarter of children's products are fragrance-free.”

    Why not: Parfum-free is not fragrance-free: essential oils and named allergens were not counted. Source: Uber 2024, Jornal de Pediatria (Rio de Janeiro)

  • “Fragrance in children's cosmetics causes early puberty, cancer or hormone disruption.”

    Why not: Inferred from phthalate studies with non-fragrance exposure; nothing measured in the products. Source: Uber 2024, Jornal de Pediatria (Rio de Janeiro)

  • “Brazilian wet wipes are far more fragranced than US wipes (79% vs 33%).”

    Why not: Difference mostly reflects labeling conventions. Source: Uber 2024, Jornal de Pediatria (Rio de Janeiro)

  • “Fragrance chemicals in daycare air exceed cancer safety levels.”

    Why not: Exceedances were benzene, ethylbenzene, chloroform, naphthalene; none fragrance. Source: Hoang 2016, Indoor Air

  • “Fragrance chemicals in childcare air are at harmful levels.”

    Why not: 0/16 benchmarks exceeded; most fragrance VOCs have none; harm unknown. Source: Hoang 2016, Indoor Air

  • “Switching to low-toxicity or green cleaners cleans up childcare air.”

    Why not: Low-toxicity cleaner users had similar household-source VOC levels. Source: Hoang 2016, Indoor Air

  • “Fragrance exposure causes autism / chemically sensitive parents cause autism.”

    Why not: No exposure measured; association only; fragrance is 1 of 10 QEESI items. Source: Palmer 2024, Journal of Xenobiotics

  • “22.6% of Americans are chemically intolerant.”

    Why not: Self-selected online parents; prevalence depends on definition. Source: Palmer 2024, Journal of Xenobiotics

  • “Chemical intolerance is passed to children through mast-cell epigenetic changes.”

    Why not: Speculative mechanism, no direct human evidence. Source: Palmer 2024, Journal of Xenobiotics

  • “Perfume in pregnancy harms babies.”

    Why not: No health outcomes measured; DEP/MEP toxicity disputed. Source: Braun 2014, Journal of Exposure Science and Environmental Epidemiology

  • “Perfume is the main source of phthalates.”

    Why not: Only 7% used perfume in 24 h; liquid soap raised MEP similarly. Source: Braun 2014, Journal of Exposure Science and Environmental Epidemiology

  • “Mothers' perfume harms baby boys' hormones through breast milk.”

    Why not: Product use not measured; DEP causality disputed. Source: Main 2006, Environmental Health Perspectives

  • “Phthalates in breast milk cause undescended testicles.”

    Why not: No association with cryptorchidism found. Source: Main 2006, Environmental Health Perspectives

  • “Breastfeeding is unsafe because of phthalates.”

    Why not: Study did not compare breastfeeding with formula; no such conclusion. Source: Main 2006, Environmental Health Perspectives

  • “Perfume during pregnancy feminizes baby boys.”

    Why not: Perfume use not measured; DEP not antiandrogenic in animals; MEP may mark fragrance mixture. Source: Swan 2005, Environmental Health Perspectives

  • “Phthalates cause birth defects in boys.”

    Why not: Anogenital distance is a marker associated with reduced prenatal androgen action in animal models, not itself a birth defect; this is an association from a single first-trimester urine sample, not proof of causation. Source: Swan 2015, Human Reproduction

  • “This study led to phthalate bans in children's products.”

    Why not: Policy-impact statement unsourced in our evidence base. Source: Swan 2005, Environmental Health Perspectives

  • “Musk levels in breast milk have risen 5-fold in 10 years.”

    Why not: The 5-fold compares US women with 5 German women; vs Danish women 5 years earlier it is ~1.2-fold. Source: Reiner 2007, Environmental Science & Technology

  • “Musks in breast milk harm babies / mothers using perfume should not breastfeed.”

    Why not: No health outcome measured; no breastfeeding-vs-formula comparison; infant musk intake was lower than for PCBs. Source: Reiner 2007, Environmental Science & Technology

  • “Lavender and tea tree oil are proven hormone disruptors.”

    Why not: Uncontrolled case reports with dechallenge only, plus cell assays, show an association and a plausible mechanism, not causation. Whole-animal guideline studies of linalool and linalyl acetate were negative (though they skipped the most active components). Source: Henley 2007, New England Journal of Medicine

  • “The boys had normal hormones, so the oils must be the cause.”

    Why not: One boy had raised adrenal androgens and estradiol was not measured in all cases; the paper's own data do not support 'normal steroids'. Source: Henley 2007, New England Journal of Medicine

  • “Lavender-scented products (synthetic lavender fragrance) are endocrine disruptors.”

    Why not: The studies tested essential oils, not synthetic lavender scent, and the named products were never chemically analyzed. Source: Henley 2007, New England Journal of Medicine

  • “The cell-assay concentrations match what a child absorbs.”

    Why not: Estrogenic effects needed 100–1000 µM, roughly 100–10,000× above plausible blood levels after skin use; only the anti-androgenic effect starts near 1 µM. No child's blood level has ever been measured. Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “The children in these case reports were definitely exposed to lavender oil.”

    Why not: No product was analyzed by the authors. An essential-oil industry analysis reported the boy's cologne declared and contained no essential oil (DEP, alpha-isomethyl ionone and azo dyes instead), while one girl's baby bath did contain lavender oil at a 'very low' level; unquantified. Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “Linalool is the hormone-active ingredient in lavender.”

    Why not: Linalool was middling; α-terpineol and terpinen-4-ol were the most active, and the tested components recovered only about half of the whole oils' activity. Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “Lavender oil is half as strong as estradiol.”

    Why not: The ~50% figure is from the 2007 cell system; the same lab's 2019 system put the same oils at 17–18%. Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “Eucalyptol is the safe terpene.”

    Why not: It was inactive on estrogen and androgen receptors, but a separate 2024 study reports it inhibits the steroid-synthesis enzyme CYP17A1 (not yet verified in our evidence base). Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “The researchers who found the lavender link recommend avoiding lavender products.”

    Why not: Ramsey 2019 states explicitly: 'We are not recommending any avoidance of these products.'. Source: Ramsey 2019, The Journal of Clinical Endocrinology & Metabolism

  • “Lavender has been proven safe for children, or the link has been debunked.”

    Why not: The reviews undercount (they omit about 20 exposed children in clinic tallies) and misread lab data; the null survey (RR 2.8, 95% CI 0.35–22) had about 5% power. The honest statement is 'not ruled out'. Source: Hawkins 2020, Complementary Therapies in Medicine Industry-funded

  • “Natural essential oils are a safe swap for synthetic fragrance, or are more dangerous than it.”

    Why not: Neither has been compared in children. Source: Hawkins 2020, Complementary Therapies in Medicine Industry-funded

  • “The pro-safety survey was industry-funded, so it is wrong.”

    Why not: The funding is a documented, undeclared conflict, but the paper's real weaknesses are its low power and self-selected, parent-reported design, which would be the same with any funder. Source: Hawkins 2021, International Journal of Pediatrics and Adolescent Medicine Industry-funded

  • “Most children who use lavender products develop breast growth.”

    Why not: Nobody claims this; the case reports describe rare, reversible cases. Source: Hawkins 2021, International Journal of Pediatrics and Adolescent Medicine Industry-funded

  • “If a child with breast growth was exposed to an estrogen-like chemical, that is substantial evidence the chemical caused it.”

    Why not: The letter's own sentence, contradicted by its concession that 4 cases cannot establish causality; in vitro ER activation needs 100-1000 uM and no child's exposure was measured. Source: Ramsey et al. 2020 (JCEM reply), The Journal of Clinical Endocrinology & Metabolism

  • “Industry testing proved there was no lavender oil in the products the children used.”

    Why not: Industry assays, not independent, no numbers; the Consortium letter found lavender oil ('very low') in the Baby Magic bath and did not report Mi Tesoro; by the NIEHS reply's account Larkman's analysis also found linalool and linalyl acetate in some products. Source: Ramsey et al. 2020 (JCEM reply), The Journal of Clinical Endocrinology & Metabolism

  • “The lab results linking lavender to hormone effects were just plastic leaching from the culture dishes.”

    Why not: Vegetable-oil controls were negative and activity differed by constituent (limonene, a strong plastic solvent, was inactive); not directly tested with glassware. Source: Ramsey et al. 2020 (JCEM reply), The Journal of Clinical Endocrinology & Metabolism

  • “Lavender diffusers cause early puberty in children.”

    Why not: The evidence is five rats per group, one species, one sex and one unmeasured dose, with no human data; the paper concludes only that inhalation 'might trigger' early pubertal onset in female rats. Source: Kim & Lim 2022, Journal of Korean Medical Science

  • “The lavender dose the rats got is like a home diffuser.”

    Why not: No air concentration was measured in the cage, and no measurement of a running diffuser in a real room exists, so no comparison with a child's exposure can be made. Source: Kim & Lim 2022, Journal of Korean Medical Science

  • “A lavender nasal spray brings puberty forward.”

    Why not: That group's result was not statistically significant (36.6 vs 38.4 days, P = 0.151), and the paper's abstract swaps the nasal-spray and diffuser labels relative to its own tables. Source: Kim & Lim 2022, Journal of Korean Medical Science

  • “This rat study proves lavender acts as an estrogen.”

    Why not: Estradiol did not rise significantly (4.9/5.3 vs 3.9 ng/mL); the signal was in the pituitary hormones LH and FSH, which is a different, central mechanism from the estrogen-receptor activity reported in cell studies. Source: Kim & Lim 2022, Journal of Korean Medical Science

  • “Lavender oil damages the kidneys.”

    Why not: One organ-weight difference (kidney 1.926 vs 1.664 g per 150 g body weight) in one group of five rats, with no measure of kidney function or nephron number; the authors offer it as a hypothesis. Source: Kim & Lim 2022, Journal of Korean Medical Science

  • “Sunscreen ingredients disrupt human hormones.”

    Why not: Every effect in this paper is in rats or in cultured cells. No human hormone, puberty or reproductive outcome was measured, and the authors note human tissue concentrations of these filters were unpublished. Say 'in rats and in cells'. Source: Schlumpf 2004, Toxicology

  • “Sunscreen chemicals cause early puberty.”

    Why not: The direction is the opposite: 4-MBC and 3-BC DELAYED male puberty and left female vaginal opening unaffected at every dose. Do not merge this with the lavender-inhalation rat study, which advanced puberty in females. Source: Schlumpf 2004, Toxicology

  • “There is no safe level of the UV filter 3-BC.”

    Why not: 0.24 mg/kg/day was the lowest dose tested and it was effective, so no no-effect level was established. That is missing data, not a demonstration that every level is harmful. Source: Schlumpf 2004, Toxicology

  • “UV filters break down in sunlight into more harmful photoproducts.”

    Why not: Plausible and completely untested here. The paper contains no irradiation experiment, no photostability data and no photoproduct; every assay used fresh compound in the dark. No evidence base source yet reports a UV-filter photoproduct. Source: Schlumpf 2004, Toxicology

  • “Avoid sunscreen because its ingredients are hormone disruptors.”

    Why not: The paper tests individual filters at doses far above cosmetic use, says nothing about sun protection or skin cancer, and found avobenzone inactive in every assay. 4-MBC and 3-BC are not the filters dominating current products. Source: Schlumpf 2004, Toxicology

  • “Two-thirds of children are exposed to perfume.”

    Why not: One Brazilian hospital sample; a US survey found about a fifth of children used fragrance products; not generalizable across countries. Source: Melo 2020, Revista Paulista de Pediatria

  • “Most children wear perfume every day.”

    Why not: The survey asked whether perfume was used, not how often. Source: Melo 2020, Revista Paulista de Pediatria

  • “Perfume caused skin problems in these children.”

    Why not: No skin outcome was linked to any product; contact-dermatitis risk is the authors' citation of reviews. Source: Melo 2020, Revista Paulista de Pediatria

  • “EPA says the phthalates in fragrance harm male fertility.”

    Why not: EPA's robust/moderate ratings are for DEHP, DBP, DINP, BBP and DIBP; DEP (the fragrance phthalate) was slight/indeterminate on every outcome. Source: Radke 2018 (US EPA), Environment International

  • “Phthalates in breast milk lower baby boys' testosterone.”

    Why not: EPA excluded the milk study (Main 2006) as a critically deficient exposure measure; infant-testosterone evidence indeterminate; in Main only mBP, not mEP, was significant. Source: Radke 2018 (US EPA), Environment International

  • “EPA has shown diethyl phthalate (DEP) is safe for baby boys.”

    Why not: The review rated DEP 'slight', not 'compelling evidence of no effect', and asked for more high-confidence studies. Source: Radke 2018 (US EPA), Environment International

  • “Half of baby products are fragranced.”

    Why not: In Denmark baby-care products were the least fragranced category (38.0%, 178/468); the ~half figure is for all children's cosmetics. Source: Botvid 2023, Contact Dermatitis

  • “Three in four children's products worldwide are scented.”

    Why not: 74% is Brazil's parfum count (Uber 2024); a Danish registry with a broader definition found 53.8%. Source: Botvid 2023, Contact Dermatitis

  • “Children are exposed to 16 fragrance allergens from their products.”

    Why not: 16 was the maximum in one baby perfume; category means were 0.4-1.8 named allergens per product. Source: Botvid 2023, Contact Dermatitis

  • “Children's products still contain banned fragrance allergens (Lyral, Lilial).”

    Why not: 15 registry products scanned 2015-22 declared HICC or BMHCA, probably before the EU bans took full effect (2021, 2022); post-ban sale not shown. Source: Botvid 2023, Contact Dermatitis

  • “A children's product with no named allergens on the label is allergen-free.”

    Why not: Allergens below 10 ppm (leave-on) / 100 ppm (rinse-off) need not be named, and only 26 allergens were declarable vs 54 chemicals and 28 extracts established as allergens. Source: Botvid 2023, Contact Dermatitis

  • “This study shows cleaning products cause allergies in children, not just wheeze.”

    Why not: Isolated atopy (skin-prick positivity alone) showed no significant association (adjusted OR 1.14, 95% CI 0.96–1.35); only recurrent wheeze combined with atopy was raised (adjusted OR 1.49), not atopy independent of respiratory symptoms. Source: Parks et al. 2020, CMAJ (Canadian Medical Association Journal)

  • “This cohort found a real, confirmed sex difference, with girls more affected than boys by cleaning-product exposure.”

    Why not: All four outcome odds ratios were numerically larger in girls, but the sex-interaction p-values did not reach statistical significance; the authors describe this as hypothesis-generating only, not a confirmed finding. Source: Parks et al. 2020, CMAJ (Canadian Medical Association Journal)

  • “Comparing high vs. low household cleaning-product use directly shows a significant increase in childhood wheeze and asthma risk.”

    Why not: The categorical (tertile, high-vs-low) comparison was not statistically significant for any outcome (e.g. asthma adjusted OR 1.57, 95% CI 0.98–2.53); only the continuous per-interquartile-increase model reached significance. Source: Parks et al. 2020, CMAJ (Canadian Medical Association Journal)

  • “Benzyl alcohol, limonene and linalool are the top three fragrance chemicals in US baby products.”

    Why not: This US survey only individually quantifies benzyl alcohol (32/255 fragranced products); it does not report limonene or linalool prevalence at all. The "top three" ranking is confirmed only for Denmark (Botvid 2023), not the US. Source: Bonchak 2018, Dermatitis

  • “Most baby and children's personal care products today are free of contact allergens.”

    Why not: This is a single 2018 US retail snapshot; 55% of products contained at least one screened allergen at the time, and current product formulations have not been re-verified. Source: Bonchak 2018, Dermatitis

  • “Paying more for a baby product guarantees it has fewer allergens, or cheap products are unsafe.”

    Why not: The price-allergen link is a population-level correlation with no mechanism tested and no per-product guarantee; specific brands and prices were not re-verified, and an equivalent adult-moisturizer study (Xu 2017) found the same direction but no significant effect. Source: Bonchak 2018, Dermatitis

  • “Perfume raises phthalate levels in the air pregnant women breathe.”

    Why not: This study found NO association between perfume use and DEP in personal air, only in urine; the authors suggest perfume's DEP exposure is mainly dermal, not inhaled. Source: Just 2010, Journal of Exposure Science and Environmental Epidemiology

  • “Nail polish doesn't expose people to phthalates because this study found no link between nail product use and DnBP/MnBP.”

    Why not: Only 10% of women used nail products in 48h and the questionnaire lumped polish with remover; occupational nail-salon studies (Hines 2009, Kwapniewski 2008) DID find DnBP exposure from heavy repeated contact. Source: Just 2010, Journal of Exposure Science and Environmental Epidemiology

  • “This study proves diethyl phthalate itself harms pregnancy.”

    Why not: Exposure-only study, no health outcome measured; DEP's own reproductive toxicity is separately disputed and rated 'slight' by Radke 2018. Source: Just 2010, Journal of Exposure Science and Environmental Epidemiology

  • “Children's cosmetics contain more fragrance allergens than adult products.”

    Why not: For hydro-alcoholic perfumes this 1999 study found the opposite — children's products had fragrance-mix allergens less often (isoeugenol 2/7 vs 7/10 in the same lab's adult-perfume survey) and at lower concentration (hydroxycitronellal max 0.3% vs 1.19%) than the 10 best-selling adult fine fragrances. Source: Rastogi 1999, Contact Dermatitis

  • “Children's cosmetic-toy perfumes as a category exceed fragrance safety guidelines.”

    Why not: Only 1 of 3 items in the one toy perfume-blending set tested (the lilac essence) exceeded a guideline; the widely-quoted "geraniol in 7/7" finding is from a separate group of non-toy children's perfumes and a deodorant, not from toys. Source: Rastogi 1999, Contact Dermatitis

  • “A Washington DC childcare study confirms (or refutes) that California's high childcare limonene levels are a general US finding.”

    Why not: This pilot's fixed 7-VOC panel (benzene, carbon tetrachloride, chloroform, ethylbenzene, o-/p-xylene, toluene) includes no limonene, other terpene, or siloxane; it has no data bearing on the California limonene finding in either direction. Source: Quirós-Alcalá 2016, Environmental Research

  • “DC childcare air is more polluted overall than California childcare air.”

    Why not: Only true for the narrow chlorinated-solvent/BTEX panel measured; the same DC facilities had somewhat lower particulate matter (PM2.5/PM10) than the California comparison studies, and no fragrance/terpene comparison is possible at all. Source: Quirós-Alcalá 2016, Environmental Research

  • “A specific household product or product category (such as sprays, bleach or air fresheners) is the main culprit behind children's wheezing.”

    Why not: The authors specifically tested aerosol-based, volatile-chemical and bleach-based subgroups and a principal-component grouping of the 18 products and found no statistical improvement over the single overall composite exposure score; their own conclusion is that overall chemical burden, not any one product, drives the association. Source: Mikeš 2019, Science of the Total Environment

  • “This study confirms Parks 2020's finding that household chemical exposure does not affect allergic/atopic disease in children.”

    Why not: This paper's atopic-rash score is used only as an adjustment covariate in the wheeze-phenotype model, not measured as an outcome of chemical exposure, so it cannot confirm or refute Parks 2020's isolated skin-prick-atopy null result; it is a different measurement of a different quantity. Source: Mikeš 2019, Science of the Total Environment

  • “The evidence for chemical intolerance and child autism has gotten stronger over time, rising from 3x in 2015 to 5.7x in 2024.”

    Why not: Not a like-for-like comparison: 2015's OR 3.01 used a binary QEESI >=40/>=40 cutoff in a case-control sample, while 2024's headline RR 5.7 compares only the top vs bottom decile of a different, cross-sectional sample; part of the apparent rise is the choice of a more extreme comparison group, not necessarily a larger true effect, and the two studies share two authors (Palmer, Miller), so they are not independent replications. Source: Heilbrun 2015 / Palmer 2024, Journal of the American Board of Family Medicine

  • “This study shows all household cleaning products raise the risk of infant respiratory problems during pregnancy.”

    Why not: The paper found no association at all for bleach, ammonia, furniture polish, glass cleaners or multiuse cleaners (all ORs 0.91-1.03, non-significant). Only spray-applied products, solvents and air fresheners showed a significant association; the risk in this study is product-specific, not general to all cleaning products. Source: Casas 2013, International Journal of Public Health Industry-funded

  • “Counting how many different cleaning products a pregnant woman uses predicts her infant's respiratory risk.”

    Why not: This paper explicitly tested a summed cleaning-product-count score and found it was NOT significantly associated with infant LRTI or wheezing (data not shown by the authors) — unlike the frequency-weighted composite scores used in two sibling cohort studies (Parks 2020, Mikeš 2019), which did find their overall scores predictive. Don't generalize the 'overall burden matters' framing from those other two papers to this one's simpler count-based approach. Source: Casas 2013, International Journal of Public Health Industry-funded

  • “Teenagers get objectively confirmed sensory hyperreactivity as often as adults.”

    Why not: Objectively confirmed SHR (capsaicin-positive plus questionnaire-positive) was 0.9% in teenagers vs 6.3% in the comparable adult study, a roughly 7-fold gap larger than for self-report alone. Source: Andersson 2008, International Journal of Hygiene and Environmental Health

  • “This proves chemical sensitivity in teenagers is caused by anxiety.”

    Why not: Anxiety was one of three independent risk factors for the self-reported measure, but the objective capsaicin-cough measure did not correlate with anxiety at all (r=-0.03) Source: Andersson 2008, International Journal of Hygiene and Environmental Health

  • “This teenager study confirms the Swedish national adult figure that one in three people react to fragranced products.”

    Why not: Different population (teenagers 13-19, not adults 18-65) and a different, broader question (bothered by strong odors in general, not fragranced consumer products specifically) Source: Andersson 2008, International Journal of Hygiene and Environmental Health

  • “Breastfeeding exposes babies to significant phthalate levels.”

    Why not: This study found the opposite: phthalate oxidative metabolites were detected in under 10% of milk samples, near the limit of quantification, even in women with fully detectable urinary phthalate levels. Source: Hines 2009, Environmental Health Perspectives

  • “This study proves MEP/DEP is nearly absent from breast milk.”

    Why not: MEP itself was never measured in milk in this study; the under-10%-detection figure applies to four other, DEHP-derived oxidative metabolites, not the fragrance phthalate metabolite. Source: Hines 2009, Environmental Health Perspectives

  • “Nail polish, not perfume, explains women's high urinary MEP.”

    Why not: The study did not ask about perfume or cologne use, so it cannot rule fragrance products in or out as a co-contributor to urinary MEP. Source: Hines 2009, Environmental Health Perspectives

  • “This study shows perfume affects baby boys' development.”

    Why not: Diethyl phthalate (DEP/MEP), the phthalate most tied to fragrance and perfume use, was the one phthalate class with a clean null result in this study; the phthalate that did replicate (DEHP) is a PVC plasticizer, not primarily a fragrance ingredient. Source: Swan 2015, Human Reproduction

  • “The exact size of the DEHP effect can be precisely compared between this study and the original 2005 study using the published beta-coefficients.”

    Why not: The paper's own Discussion text (beta -1.43, -1.71, -1.49 for MEHP/MEOHP/MEHHP) and its own Table III (beta -1.21, -1.60, -1.47 for the same three metabolites and outcome) do not agree exactly — an internal inconsistency in the primary source itself. Quote direction and significance, not the precise magnitude comparison. Source: Swan 2015, Human Reproduction

  • “This proves lavender causes breast growth in boys.”

    Why not: Three more uncontrolled case reports with no rechallenge and no comparison group; prepubertal gynecomastia can resolve on its own regardless of any product change. Source: Diaz 2016, Journal of Pediatric Endocrinology and Metabolism

  • “These are three additional cases beyond what's already been counted in the lavender literature.”

    Why not: This paper's three boys were seen at the same hospital as, and by a co-author of, Ramsey 2019's later clinic-tally study and are very likely already inside that count, not separate from it. Source: Diaz 2016, Journal of Pediatric Endocrinology and Metabolism

  • “Chemical testing proves all agua de violetas colognes contain lavender.”

    Why not: This test confirmed lavender in one specific bottle; an industry-funded analysis of a different named 'violet water' product found no lavender oil at all, only diethyl phthalate. Source: Diaz 2016, Journal of Pediatric Endocrinology and Metabolism

  • “Musk levels in breast milk have been rising over the past decade.”

    Why not: This paper's own same-population, same-lab repeated series (1996-2003) found no significant HHCB time trend (p=0.127); AHTN and musk xylene instead declined significantly (about 11%/yr and 17%/yr), directly disputing the earlier 'rising' narrative built from a cross-country comparison. Source: Lignell 2008, Environmental Science & Technology

  • “Using any perfumed product (perfume, deodorant, or detergent) raises all musk chemical levels in the body about equally.”

    Why not: The associations found were specific: perfume predicted only HHCB, laundry detergent predicted only AHTN, deodorant use predicted none of the three musks tested, and musk xylene was predicted by no product category. Source: Lignell 2008, Environmental Science & Technology

  • “Infant musk exposure from breast milk is a known safety margin because it falls far below adult cosmetic-safety intake limits.”

    Why not: The comparison intake used an adult-derived provisional tolerable daily intake with no infant-specific toxicity data behind it; the paper's own authors call the comparison 'questionable' and state the lack of toxicity data makes it difficult to generalize about the safety of musk exposure of breast-fed infants. Source: Lignell 2008, Environmental Science & Technology

  • “This case is independent proof on top of the US lavender cases, so the link is now confirmed by multiple countries.”

    Why not: It is genuinely from a different country and hospital, but it is still just one uncontrolled case report with no product testing and no rechallenge — the same weak evidence type as the US cases, not stronger evidence because it is geographically separate. Source: Linklater & Hewitt 2015, Journal of Paediatrics and Child Health

  • “The exposure in this case was uncovered through careful clinical detective work, the same way it was in the US cases.”

    Why not: The family disclosed the exposure only after watching a documentary about the lavender-and-breast-development link, a media-primed disclosure rather than the clinician-directed questioning used in the Henley and Diaz case reports — a weaker and more bias-prone way for a case to come to light. Source: Linklater & Hewitt 2015, Journal of Paediatrics and Child Health

Indoor air (104)
  • “Fragranced laundry products make dryer vents emit benzene and other hazardous air pollutants.”

    Why not: BTEX highest in the no-product control; acetaldehyde 41 ug/m3 without product. Source: Steinemann 2013, Air Quality, Atmosphere & Health

  • “One detergent's dryer vents emit 3% as much acetaldehyde as all the county's cars.”

    Why not: Baseline-corrected ~1.5%, from single samples in two homes. Source: Steinemann 2013, Air Quality, Atmosphere & Health

  • “Neighbors' dryer vents expose you to harmful chemical doses.”

    Why not: No receptor measurement; outdoor dilution not assessed. Source: Steinemann 2013, Air Quality, Atmosphere & Health

  • “One cleaning session fills your home with 56 ug/m3 of particles and 5.6 ug/m3 of extra formaldehyde.”

    Why not: Modeled upper bounds; label-dose house measured 4-7 ug/m3. Source: Nazaroff & Weschler 2004, Atmospheric Environment

  • “Fragrance chemicals cause occupational asthma in cleaners.”

    Why not: Evidence is for cleaning products generally (sprays, bleach, quats) Source: Nazaroff & Weschler 2004, Atmospheric Environment

  • “Air fresheners and cleaners directly release formaldehyde.”

    Why not: No primary formaldehyde without ozone in this study. Source: Singer 2006, Atmospheric Environment

  • “A plug-in air freshener creates as much indoor particle pollution as cleaning.”

    Why not: Air freshener added 2-5 µg/m³ vs 130-280 from cleaning pulses. Source: Singer 2006, Atmospheric Environment

  • “A plug-in air freshener exceeds California's formaldehyde safety limit.”

    Why not: True only against the 2000 REL; the revised 2008 limit is not exceeded by the increment alone. Source: Singer 2006, Atmospheric Environment

  • “People with less education breathe more cleaning chemicals.”

    Why not: Text typo; tables/figure show higher-educated had higher terpene exposure. Source: Edwards 2006, Atmospheric Environment Industry-funded

  • “People breathe cleaning-product scent chemicals at chamber-study levels all day.”

    Why not: 48-h personal limonene ~3 ppb mean, ~30 ppb max; 10-30x below chamber levels. Source: Edwards 2006, Atmospheric Environment Industry-funded

  • “Fragrance surveys show that more exposure causes more symptoms (dose-response).”

    Why not: Self-reported product use classifies only 20% correctly on measured exposure. Source: Edwards 2006, Atmospheric Environment Industry-funded

  • “Air fresheners fill your car with benzene and toluene.”

    Why not: Detected in headspace but in-car levels unchanged; road air dominates. Source: Jo 2008, Chemosphere

  • “The 31 mg/m3 chamber level shows what people breathe.”

    Why not: Chamber ~1,000x real in-car levels. Source: Jo 2008, Chemosphere

  • “Air fresheners contain carbon tetrachloride or prednisone.”

    Why not: Library-only misidentifications. Source: Jo 2008, Chemosphere

  • “Cleaning with scented products exposes you to these levels every day.”

    Why not: Heavy-mopping peaks; label-dose 9-34 ppb; homes average 3-7 ppb. Source: Rosales 2022, Science Advances

  • “These particles damage the brain.”

    Why not: Toxicity unknown; no health outcomes measured. Source: Rosales 2022, Science Advances

  • “Indoor air is four times more polluted than outdoor air.”

    Why not: Indoor/outdoor ratios range from ~1 to ~60 by compound; the average is meaningless. Source: Weisel 2002, Environmental Health Perspectives

  • “Indoor chemicals are proven asthma triggers at the levels found in homes.”

    Why not: Chamber effects at 25 mg/m3, far above home levels; home studies confounded by dust mites. Source: Weisel 2002, Environmental Health Perspectives

  • “Chemicals in indoor air are as dangerous as radon or secondhand smoke.”

    Why not: Upper bounds compared with central estimates; like-for-like 5-10x lower. Source: Wallace 1991, Environmental Health Perspectives

  • “Indoor sources cause 80-100% of chemical exposure.”

    Why not: Compound-specific; benzene ~60% indoor. Source: Wallace 1991, Environmental Health Perspectives

  • “Air-freshener fragrance causes cancer.”

    Why not: Carcinogen was p-dichlorobenzene, a non-fragrance active. Source: Wallace 1991, Environmental Health Perspectives

  • “Indoor air is several times more polluted than outdoor air (blanket rule).”

    Why not: Traffic aromatics only 1.2-1.5x indoors; excess is compound-specific. Source: Geiss 2011, Atmospheric Environment

  • “Typical homes reach the terpene levels used in lab chamber studies.”

    Why not: Only top few percent of homes; median 20-60x lower. Source: Geiss 2011, Atmospheric Environment

  • “Cleaning with scented products fills your home with particle pollution (mass).”

    Why not: Particle mass 4-7 ug/m3 at label dose, 5 even without ozone. Source: Rossignol 2013, Atmospheric Environment

  • “One cleaning session creates lab-chamber levels of scent chemicals.”

    Why not: Limonene peaks 9-34 ppb, back to background within ~1 h. Source: Rossignol 2013, Atmospheric Environment

  • “The fragrance is the source of cleaner formaldehyde.”

    Why not: Primary formaldehyde unattributed. Source: Rossignol 2013, Atmospheric Environment

  • “Home air is 290 times more polluted than outdoor air.”

    Why not: Limonene-only ratio; benzene ~1.5; ratios compound-specific. Source: Gokhale 2008, Science of the Total Environment

  • “Home limonene levels are high enough to cause irritation or lab-study chemistry.”

    Why not: Weekly mean ~2.6 ppb, 5-10x below chamber conditions. Source: Gokhale 2008, Science of the Total Environment

  • “Most toluene exposure comes from household products.”

    Why not: Conflicts with larger traffic-attribution studies; products not measured. Source: Gokhale 2008, Science of the Total Environment

  • “Indoor air in Europe carries cancer risks up to 1,000 times the acceptable level.”

    Why not: Rests on moth-ball naphthalene in n=42 Athens homes; formaldehyde ~10^-4 is the robust figure. Source: Sarigiannis 2011, Environment International

  • “Fragranced products cause Europe's indoor formaldehyde problem.”

    Why not: Formaldehyde attributed mainly to building materials; secondary formation not modeled. Source: Sarigiannis 2011, Environment International

  • “Limonene and pinene in homes are a health risk (or: are proven harmless).”

    Why not: Parent compounds within margins; oxidation products and peaks not assessed. Source: Sarigiannis 2011, Environment International

  • “These are the levels of reactive particles in your home.”

    Why not: Chamber 32-102 ppb limonene vs ~3-7 ppb typical measured personal exposure. Source: Chen & Hopke 2010, Indoor Air

  • “This proves scented cleaners harm your lungs.”

    Why not: No people, no health outcome, no dose-response measured. Source: Chen & Hopke 2010, Indoor Air

  • “One spray of perfume makes indoor air 3× more polluted than city air.”

    Why not: The 3× compares a transient PM1 peak with Zürich's annual mean, at 35–40 ppb ozone (above typical indoor levels); at lower ozone/higher ventilation PM1 fell by >50%. Source: Wu 2024, Environmental Science & Technology Letters

  • “The particles formed from scented personal-care products are proven to damage the lungs.”

    Why not: No toxicity, deposited dose or health outcome was measured; the lung-damage statement is a citation of other studies. Source: Wu 2024, Environmental Science & Technology Letters

  • “Perfume releases dangerous levels of alcohol into the room.”

    Why not: Ethanol peaked at 2–4 ppm, several hundred times below the 1,000 ppm occupational short-term limit. Source: Wu 2024, Environmental Science & Technology Letters

  • “Personal care products release over 200 toxic chemicals.”

    Why not: >200 is a count of instrument-detected VOCs, not of hazardous ones; counts depend on detection limits. Source: Wu 2024, Environmental Science & Technology Letters

  • “Scented personal care products are a major source of indoor siloxanes.”

    Why not: None of the five fragranced PCPs tested emitted any cyclic methyl siloxane; siloxanes come from silicone-containing products. Source: Wu 2024, Environmental Science & Technology Letters

  • “Fragrance-free products don't pollute indoor air.”

    Why not: The fragrance-free lotion in Wang 2024 was the largest single VOC emitter (preservative) and its plant oils made aldehydes with ozone. Source: Wang 2024, Environmental Science & Technology

  • “4-oxopentanal or 6-MHO in indoor air shows that fragranced cleaners are reacting with ozone.”

    Why not: People make both from skin squalene and ozone; in occupied rooms they are not product-specific markers. Source: Wang 2024, Environmental Science & Technology

  • “Showering less makes indoor air toxic.”

    Why not: The study measured chemistry and odorous acids, not health effects, in 4 young men at ozone 6–9× typical indoor levels. Source: Wang 2024, Environmental Science & Technology

  • “Skin lotion protects you from indoor ozone.”

    Why not: Lotion lowered squalene-product yields but raised aldehydes; total ozone uptake was unchanged. Source: Wang 2024, Environmental Science & Technology

  • “Your shampoo and shower gel pollute the air like traffic.”

    Why not: The authors' own UK estimate for these products is ~0.4 kt/yr against 807 kt total VOC; large 'consumer product' totals (McDonald 2018) include aerosols, paints, inks and glues. Source: Yeoman 2020, Indoor Air

  • “Showering with scented products gives you dangerous formaldehyde levels.”

    Why not: The +~4 ppb (about 5 µg/m³) is modeled, lasts about an hour, and is far below the WHO 100 µg/m³ short-term guideline. Source: Yeoman 2020, Indoor Air

  • “Bathroom air reaches 375 ppb limonene after every shower.”

    Why not: 375 ppb is a model result; the one measured person ranged 80–380 ppb depending on amount used, and 'limonene' is the sum of all monoterpenes. Source: Yeoman 2020, Indoor Air

  • “Shampoo and shower gel release lots of alcohol vapor.”

    Why not: Ethanol was a minor emission from these non-aerosol products; ethanol dominates perfumes and sprays, which this study excluded. Source: Yeoman 2020, Indoor Air

  • “Fragrance chemicals in office air reach irritating levels.”

    Why not: This review puts typical office VOCs at least 100× below human irritation thresholds; the concern is odor and oxidation products. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Scented-product particles (SOA) are proven to damage the airways.”

    Why not: Wolkoff 2013 finds the gas-phase products, not SOA, responsible for irritation, and a 3-h lime-oil + ozone SOA exposure had no effect in 22 women; particle ROS data are mechanistic only. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Limonene in office air is protective (or, from the same study, proven harmful).”

    Why not: The BASE association (Apte 2008) is indirect: limonene was measured, its oxidation products were not. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Fragrance causes asthma.”

    Why not: The toxicology review says fragrances are not considered to cause asthma; our evidence supports exacerbation and non-allergic reactivity, and surveillance new-onset cases are unconfirmed by challenge. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Air-freshener sprays cause measurable airway changes in asthmatics.”

    Why not: In the one challenge study cited (Opiekun 2003; 164 asthmatics), moderate asthmatics reported more nasal congestion but ocular redness, nasal swelling and FEV1 were unchanged. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Office formaldehyde is above the sensory-irritation threshold in most buildings.”

    Why not: The same Salonen 2009 study is cited both ways; the answer depends on whether an assessment-factor-divided value (~25 µg/m³) or a human LOAEL (~400–600 µg/m³) is used. Source: Wolkoff 2013, International Journal of Hygiene and Environmental Health

  • “Your body turns perfume into toxic chemicals.”

    Why not: The study deliberately excluded scented products; no fragrance chemistry, toxicity or health effect was measured. Occupant OH acting on fragrance terpenes is a our inference only. Source: Zannoni 2022, Science

  • “People create high OH radical levels indoors everywhere.”

    Why not: The headline value needs 35 ppb indoor ozone with brisk ventilation; at the typical ~5 ppb the authors' own model gives ~3×10⁴ cm⁻³, below a light-driven value the paper calls small. Source: Zannoni 2022, Science

  • “A fragrance-free home has no indoor air chemistry.”

    Why not: Occupants plus ozone produce OH and oxidation products (6-MHO, 4-oxopentanal, methacrolein) with no products present; fragrance adds terpenes on top, it is not the only source. Source: Zannoni 2022, Science

  • “Hair dye or nail polish releases dangerous formaldehyde levels (over 1 ppm).”

    Why not: The consumer monitor's formaldehyde channel also rose with pure acetone, which contains none; the paper's two figures of the same test disagree up to 11×. Source: Grigoryants 2025, Cureus

  • “Salon ventilation doesn't work; you need an air purifier.”

    Why not: The exhaust fan was tested in a sealed room where it could not draw its rated air; no salon was studied. Source: Grigoryants 2025, Cureus

  • “An air purifier removes salon chemicals within a minute.”

    Why not: 7.6 m³ box at ~53 air changes/h; in a real salon the same unit gives a fraction of that, and plain activated carbon captures acetone and formaldehyde poorly. Source: Grigoryants 2025, Cureus

  • “Using nail polish remover at home exceeds safety limits.”

    Why not: Even 1 mL of acetone fully evaporated into this 7.6 m³ room gives ~43 ppm, below NIOSH (250 ppm) and OSHA (1,000 ppm) limits. Source: Grigoryants 2025, Cureus

  • “This study shows fragranced hair and nail products pollute indoor air.”

    Why not: The paper never mentions fragrance and did not characterize any product's ingredients. Source: Grigoryants 2025, Cureus

  • “Scented-product and ozone chemistry is proven to cause symptoms in people.”

    Why not: The largest human test (n = 130, 140 µg/m³ particles, 40 µg/m³ formaldehyde) found no significant acute effect in healthy women. Source: Fiedler 2005, Environmental Health Perspectives

  • “This study proves indoor chemical and ozone reactions are harmless.”

    Why not: Asthma and MCS were excluded; single short exposure; no repeated-exposure, blink-rate or cardiovascular endpoints. Source: Fiedler 2005, Environmental Health Perspectives

  • “Office-air complaints are really just stress.”

    Why not: Stress raised anxiety and cortisol but not irritation or respiratory symptoms, and did not interact with the chemicals. Source: Fiedler 2005, Environmental Health Perspectives

  • “VOC mixtures at 25 mg/m³ cause airway inflammation.”

    Why not: A 26 mg/m³ mixture gave no symptom, lung-function or nasal-inflammation change in 130 women; positive studies were small and in other populations. Source: Fiedler 2005, Environmental Health Perspectives

  • “Hot, humid weather makes your body pollute the air far more.”

    Why not: Temperature and humidity explained only 2.5–3% each of the variation in Zannoni 2021; the paper's own totals conflict (41 → 63 s⁻¹ in the text vs 32 → 40 in Figure 4), and what rose most was ammonia, not reactive carbonyls. Source: Zannoni 2021, Environmental Science & Technology

  • “Long sleeves protect you from indoor ozone chemistry.”

    Why not: Worn clothing reacted with ozone about as fast as skin; long clothing lowered occupant OH reactivity by only ~15–20%, and no exposure or health effect was measured. Source: Zannoni 2021, Environmental Science & Technology

  • “4-oxopentanal and 6-MHO from skin are proven respiratory irritants at indoor levels.”

    Why not: Zannoni 2021 cites other work for irritancy and measured no health endpoint; concentrations were a few ppb in a chamber at ~35 ppb ozone. Source: Zannoni 2021, Environmental Science & Technology

  • “Plug-in air fresheners turn 90% of the ozone they meet into formaldehyde.”

    Why not: The 90% figure occurred in one condition (1 ach, moderate ozone) with air-freshener vapor levels 30-45x what the same plug-in produces in a real room; most bench conditions gave 29-38%. Source: Destaillats 2006, Environmental Science & Technology

  • “These lab chamber formaldehyde and particle levels are what you actually breathe at home when using scented cleaners or air fresheners.”

    Why not: The chamber ran at hundreds of ppb of terpenes and up to 250 ppb supply ozone; in a real 50 m3 room the same three products gave only +6 to +16 ppb formaldehyde (Singer 2006). Source: Destaillats 2006, Environmental Science & Technology

  • “Scented cleaning products and air fresheners make ultrafine particles with a 4-16% yield.”

    Why not: 4-16% is the paper's total SOA mass yield (all particle sizes); ultrafine particles were only 1-4% of the mass at steady state. The paper's own Significance section mislabels this. Source: Destaillats 2006, Environmental Science & Technology

  • “Cleaning products push 2-butoxyethanol above safety limits.”

    Why not: Measured 1-h levels (up to 2,300 ug/m3) were below California's acute REL (14 mg/m3); only the authors' small-apartment model (~7 mg/m3) and heavier use or a closed bathroom approach it. Source: Singer 2006, Indoor Air, Indoor Air

  • “Cleaning with full-strength cleaner gave 6,000 ug/m3 of 2-butoxyethanol.”

    Why not: That is the abstract's lumped range; the 6,200 ug/m3 figure is limonene from dilute floor mopping, and full-strength 2-BE peaked at 2,300 ug/m3 (abstract vs Results) Source: Singer 2006, Indoor Air, Indoor Air

  • “The solvent in a scented cleaner always exceeds the scent.”

    Why not: True for one French cleaner (Rossignol 2013, solvent 16x scent); reversed for the one product here with both a glycol ether and limonene (scent 3-5x solvent) Source: Singer 2006, Indoor Air, Indoor Air

  • “Diluting your cleaner cuts what you breathe.”

    Why not: Dilute mopping emitted a smaller fraction of each gram (2-11% vs 25-130%), but the room still reached 1-h concentrations as high as or higher than full-strength counter cleaning because mopping covers more surface per room volume. Source: Singer 2006, Indoor Air, Indoor Air

  • “Older people or teenagers pollute indoor air differently from young adults.”

    Why not: The paper found only small, largely unexplained differences between age groups in the skin-ozone reaction products, smaller than the natural day-to-day variation within one group. Source: Bekö 2020, Indoor Air

  • “Breath chemicals measured from people are a reliable indoor air marker.”

    Why not: The paper explicitly found breath compounds (acetone, isoprene) far less repeatable than skin-oil compounds, undermining their use as precise indoor markers. Source: Bekö 2020, Indoor Air

  • “This study shows what a real commuter actually breathes from a car air freshener plus ozone.”

    Why not: The 100 ppb ozone condition is above every in-car ozone value the paper itself cites (2-86 ppb); humidity and ventilation were excluded from the chamber; the authors state their own results 'might be overestimated' and are 'not intended as direct representations of specific ambient conditions'. Source: Lamorena & Lee 2008, Journal of Hazardous Materials

  • “Hot cars always make air-freshener secondary pollution worse.”

    Why not: Raising the chamber from 30C to 40C cut peak particle mass 4-6x (19.1-24.1 to 3.80 ug/m3) because higher temperature favors the gas phase over particles; some gas-phase carbonyls (acetaldehyde) did rise with temperature, so the total irritant burden shifts composition rather than simply increasing. Source: Lamorena & Lee 2008, Journal of Hazardous Materials

  • “This study proves that ultrafine particles from school cleaning harm children's health.”

    Why not: No symptom, lung-function, or biomarker data were collected in this study; only particle number, chemistry and ozone were measured. It is an exposure-characterization study, not a health-effects study. Source: Morawska 2009, Environmental Science & Technology

  • “The paints and glues used in this school were shown to be safe because the tested samples didn't contain limonene.”

    Why not: Only 4 of roughly 30 art materials in use were tested for limonene, and the largest ultrafine-particle bursts in the entire study occurred during art activities, not cleaning. The other ~26 materials were never tested; the paper itself flags this as an untested gap. Source: Morawska 2009, Environmental Science & Technology

  • “This proves that limonene-scented cleaning products and air fresheners irritate your eyes at home.”

    Why not: The exposure was local (one eye via a sealed eyepiece), not a room; the limonene concentrations used (220 ppb starting, 75 ppb residual) are, by the authors' own admission, one to two orders of magnitude above typical indoor levels; and a larger whole-body study at an even higher limonene dose (Fiedler 2005, 130 women) found no eye-irritation symptom increase. Source: Klenø & Wolkoff 2004

  • “It's the ultrafine particles from limonene-ozone reactions that irritate the eyes.”

    Why not: Ultrafine particle counts were negligible (<30 particles/cm3, detection limit 2/cm3) in every mixture tested; the authors attribute the effect entirely to gas-phase oxidation products, not particles. Source: Klenø & Wolkoff 2004

  • “Ozone alone irritates the eyes.”

    Why not: Blink frequency was completely flat for ozone alone (0% change, P=0.98), even though half the subjects subjectively reported some irritation from it — a sign/symptom mismatch, not evidence that ozone itself raises blink rate. Source: Klenø & Wolkoff 2004

  • “More limonene-ozone reaction extent or concentration means worse eye irritation (a clean dose-response).”

    Why not: The paper explicitly found no dose-response relationship across its four LOPs concentrations (R2=0.7, not significant); a higher concentration (LOPs II) did not produce a significantly bigger blink-frequency increase than a lower one (LOPs I), while the highest-reaction-extent mixture (LOPs III) gave the largest effect out of proportion to its concentration. Source: Nøjgaard 2005, Toxicology Letters

  • “The 0.23 mg/m3 limonene + 0.08 mg/m3 ozone blink-frequency LOEL is a well-replicated, precise threshold for eye irritation.”

    Why not: It is a single LOEL from a 10-man, single-lab, single-eye study. This same lab's own nominally comparable re-test of an earlier exposure (Klenø & Wolkoff 2004) at nearly identical residual concentrations found a 3.5-fold smaller effect (12% vs 42%) than the original — genuine same-lab magnitude instability, not independent replication. Source: Nøjgaard 2005, Toxicology Letters

  • “This limonene-ozone eye-irritation finding generalizes to women or the general population.”

    Why not: Women were excluded from this study specifically because they are expected to be more sensitive to eye irritation than men, meaning real-world, mixed-sex sensitivity is plausibly understated here, not overstated; the study explicitly says it is not representative of typical office workers. Source: Nøjgaard 2005, Toxicology Letters

  • “Fragrance chemicals in indoor air are proven safe.”

    Why not: This review covers only four fragrances and two reaction systems, explicitly says its conclusions do not extend to other fragrances, and does not address chronic exposure or sensitive subgroups. Source: Wolkoff & Nielsen 2017, Environment International

  • “This review proves fragranced cleaning products don't cause asthma.”

    Why not: The authors say the fragrance component specifically is not established as causative among cleaners with work-related asthma, but explicitly call the true causative agent(s) still unidentified, and flag aggressive chemicals like bleach as more strongly implicated. Source: Wolkoff & Nielsen 2017, Environment International

  • “Ozone plus fragrance terpenes definitely doesn't cause airway effects.”

    Why not: The authors' own threshold (>200 µg/m3 ozone at high limonene) is a specific dose below which effects are not expected in the studies they reviewed, not a general safety finding, and it does not cover repeated exposure, susceptible groups, or terpenes other than limonene and alpha-pinene. Source: Wolkoff & Nielsen 2017, Environment International

  • “The specific numbers in this review (the 4-oxopentanal bronchoconstriction reference value, the Fiedler 2005 ozone/formaldehyde figures) are reliable exactly as given.”

    Why not: Both are flagged in our evidence base as needing verification against their cited primaries; the Fiedler 2005 ozone/formaldehyde pair in this review appears transposed relative to the primary study's own Table 2. Source: Wolkoff & Nielsen 2017, Environment International

  • “Typical homes or offices currently exceed a demonstrated harm threshold for 4-OPA or the other ozone-terpene reaction products this study tested.”

    Why not: The paper's own conclusion is the opposite — measured real-world 4-OPA and 6-MHO levels sit at hazard indices of 0.3 or less against the derived reference values, i.e. below them, not above. Source: Wolkoff et al. 2012/2013, Toxicology Letters

  • “4-OPA and other ozone-terpene reaction products have been shown to cause health effects in humans at real indoor concentrations.”

    Why not: This paper contains no human exposure or epidemiology data at all — the reference values are extrapolated from 60-minute, ppm-range mouse exposures (three to five orders of magnitude above measured indoor levels) using standard assessment factors, not observed at ppb concentrations in any species. Source: Wolkoff et al. 2012/2013, Toxicology Letters

  • “This UK home study proves fragrance chemicals turn into formaldehyde in your home.”

    Why not: The paper calculates a formaldehyde-formation potential from a published oxidation yield; it does not measure the ozonolysis reaction itself, and its own parallel formaldehyde measurements track occupant behavior generally, not an isolated monoterpene-oxidation signal (formaldehyde has other indoor sources) Source: Wang 2017, Environmental Science: Processes & Impacts

  • “Most UK homes reach the extreme scent-chemical levels found in this study.”

    Why not: The 1,439 ug/m3 figure was one home out of 25, explicitly reported by the authors as an outlier; the median UK home was far lower. Source: Wang 2017, Environmental Science: Processes & Impacts

  • “This study measured short-term exposure peaks from cleaning and fragrance products.”

    Why not: Everything reported is a 5-day (or longer) time-average; the authors state short-term transient concentrations were likely much higher and were not captured by this canister method. Source: Wang 2017, Environmental Science: Processes & Impacts

  • “This proves cleaning products and fragrances cause the highest indoor VOC levels.”

    Why not: Cumulative frequency of use of all 13 tracked VOC-containing product categories, including cleaning sprays and fragrances, had no significant relationship with total or individual VOC concentrations (R-squared<0.001); the highest-VOC homes were linked to aerosol-propellant hydrocarbons, not to reported product-use frequency. Source: Heeley-Hill 2021, Environmental Science: Processes & Impacts Industry-funded

  • “Scented candles or plug-in air fresheners are the main source of VOCs in UK homes.”

    Why not: Candles showed no distinguishing concentration link in this study; plug-in air fresheners showed only a weak covariance with limonene specifically (alongside insecticides), not with total VOC burden, and n-butane (not a fragrance compound) was the dominant VOC overall. Source: Heeley-Hill 2021, Environmental Science: Processes & Impacts Industry-funded

  • “This 60-home Ashford cohort represents typical UK or global indoor air.”

    Why not: One town's panel-recruited sample; self-reported product use was not validated against actual formulation or dose, and no ventilation or air-exchange data were collected; the authors scope their own conclusions to UK habits, products and behavior. Source: Heeley-Hill 2021, Environmental Science: Processes & Impacts Industry-funded

  • “This mouse study proves fine particles from scented cleaners and air fresheners are harmless to breathe.”

    Why not: Tests only acute sensory/airflow-limitation reflexes in mice at a single particle mass (~10 mg/m3, itself far above real indoor SOA mass); does not test chronic exposure, lower-airway inflammation, cardiovascular endpoints, particle-bound ROS specifically, or humans. See C155. Source: Wolkoff et al. 2008, Toxicology Letters

  • “This study shows exactly which chemical causes the lower-airway (conducting-airway) irritation from ozone-limonene mixtures.”

    Why not: The paper's own dose-response modeling covers only the upper-airway/sensory-irritation endpoint (respiratory frequency, time-of-brake); the conducting-airway (VD/VT, airflow-limitation) effect's causal chemical is explicitly stated as unidentified, with only an untested speculation (limonene's secondary endo-ozonide) offered. Source: Wolkoff et al. 2008, Toxicology Letters

  • “This study proves that switching to fragrance-free laundry products cuts hazardous air pollutants like acetaldehyde and benzene from dryer vents.”

    Why not: The study measured D-limonene only; no acetaldehyde, benzene or other HAP data were collected at the vent. The HAP/carcinogen claims belong to a different, smaller study (Steinemann 2013) with its own no-product-control problems. Source: Goodman 2019, Air Quality, Atmosphere & Health

  • “An independent study confirmed Steinemann's dryer-vent emission findings.”

    Why not: Anne Steinemann co-authored both the 2013 study and this one; it is a within-program follow-up with a stronger design, not an outside lab's independent replication. Source: Goodman 2019, Air Quality, Atmosphere & Health

  • “Switching to fragrance-free laundry products protects your neighbors from dryer-vent exposure.”

    Why not: Nothing was measured beyond the dryer's vent outlet (~200 mm from the duct exit, undiluted source air) in either dryer-vent study; no downwind or neighbor dose has ever been measured for this exposure pathway. Source: Goodman 2019, Air Quality, Atmosphere & Health

Skin allergy (60)
  • “175 fragrance ingredients cause allergies.”

    Why not: 175 sums all SCCS categories incl. possible and animal-only; 82 established in humans. Source: Kumar 2020, Journal of Cosmetic Dermatology

  • “658 patients were allergic to fragrance.”

    Why not: 658 were tested; 67 (10.2%) reacted. Source: Kumar 2020, Journal of Cosmetic Dermatology

  • “13% of people are allergic to fragrance.”

    Why not: Apparent typo for 1-3%; European general-population estimates are 1-4.5%. Source: Kumar 2020, Journal of Cosmetic Dermatology

  • “1.3% of people are allergic to oxidized linalool.”

    Why not: Consecutive dermatitis patients, not the public. Source: Matura 2005, Contact Dermatitis

  • “Limonene and linalool are allergens.”

    Why not: Pure compounds non-sensitizing; the air-oxidation products are the allergens. Source: Matura 2005, Contact Dermatitis

  • “Up to 5% of people are allergic to oxidized limonene.”

    Why not: Clinic dermatitis patients, not the general public. Source: Karlberg 2013, Contact Dermatitis

  • “Limonene and linalool themselves are strong allergens.”

    Why not: Pure parents are weak sensitizers; oxidation products drive allergy. Source: Karlberg 2013, Contact Dermatitis

  • “One in three people is allergic to fragrance.”

    Why not: Confirmed allergy ~4.5%; 32% is self-reported symptoms. Source: Sukakul 2024, Acta Dermato-Venereologica Industry-funded

  • “EU labels now list every fragrance ingredient.”

    Why not: Only 56 named allergens above thresholds. Source: Sukakul 2024, Acta Dermato-Venereologica Industry-funded

  • “The European fragrance allergy rate is settled at 1-3% (or at 4.5%).”

    Why not: Estimates differ by test markers and era. Source: Sukakul 2024, Acta Dermato-Venereologica Industry-funded

  • “5-7% of people are allergic to limonene or linalool.”

    Why not: Rates are in referred dermatitis patients. Source: Bråred Christensson 2016, Contact Dermatitis Industry-funded

  • “Limonene itself is a skin allergen.”

    Why not: Parent compound near-inert; oxidation products are the allergens. Source: Bråred Christensson 2016, Contact Dermatitis Industry-funded

  • “7% of people are allergic to linalool.”

    Why not: Patients being tested for dermatitis; general-population fragrance allergy 1-4.5%. Source: Christensson 2012, Contact Dermatitis

  • “Linalool is an allergen.”

    Why not: Pure linalool non- or very weakly allergenic; oxidation products are the allergens. Source: Christensson 2012, Contact Dermatitis

  • “Limonene is a skin irritant.”

    Why not: Pure limonene non-irritant at 5-40%; only oxidized limonene irritates. Source: Bråred Christensson 2009, Contact Dermatitis Industry-funded

  • “Scented products irritate skin at normal use.”

    Why not: Tested at 2.5-40%, far above product levels. Source: Bråred Christensson 2009, Contact Dermatitis Industry-funded

  • “Up to 1 in 5 people are allergic to linalool.”

    Why not: Rates are from patch-tested dermatitis patients. Source: Ogueta 2022, Contact Dermatitis

  • “Limonene and linalool are allergens (without saying once oxidized).”

    Why not: Fresh compounds 0-0.88% positive. Source: Ogueta 2022, Contact Dermatitis

  • “Fragrance chemicals destroy skin cells.”

    Why not: Non-cytotoxic dose used; ferroptosis link indirect. Source: Moore 2025, Contact Dermatitis

  • “Fresh limonene or linalool damages skin cells.”

    Why not: Only hydroperoxides tested. Source: Moore 2025, Contact Dermatitis

  • “Linalool itself is a strong skin allergen.”

    Why not: Mechanism concerns the oxidized form. Source: Kuresepi 2020, Chemical Research in Toxicology

  • “Scented products damage your skin cells.”

    Why not: In vitro at up to 50 mM with Fenton iron; no human exposure data. Source: Moore 2025, Contact Dermatitis

  • “Limonene damages skin.”

    Why not: Effect is from the hydroperoxide oxidation product, not fresh limonene. Source: Moore 2025, Contact Dermatitis

  • “Nearly 1 in 10 people is allergic to fragrance chemicals.”

    Why not: Dermatitis clinic patients; general-population patch-test estimates are 1-4.5%. Source: Sukakul 2022, Contact Dermatitis

  • “Limonene and linalool cause allergy.”

    Why not: The air-oxidized hydroperoxides sensitize; fresh parent chemicals are weak. Source: Sukakul 2022, Contact Dermatitis

  • “Citrus and lavender scents are allergens.”

    Why not: The fresh parent terpenes are weak; the oxidation products sensitize. Source: Karlberg & Lepoittevin 2021, Contact Dermatitis

  • “Cinnamal causes cancer or is toxic when absorbed through the skin.”

    Why not: 2-year NTP feeding negative for carcinogenicity; systemic dermal exposure thousands of times below the NOAEL; the hazard is skin allergy and eye irritation. Source: RIFM Expert Panel 2005, Food and Chemical Toxicology Industry-funded

  • “15% of people become allergic to cinnamyl alcohol.”

    Why not: 79/527 was at 10% under exaggerated maximization testing, 25x the permitted 0.4%. Source: RIFM Expert Panel 2005, Food and Chemical Toxicology Industry-funded

  • “3.5% of Europeans are allergic to fragrance (as a settled rate).”

    Why not: Pooled FM I across 1966-2017; EDEN 2008-11 gave 1.8-2.6% for FM I and 0.8-1.9% clinically relevant fragrance allergy. Source: Alinaghi 2018, Contact Dermatitis

  • “1 in 5 people are allergic to fragrance.”

    Why not: The 20% is any contact allergen, mostly nickel; fragrance markers are 1.8-3.5% each. Source: Alinaghi 2018, Contact Dermatitis

  • “Fragrance allergy is rising in the general population.”

    Why not: This meta-analysis has no fragrance time trend; overall contact allergy was lower in post-2007 studies; rising trends are clinic data for oxidized terpenes. Source: Alinaghi 2018, Contact Dermatitis

  • “Lavender oil is a strong allergen / forms strong allergens.”

    Why not: Oxidized oil reached only moderate mouse potency (EC3 4.4% after 45 weeks; fresh 36% = weak); 'strong' in Hagvall 2008's title refers to the purified hydroperoxides. Source: Hagvall 2008, Contact Dermatitis Industry-funded

  • “Your lavender oil becomes allergenic within weeks of opening.”

    Why not: Oils were left neat in open lab flasks; oxidation in a capped consumer bottle, often with added antioxidant, was not measured. Source: Hagvall 2008, Contact Dermatitis Industry-funded

  • “Oxidized lavender oil makes people allergic.”

    Why not: Human data are elicitation in 4 already-sensitized patients, with no fresh-oil comparison and no induction data. Source: Hagvall 2008, Contact Dermatitis Industry-funded

  • “Lavender oil's allergen potency halves in air (EC3 11% -> 4.4%).”

    Why not: A misreading of Karlberg 2013; the primary gives fresh 36%, i.e. an ~8-fold rise. Source: Hagvall 2008, Contact Dermatitis Industry-funded

  • “This study proves deodorants with fragrance are unsafe for everyone.”

    Why not: Reactions occurred only in the ~17 patients already allergic to cinnamaldehyde from prior sensitization; the same deodorants caused zero reactions in 20 non-allergic people. This is an elicitation-threshold study in a known-allergic population, not a general safety finding. Source: Bruze et al. 2003, Journal of the American Academy of Dermatology

  • “0.01% cinnamal in a deodorant is a proven safe, irritant-free level.”

    Why not: 0.01% is the lowest concentration tested and it still elicited a reaction in 1 of 9 sensitized patients; the authors state the true no-effect concentration is undetermined and recommend going lower still. Source: Bruze et al. 2003, Journal of the American Academy of Dermatology

  • “Any amount of oxidized linalool causes eczema in allergic people.”

    Why not: The lowest concentration tested (0.1% oxidized linalool in a perfume base, 0.019% hydroperoxides) produced no formal positive reaction in any of the 6 participants, only a weak sub-threshold tendency in one. Source: Andersch Björkman 2014, Contact Dermatitis

  • “This study shows how common oxidized-linalool allergy is in the general population.”

    Why not: Only 6 already patch-test-positive volunteers were tested; this is an elicitation-threshold study, not a prevalence study (see src-2012-air-oxidized-linalool-fragrance-contact-allergy for prevalence, 6.9% of dermatitis patients). Source: Andersch Björkman 2014, Contact Dermatitis

  • “Sensitized people react to as little as 1 ppm of any oxidized fragrance terpene.”

    Why not: The 1 ppm figure is specific to Delta-3-carene in older, narratively-reviewed turpentine literature; the modern limonene-specific primary shows reactions starting around 24-140 ppm, one to two orders of magnitude higher. Source: Bennike 2019, Contact Dermatitis

  • “A doubtful or borderline patch-test reaction to limonene hydroperoxides means you are allergic.”

    Why not: Only 15% of doubtful reactors reacted even to repeated realistic exposure, statistically indistinguishable from non-allergic controls (P=0.36). Source: Bennike 2019, Contact Dermatitis

  • “A product labeled 'fragrance free' for children is free of contact allergens.”

    Why not: 80.8% (42/52) of US pediatric products labeled 'fragrance free' in this 2013 survey contained at least one NACDG-tray contact allergen; 'fragrance free' governs added scent, not the broader set of sensitizing preservatives, surfactants and botanicals (Hamann 2015). Source: Hamann 2015, Journal of Allergy and Clinical Immunology

  • “This 2015 label survey shows that hypoallergenic-marketed baby products actually cause allergic contact dermatitis or worsen atopic dermatitis in children.”

    Why not: Hamann 2015 is an ingredient-label survey only — no patients, patch testing, sensitization outcomes or product-use concentrations were studied; it establishes that labeled allergens are present on the label, not that any child reacted to them. (Duplicates the causal-overstatement point already flagged for Xu 2017's 'hypoallergenic products cause allergies' avoid entry; kept here because the underlying paper and population, pediatric vs adult, differ.) Source: Hamann 2015, Journal of Allergy and Clinical Immunology

  • “The general-population fragrance allergy rate is a settled 4.5%.”

    Why not: This single paper alone reports at least two different ~4% figures with different definitions (4.1% raw marker-positive; 4.5% positive to any single FM I/II ingredient), neither identical to a separately-cited 'six-marker union including colophonium' 4.5% attributed to a different companion paper. Colophonium is not even tested in this study. Source: Diepgen 2015 (EDEN), British Journal of Dermatology Industry-funded

  • “This fragrance-allergy prevalence study is independent, EU-backed evidence.”

    Why not: The study's own funding statement names the Research Institute for Fragrance Materials (RIFM), the fragrance industry's own scientific body, not an EU grant, despite the academic-sounding 'European Dermato-Epidemiology Network' name. Source: Diepgen 2015 (EDEN), British Journal of Dermatology Industry-funded

  • “A positive fragrance patch test means a person currently has allergic contact dermatitis from fragrance.”

    Why not: A patch test measures sensitization only; this study's own clinical-relevance algorithm found only about half of marker-positive people also reported the relevant product avoidance and skin symptoms. Source: Diepgen 2015 (EDEN), British Journal of Dermatology Industry-funded

  • “Limonene, found in 78% of household products, is a major cause of hand-eczema fragrance allergy.”

    Why not: Oxidized limonene (the allergenic form) reacted in only 0.8-0.9% of these hand-eczema patients; parent limonene is not itself an established contact allergen. Citral (4.3%) and hydroxycitronellal (3.0%) were the leading allergens, not limonene. Source: Heydorn 2003, Contact Dermatitis Industry-funded

  • “10.2% of hand-eczema patients reacting to fragrance chemicals means about 1 in 10 people in the general population is allergic to fragrance.”

    Why not: This is a clinic-referred hand-eczema population; general-population fragrance contact allergy is much lower (1.9-4.5% depending on marker set and definition). Source: Heydorn 2003, Contact Dermatitis Industry-funded

  • “This proves fragrance products don't cause skin allergy from oxidized linalool.”

    Why not: The clinical evidence that oxidized linalool causes contact allergy is strong and independent of this paper; this study only shows that two specific product types, as tested, don't appear to deliver much hydroperoxide exposure, and the study's own authors say they don't know where the clinical exposure comes from instead. Source: Kern 2014, Analytical and Bioanalytical Chemistry Industry-funded

  • “Industry testing shows fragrance is safe.”

    Why not: A single industry-funded study of two product categories, not independently replicated; per our grading rule it stays below 'strong' regardless of its result. Source: Kern 2014, Analytical and Bioanalytical Chemistry Industry-funded

  • “Old perfume doesn't need to be thrown away.”

    Why not: The advice to close containers and discard products a year after opening is unproven either way; this paper weakens one assumed mechanism behind it (in-bottle oxidation) for two product types, but does not test whether the advice reduces dermatitis, and doesn't cover creams, lotions or other product types. Source: Kern 2014, Analytical and Bioanalytical Chemistry Industry-funded

  • “42% of people are missed by standard fragrance allergy testing, as a general-population figure.”

    Why not: This is a UK tertiary-referral clinic figure (Mann 2014), not a general-population rate; general-population clinically relevant fragrance allergy is about 1.9% (EDEN/Diepgen 2015). Source: Mann 2014, Contact Dermatitis

  • “Standard fragrance allergy screening reliably misses about 42% of cases everywhere.”

    Why not: A comparably-designed Danish study (Heisterberg 2011) using nearly the same protocol found only 15.6% missed, so the 42% figure does not generalize across clinics without qualification. Source: Mann 2014, Contact Dermatitis

  • “This study shows how much fragrance allergy is missed under real-world, everyday (partly air-oxidized) fragrance exposure.”

    Why not: Mann 2014 deliberately used unoxidized limonene and linalool throughout; the authors themselves note the true miss rate under real-world (partly oxidized) exposure could be even higher, but this was not measured here. Source: Mann 2014, Contact Dermatitis

  • “This study proves oxidized-limonene/linalool skin allergy isn't real or isn't caused by fragranced products.”

    Why not: The clinical allergy is well-established and not in dispute; this study only shows the industry could not chemically confirm where the exposure comes from in the products it tested, including patient-blamed ones. Source: Natsch 2019, Food and Chemical Toxicology Industry-funded

  • “This study proves storage and aging don't matter, so there's no point discarding old fragranced products.”

    Why not: This is the industry's own conclusion for the specific categories and storage conditions tested (fine fragrances, antiperspirants, creams/lotions, up to 6 years at room temperature) and has not been independently replicated by scientists without fragrance-industry funding; essential oils and raw materials are separately known to accumulate hydroperoxide and were not covered by this storage claim. Source: Natsch 2019, Food and Chemical Toxicology Industry-funded

  • “Industry testing proves fragranced products are safe from this allergen.”

    Why not: A single research program (IDEA), funded and staffed almost entirely by fragrance companies and their trade association, is not an independent audit; per our grading rule it cannot move a safety claim to "strong" on its own. Source: Natsch 2019, Food and Chemical Toxicology Industry-funded

  • “Patch testing carries a meaningful anaphylaxis risk, including from fragrance chemicals like cinnamic aldehyde.”

    Why not: Patch-test anaphylaxis occurs in roughly 1 of 100,860 tests; cinnamic aldehyde is among the allergens implicated in reported cases, but this is a rare event and not a reason to avoid diagnostic testing. Source: Aristizabal-Torres 2025, JAAD Reviews

  • “This review's 0.7-2.6% and 11.1% fragrance-allergy prevalence figures are new or independent evidence.”

    Why not: Both numbers trace to studies already in our evidence base (Diepgen 2015 EDEN; NACDG 2019-2020 via Rodriguez 2024), re-cited at second or third hand through an intermediate review (Reeder 2020) rather than independently measured. Source: Aristizabal-Torres 2025, JAAD Reviews

  • “Deep-learning algorithms for reading patch tests are validated, deployed clinical tools.”

    Why not: The cited studies are early-stage (single-arm trials, small comparisons with human readers), two of them sharing co-authors with this review itself, and none are fragrance-specific. Source: Aristizabal-Torres 2025, JAAD Reviews

Green, natural and unscented (43)
  • “Green products grew 79% in two years.”

    Why not: 79% is an average per-store rise; report totals +118%; neither measures the market. Source: Dahl 2010, Environmental Health Perspectives

  • “Greenwashing harms health.”

    Why not: Asserted with environmental examples only; no health data. Source: Dahl 2010, Environmental Health Perspectives

  • “Certified-green cleaners give off fewer harmful chemicals.”

    Why not: Untested; audits check paperwork not chemistry. Source: Dahl 2010, Environmental Health Perspectives

  • “Tampons contain dangerous levels of carcinogens.”

    Why not: Low ng/g levels; tampon cancer risk <1e-6. Source: Lin 2020, Environment International

  • “Fragrance puts benzene and 1,4-dioxane into feminine products.”

    Why not: 1,4-dioxane comes from surfactant base; benzene source unattributed. Source: Lin 2020, Environment International

  • “Perfumers admit token natural ingredients are common practice.”

    Why not: She describes the temptation and advises against it; no frequency data. Source: Ellena 2008, Chemistry & Biodiversity Industry-funded

  • “Ellena 2008 shows how many ingredients a perfume contains / what share is synthetic / how secret formulas are.”

    Why not: The essay contains none of these figures and no mention of trade secrecy. Source: Ellena 2008, Chemistry & Biodiversity Industry-funded

  • “The lavender/tea tree oil concern has been debunked; essential oils are proven safe for children.”

    Why not: The review adds no data, omits ~20 undetailed clinic cases and misreports primaries; the only null survey is small, self-selected and part tea-tree-industry-funded; the essential-oil industry letter itself only argues 'no causal link can be established', reports lavender oil present in one case product, and relocates another case to synthetic fragrance with DEP rather than showing safety. Source: Braunstein & Braunstein 2023, touchREVIEWS in Endocrinology Industry-funded

  • “12.8% of people are allergic to fragrance.”

    Why not: That figure is among patients referred for patch testing; general-population rates for single markers are about 2–3.5%. Source: Rodriguez 2024, Cutis

  • “Standard allergy tests miss 40% of fragrance allergy.”

    Why not: That figure is relative to testing 26 individual fragrance chemicals in one UK clinic; another clinic found about 10% missed by the screening mixes. Source: Rodriguez 2024, Cutis

  • “All 'unscented' products contain fragrance.”

    Why not: The review says 'numerous' products do but gives no survey or count. Source: Rodriguez 2024, Cutis

  • “Essential oils are more allergenic than synthetic fragrance.”

    Why not: 80 of 162 is a count of documented allergens, not a risk comparison. Source: Rodriguez 2024, Cutis

  • “Buying 'fragrance-free' is enough for someone with fragrance allergy.”

    Why not: The review's point is the opposite: the label is not enough, and a checked product list from the dermatologist is needed. Source: Rodriguez 2024, Cutis

  • “Natural cosmetics contain more fragrance allergens than conventional ones.”

    Why not: Klaschka 2016 infers it from where essential oils sit in the ingredient list; nothing was measured and the sample had no conventional comparison group. Source: Klaschka 2016, Environmental Sciences Europe

  • “EU labels hide the fragrance allergens that come from essential oils.”

    Why not: In Klaschka 2016's own sample 58 of 100 products declared allergens as coming from natural sources; the real gap is constituents outside the listed allergens, oxidation products and unverified compliance. Source: Klaschka 2016, Environmental Sciences Europe

  • “Natural cosmetics contain carcinogens.”

    Why not: A few botanical raw materials (rose, nettle extract) carry suspected-CMR statements from notifiers' self-classification; no concentration or exposure assessed; the most-used natural ingredients are unclassified. Source: Klaschka 2016, Environmental Sciences Europe

  • “Natural-brand cosmetics are free of parabens and phthalates.”

    Why not: Klaschka 2016 found none on labels, but chemical analysis found unlisted parabens and phthalates in 'alternative' products (Dodson 2012) Source: Klaschka 2016, Environmental Sciences Europe

  • “Nearly half of fragrance-free products contain hidden fragrance.”

    Why not: The 45% is one product class (body moisturizers) and counts any CAMP fragrance cross-reactor or botanical declared by name; that is neither added scent nor hidden. Source: Xu 2017, JAMA Dermatology

  • “Fragrance-free products are secretly masked with perfume.”

    Why not: Xu 2017 asserts masking in its Discussion but did not measure it, and its citation for the point appears unrelated. Source: Xu 2017, JAMA Dermatology

  • “Hypoallergenic products cause allergies.”

    Why not: The survey shows listed allergens are present, not that users reacted; most users are not sensitized to them. Source: Xu 2017, JAMA Dermatology

  • “Parabens are the worst ingredient in your moisturizer.”

    Why not: Dermatologists (NACDG) rank parabens as the least allergenic common preservative; replacements such as methylisothiazolinone and formaldehyde releasers sensitize more. Source: Xu 2017, JAMA Dermatology

  • “Natural moisturizers are safer for sensitive skin.”

    Why not: The single product with the most allergens (8) was marketed 'all natural', and some plant oils lack efficacy data or may harm the skin barrier. Source: Xu 2017, JAMA Dermatology

  • “One dab of face moisturizer gives you up to 300 times a day's worth of indoor air pollution.”

    Why not: ×339 (ethanol) and ×16 (limonene) are the paper's means over only the products with a measurable dose, not maxima; 9 of 16 products gave no ethanol; the paper's own concentration traces imply much smaller doses; and it compares one compound, not 'pollution'. Source: Yeoman 2022, Indoor Air

  • “Face creams expose you to unsafe levels of limonene.”

    Why not: The largest tabulated dose was ~1.2 mg; the authors found no product exceeded the UK 30-min (90 mg/m³) or 24-h (9 mg/m³) limonene guideline. Source: Yeoman 2022, Indoor Air

  • “Choose green or natural moisturizers to avoid fragrance chemicals.”

    Why not: Green-marketed and regular day moisturizers emitted the same limonene and ethanol (Yeoman 2022); natural origin does not change the molecule. Source: Yeoman 2022, Indoor Air

  • “Headspace tests of a product show how much of it you breathe.”

    Why not: In Yeoman 2022 the top limonene headspace emitter gave zero inhaled limonene at the mannequin's nose, and two high-ethanol products gave zero inhaled ethanol. Source: Yeoman 2022, Indoor Air

  • “'Natural ingredients' cosmetics are essentially allergen-free or hypoallergenic.”

    Why not: This 1996 chemical analysis found the opposite for natural-ingredient perfumes specifically (91% contained at least one known fragrance sensitizer, sometimes at concentrations shown to sensitize humans); even the non-perfume natural cosmetics tested positive over a third of the time. Source: Rastogi 1996, Contact Dermatitis

  • “91% of all natural cosmetics contain a fragrance allergen.”

    Why not: DON'T CLAIM as a category-wide figure: 91% (20/22) applies to natural-ingredient PERFUMES only; the other 20 natural cosmetic products (shampoos, creams, lotions, etc.) in the same study were positive only 35% (7/20) of the time — a review (Pastor-Nieto 2021) collapsed this distinction and has been corrected. Source: Rastogi 1996, Contact Dermatitis

  • “This 1996 chemical analysis describes current 'natural' cosmetic products.”

    Why not: This is a 1996 Danish market snapshot, nearly 30 years old; EU fragrance-allergen labeling rules (the 26 allergens, Directive 2003/15/EC) postdate this study by about a decade, and product reformulation since is not tracked here. Source: Rastogi 1996, Contact Dermatitis

  • “An Allergy UK Seal of Approval / Product Endorsement means a product meets a published fragrance-free or low-fragrance standard.”

    Why not: Fragrance is never mentioned on the page, and no fragrance-specific criterion, ingredient list or test protocol is published there. Source: Allergy UK 2026

  • “Because Allergy UK doesn't publish its endorsement criteria, its Seal of Approval is worthless or the underlying testing is weak.”

    Why not: Absence of published criteria on the public page is not evidence about the rigor of the testing itself, only about what is disclosed; overstating this in either direction is not supported. Source: Allergy UK 2026

  • “Manufacturers pay Allergy UK / Allergy Research Ltd a fee to have their products endorsed.”

    Why not: The page never states a fee or payer; this is a plausible inference from the page's business-enquiry-form structure, not something the source confirms. Source: Allergy UK 2026

  • “EPA Safer Choice fragrance-free certification means the product is odorless.”

    Why not: EPA's own text says certified products 'may still have an odor and not be on the IFRA Transparency List,' since surfactants or solvents can carry an odor. Source: US EPA Safer Choice

  • “EPA lab-tested this product's fragrance content before certifying it fragrance-free.”

    Why not: Nothing in either document describes chemical analysis of the finished product; the review is against declared ingredient lists (SCIL and the IFRA Transparency List), not laboratory testing. Source: US EPA Safer Choice

  • “Any product labeled 'fragrance-free' meets EPA's Safer Choice criteria.”

    Why not: These specific criteria apply only to products that actually carry the EPA Safer Choice fragrance-free notation; an uncertified manufacturer's own 'fragrance-free' claim is governed by no federal rule at all in the US. Source: US EPA Safer Choice

  • “EPA's fragrance-free label proves the excluded fragrance chemicals are unsafe, or that everything left in the product is safe.”

    Why not: EPA's safety basis is the general Safer Choice/SCIL 'safer chemical' screen applied to the whole formulation, not a fragrance-specific or allergenicity-specific risk assessment; the fragrance-free criteria are about chemical identity (is it on the IFRA list) and prior SCIL vetting, not a fresh toxicological judgment. Source: US EPA Safer Choice

  • “Canada requires full fragrance ingredient disclosure on cosmetic labels.”

    Why not: Canada requires disclosure of a growing but still short list of named allergens above a threshold; the rest of any fragrance mixture, and any masking agent not on the allergen list, can still be hidden inside 'parfum'. Source: Health Canada 2026

  • “Canada's fragrance-allergen disclosure rule is already in effect.”

    Why not: As captured (2026-09-27), the first phase-in date (April 12, 2026) had not yet arrived; check the current date against the schedule (April 2026 / August 2026 / August 2028) before saying any part of the rule is currently in force. Source: Health Canada 2026

  • “'Unscented' means a Canadian cosmetic has no fragrance in it.”

    Why not: Health Canada's own guidance says the opposite is legally allowed: an 'unscented' product may contain a masking fragrance added to hide another smell. Source: Health Canada 2026

  • “Health Canada regulates whether 'fragrance-free' or 'unscented' is a truthful marketing claim.”

    Why not: Health Canada explicitly states it does not regulate marketing terms as health/safety claims; the Competition Bureau regulates false or misleading marketing claims under a separate statute. Source: Health Canada 2026

  • “Canada's cosmetic labeling rules cover laundry and other household fabric-care products.”

    Why not: Canada's Food and Drugs Act defines 'cosmetic' as products for the complexion, skin, hair or teeth; laundry products act on fabric and are regulated separately as consumer chemical products, not under these cosmetic labeling rules. Source: Health Canada 2026

  • “The NEA Seal of Acceptance means NEA itself independently lab-tested the product.”

    Why not: NEA reviews manufacturer-submitted test reports from a manufacturer-chosen lab it says it has no relationship with; NEA's own direct checks are ingredient-list review and a physical scent check, not independent safety/sensitization testing. Source: NEA 2026

  • “A product with the NEA Seal of Acceptance is guaranteed to be safe for your eczema.”

    Why not: The page itself states eczema is different for everyone and a product that works for one person may not work for another, or even for the same person over time. Source: NEA 2026

Laws and loopholes (59)
  • “EPA's ingredient database shows what is in our products; pooling brands fills disclosure gaps.”

    Why not: Only disclosed ingredients; aggregation fails for systematic non-disclosure. Source: Goldsmith 2014, Food and Chemical Toxicology

  • “Limonene and other scent chemicals are rare in products because they don't appear in disclosure databases.”

    Why not: Disclosure threshold artifact, not measurement. Source: Goldsmith 2014, Food and Chemical Toxicology

  • “Chemicals missing from product disclosures are only accidental contaminants.”

    Why not: DEP, parabens, DEA are intentional but undisclosed. Source: Goldsmith 2014, Food and Chemical Toxicology

  • “Fragrance chemicals cross into the brain and cause cognitive impairment or mood problems.”

    Why not: Speculative; no direct human evidence presented. Source: Alblooshi 2025, Frontiers in Toxicology

  • “Cosmetics contain up to 1% formaldehyde; lipsticks exceed safe metal levels (quoted from this review).”

    Why not: Table mixes limits with maxima; check primary studies. Source: Alblooshi 2025, Frontiers in Toxicology

  • “Perfumes contain forever chemicals (PFAS).”

    Why not: No US data show it; the "no fragrances" finding is EU (KEMI 2021) data quoted by FDA, and US listings name fragrance as one ingredient, so they cannot exclude PFAS inside a fragrance mixture. Source: FDA 2024, FDA report published under MoCRA §3506(b) (FDA website)

  • “PFAS are widespread in cosmetics.”

    Why not: 0.41% of US listed products (FDA Dec 2025), higher in eye/face makeup; disclosure-based figure. Source: FDA 2024, FDA report published under MoCRA §3506(b) (FDA website)

  • “Fragrance causes ADHD or lowers children's IQ.”

    Why not: Human studies measured urinary phthalates from all sources, not fragrance. Source: Pinkas 2017, Environmental Research

  • “Fragrance chemicals are proven neurotoxins.”

    Why not: Terpene data mostly show drug-like or protective effects at high doses; chronic low-dose effects unknown. Source: Pinkas 2017, Environmental Research

  • “Microplastics in makeup cause skin cancer or premature aging.”

    Why not: Cancer data are carcinoma cell lines at 0.25–1.0 mg/mL (the same study found normal skin cells grew less); aging data are cell lines, bronchial cells and mice; no human skin outcome data. Source: Han & Kim 2025, Cosmetics

  • “Microplastics disrupt your skin microbiome.”

    Why not: Every microbiome datum in the review is from the gut (mice, fish, an in vitro gut model); skin dysbiosis is explicitly 'hypothesized'. Source: Han & Kim 2025, Cosmetics

  • “Microplastics in cosmetics soak through your skin into your body.”

    Why not: Confirmed and sharpened by a second, independent review (Menichetti et al. 2025, J Xenobiot): a general literature synthesis puts the ceiling for crossing an intact Stratum Corneum around 100 nm, and the only ex vivo intact human and mouse skin data behind this claim (Song 2024, cited by both reviews) restricted any penetration to particles under 1 µm. A separate ex vivo test with the Stratum Corneum surgically removed (Martin et al. 2024) showed substantially more penetration of 100–500 nm particles once that barrier was gone — confirming the barrier, not the particle, is what usually blocks this route on healthy skin. Still no measured human dermal dose from real cosmetic use in either review. Source: Han & Kim 2025, Cosmetics

  • “Microbeads are banned, so cosmetics are now plastic-free.”

    Why not: Most bans are rinse-off only; leave-on color cosmetics still commonly contain microplastics and definitions exclude several polymer types. Source: Han & Kim 2025, Cosmetics

  • “Biodegradable PLA packaging breaks down within 6-12 months.”

    Why not: The figure comes from idealized lab/industrial-composting conditions; the authors concede real-world rates are unknown and that biodegradable polymers may fragment into nanoplastics. Source: Han & Kim 2025, Cosmetics

  • “87% of cosmetics contain microplastics.”

    Why not: It is an NGO count of products from major European brands with an unstated definition, not all cosmetics worldwide. Source: Han & Kim 2025, Cosmetics

  • “Reading labels cuts hormone-disruptor exposure by 27-45%.”

    Why not: HERMOSA gave girls pre-screened products; it did not test consumer label reading, and ethyl/butyl paraben rose. Say 'switching to pre-screened products'. Source: Khalid & Abdollahi 2021, Iranian Journal of Pharmaceutical Research

  • “Personal care products and sunscreens emit hazardous air pollutants that are never on the label.”

    Why not: The HAP study (Steinemann 2009) tested air fresheners and laundry products, and its HAPs came mostly from the base formula, not fragrance. Source: Khalid & Abdollahi 2021, Iranian Journal of Pharmaceutical Research

  • “Product labels never list fragrance.”

    Why not: Most fragranced products do say 'fragrance'; what is missing is what the fragrance contains (Dodson 2012: 22/34 fragrance-positive composites listed it). Source: Khalid & Abdollahi 2021, Iranian Journal of Pharmaceutical Research

  • “Science has confirmed serious harm from personal care product chemicals.”

    Why not: The review's conclusion says 'confirmed', but its own body text calls most associations preliminary; its table mixes single cohort studies, case reports and cell studies. Source: Khalid & Abdollahi 2021, Iranian Journal of Pharmaceutical Research

  • “Triclosan in sunlight turns into dioxins (citing Khalid & Abdollahi 2021).”

    Why not: The review never mentions dioxins; that route comes from primary photochemistry studies not in our evidence base. Source: Khalid & Abdollahi 2021, Iranian Journal of Pharmaceutical Research

  • “Fragrance is as dangerous as secondhand smoke.”

    Why not: The paper's analogy is about policy history and involuntary exposure; secondhand smoke causes cancer and heart disease on epidemiological evidence, and nothing comparable exists for fragrance. The shared part is airway irritation (TRPA1). Source: De Vader & Barker 2009

  • “Secondhand smoke has 4,000 chemicals and fragranced products about 100, both with carcinogens that have no safe exposure level.”

    Why not: A chemical count is not a dose; the fragrance 'carcinogens' were in 4 of 6 products (not 5) and mostly came from the non-fragrance base. Source: De Vader & Barker 2009

  • “15.9% of Americans are chemically hypersensitive (Steinemann 2004).”

    Why not: Misattributed: 15.9% appears to be a California figure (Kreutzer 1999); the cited study reported 12.6%. Verify against primaries. Source: De Vader & Barker 2009

  • “OSHA requires employers to take every reasonable precaution against fragrance exposure.”

    Why not: The quoted wording is Ontario's Occupational Health and Safety Act; US OSHA has no fragrance standard and its general duty clause covers hazards likely to cause death or serious physical harm. Source: De Vader & Barker 2009

  • “Fragrance-free workplaces are proven to improve health and save money.”

    Why not: Asserted in 2009 without data; the only figure is an unsourced perfume-sales drop; no before/after study exists. Source: De Vader & Barker 2009

  • “The fragrance industry is copying the tobacco industry's playbook.”

    Why not: The paper's only evidence is a 1999 Canadian cosmetics-association pamphlet on how to wear scent and an unsourced sales anecdote; no industry documents. Source: De Vader & Barker 2009

  • “MoCRA requires companies to disclose their fragrance ingredients / ended the fragrance trade secret.”

    Why not: Only FDA-designated allergens go on labels; FDA's own access is event-triggered, 'categories' suffice, and it is FOIA-exempt; Sec. 3503(c) protects trade secrets. Source: MoCRA 2022

  • “MoCRA banned formaldehyde, talc, PFAS or animal testing in cosmetics.”

    Why not: No formaldehyde provision; talc = asbestos test-method rule only; PFAS = a report; animal testing = non-binding sense of Congress. Source: MoCRA 2022

  • “Small businesses are exempt from MoCRA.”

    Why not: <$1M firms are exempt only from GMP and registration/listing (§612), and not at all for eye-area, injected, internal or >24-hour products; AE reporting, safety substantiation, labeling and recall still apply. Source: MoCRA 2022

  • “Under MoCRA the FDA now approves or reviews cosmetic safety before sale.”

    Why not: Substantiation stays with the company (§608); FDA sees it only via inspection or records requests. Source: MoCRA 2022

  • “MoCRA's fragrance-allergen labels are already on US products.”

    Why not: The statute sets only a proposed-rule deadline (2024-06-29); labels depend on FDA's final rule; check status. Source: MoCRA 2022

  • “MoCRA overrides state fragrance-disclosure or ingredient-ban laws.”

    Why not: §614 preempts only registration/listing, GMP, records, recalls, AE reporting and safety substantiation; labeling, ingredient bans and pre-existing state ingredient-reporting laws are preserved. Source: MoCRA 2022

  • “MoCRA protects people who react to fragrance.”

    Why not: 'Minor and transient reactions' are not injury under §608, only serious events must be reported, and second-hand/household exposure is outside the law. Source: MoCRA 2022

  • “FDA found PFAS in only 0.03% of cosmetics and in no perfumes.”

    Why not: Misattributed: the US figure is 0.41% of listed products; 0.03% (children's share) and 'no fragrances' are EU KEMI 2021 figures quoted in the report. Source: FDA 2025, FDA report published under MoCRA §3506(b) (FDA website)

  • “Fragrance-free products usually contain fragrance.”

    Why not: Scheinman gives ten examples in 1999 and a list of fifteen products she judged truly fragrance-free; the only systematic count is Xu 2017 (18/40 US moisturizers, identity-based, not masking). Source: Scheinman 1999, Journal of the American Academy of Dermatology

  • “Manufacturers routinely mask fragrance in fragrance-free products.”

    Why not: One unnamed company admitted it once in 1999; masking prevalence in fragrance-free products has never been measured. Source: Scheinman 1999, Journal of the American Academy of Dermatology

  • “Today's Cetaphil, Aveeno or Dove fragrance-free product contains fragrance.”

    Why not: Scheinman's lists are 1999-era formulations; product formulations change, and current labels were not checked for this page. Name the loophole, not a current product, unless the label has been checked. Source: Scheinman 1999, Journal of the American Academy of Dermatology

  • “IFRA bans balsam of Peru, so it isn't in products.”

    Why not: IFRA's code binds fragrance compounds made by its member fragrance houses; it does not bind a drug or cosmetic manufacturer using balsam of Peru directly as an ingredient, as US diaper-rash ointments did in the 1990s. Source: Scheinman 1999, Journal of the American Academy of Dermatology

  • “Fragrance-allergic people must avoid all fragrance for life.”

    Why not: Scheinman's own 1999 algorithm limits total avoidance to the period of active dermatitis, then tests products one at a time with a repeat open application test before reintroduction. Source: Scheinman 1999, Journal of the American Academy of Dermatology

  • “The CMAJ editorial itself measured fragrance sensitivity, or shows the CDC has banned fragrance workplace-wide.”

    Why not: It is a one-page opinion editorial with no new data; its 30%/27% figures are Caress & Steinemann survey data already in our evidence base, and it never mentions the CDC at all — the CDC quotation elsewhere in our evidence base comes from a different, still-unverified source (ASEQ-EHAQ 2020) Source: Flegel & Martin 2015, CMAJ (Canadian Medical Association Journal)

  • “Untested high-production-volume chemicals include fragrance ingredients, so fragrance chemicals cause autism.”

    Why not: Landrigan 2010's <20%-tested figure covers ~3,000 general HPV industrial chemicals (solvents, metals, pesticides); the paper never names a fragrance or cosmetic ingredient, and its own five proof-of-concept autism-linked exposures are two drugs (thalidomide, misoprostol), an anticonvulsant (valproic acid), an infection (rubella) and one agricultural pesticide (chlorpyrifos) — not fragrance. Source: Landrigan 2010, Current Opinion in Pediatrics

  • “Landrigan 2010 proves environmental chemicals cause autism.”

    Why not: The paper is explicitly a hypothesis-and-research-agenda review with no new data; its own conclusion calls for future toxicological, neurobiological and epidemiological studies to discover causes, not a claim that any beyond its five cited drug/infection/pesticide exposures are established. Source: Landrigan 2010, Current Opinion in Pediatrics

  • “Vaccines or thimerosal are linked to autism.”

    Why not: Landrigan 2010 synthesizes seven independent national studies (UK, California, Yokohama Japan, Denmark, Finland, two UK/US thimerosal cohorts) that all found no association, including a Japanese population where MMR was withdrawn in 1993 while autism incidence kept rising; the paper concludes fear of autism does not justify vaccine refusal. Source: Landrigan 2010, Current Opinion in Pediatrics

  • “Fragrance chemicals are among the untested high-production-volume industrial chemicals in this paper's testing gap, so fragrance causes neurodevelopmental disorders including autism.”

    Why not: This paper never names a single fragrance or cosmetic ingredient among its 5 confirmed developmental neurotoxicants (lead, methylmercury, PCBs, arsenic, toluene) or its 201-chemical Panel. Autism appears once, only as an example of a neurodevelopmental disorder with 'mostly unknown' causes; no chemical is linked to autism specifically anywhere in the paper. No CAUSES/ASSOCIATED_WITH/RISK_FACTOR_FOR edge to autism exists in the graph for this source. Source: Grandjean & Landrigan 2006, Lancet

  • “Grandjean & Landrigan 2006's '80% of HPV chemicals lack developmental/pediatric toxicity data' figure is the same statistic as the wiki's other claim that '<20% of HPV chemicals are tested for developmental neurotoxicity'.”

    Why not: The two figures are related but not identical: this paper's 80% concerns general developmental/pediatric toxicity testing (EPA's SIDS battery), a broader and more commonly assessed endpoint than the narrower developmental-neurotoxicity testing referenced by Landrigan 2010 and Sealey 2016, which traces to a different 1998 source (Goldman, not EPA's own report). Treat as corroborating context, not a numeric match. Source: Grandjean & Landrigan 2006, Lancet

  • “US occupational exposure limits are only about 40% laxer than Poland's.”

    Why not: This is the paper's own abstract wording; its Table 5 data show US OSHA's overall OEL level is 2.67-fold (167%) higher than Poland's, not 40% — a percentage-point-vs-percent-difference error in the abstract. See the source page's Contradictions section. Source: Schenk et al. 2008, Regulatory Toxicology and Pharmacology Industry-funded

  • “Regulators around the world broadly agree on which chemicals are dangerous; only the fine print of the exposure limit differs.”

    Why not: 460 of the 1,341 chemicals studied (34%) are regulated by only one of the 18 agencies compared, and overall stringency differs nearly threefold between agencies — the disagreement is in substance and coverage, not just wording. Source: Schenk et al. 2008, Regulatory Toxicology and Pharmacology Industry-funded

  • “Regulation (EU) No 655/2013 defines what 'free from,' 'hypoallergenic,' 'fragrance-free' or 'unscented' legally mean on a cosmetic label.”

    Why not: The regulation never uses any of these terms and Recital 7 explicitly says the common criteria are not meant to define specific claim wording; the definitional work, if it exists, sits in a separate, uncaptured Commission technical document. Source: Commission Regulation (EU) No 655/2013

  • “Regulation (EU) No 655/2013 has multiple numbered annexes (e.g. Annex III/IV) specifically governing 'free from' and 'hypoallergenic' claims.”

    Why not: The regulation has exactly one Annex, containing the six common criteria; it does not contain or reference any Annex III or IV. Source: Commission Regulation (EU) No 655/2013

  • “The UK has meaningfully diverged from EU cosmetic-claims law since Brexit.”

    Why not: As of the 2026-09-27 capture, the UK-retained text is identical in substance to the EU text, with only cross-reference wording changed (UK enforcement regulation citation; 'United Kingdom' for 'Union'). Source: Commission Regulation (EU) No 655/2013

  • “Regulation (EU) No 655/2013 gives individual EU/UK consumers a private right of legal action against a misleading cosmetic claim.”

    Why not: The regulation is enforced through national competent authorities, courts, and the EU consumer-protection cooperation network; it does not describe an individual consumer complaint or lawsuit mechanism. Source: Commission Regulation (EU) No 655/2013

  • “EU/UK rules explicitly allow 'unscented'/'fragrance-free' products to contain a disclosed masking agent, the same way Health Canada's regulation does.”

    Why not: Checked directly against the EU's own claim-specific technical guidance (this document): it never uses the words 'fragrance-free', 'unscented' or 'masking agent', and its actual 'free from perfume' wording (any perfuming-function ingredient disqualifies the claim, 'regardless of its other possible functions') points toward excluding a masking agent, not permitting one. Unlike Health Canada's CR s.21.4(3), which explicitly authorizes 'parfum' to 'produce or mask a particular odor'. Source: EC Technical Document on Cosmetic Claims 2017 Industry-funded

  • “This EC guidance document is legally binding EU law.”

    Why not: The document states twice on its own cover page that it is not a European Commission document, is not legally binding, and cannot be regarded as reflecting the Commission's official position; only Regulation (EU) No 655/2013 itself is binding law. Source: EC Technical Document on Cosmetic Claims 2017 Industry-funded

  • “This guidance proves EU 'free from perfume' products never actually contain a masking agent in practice.”

    Why not: The document constrains what companies may claim, not what they may formulate; no EU product-testing study in our evidence base checks compliance in practice. Source: EC Technical Document on Cosmetic Claims 2017 Industry-funded

  • “'Hypoallergenic' has a fixed, numeric or compositional EU legal definition.”

    Why not: Annex IV sets an evidence process (six sensitizer-exclusion routes, continuous review), not a threshold or composition standard, and the document itself says companies should check whether consumers in their country understand the term — implying it is not self-evidently or uniformly defined. Source: EC Technical Document on Cosmetic Claims 2017 Industry-funded

  • “The FDA says the phthalate DEP, commonly used in fragrance, is safe.”

    Why not: FDA's page asserts "DEP does not pose known risks for human health as it is currently used in cosmetics and fragrances" with zero citation, data or risk assessment; our own DEP/MEP epidemiological evidence is unresolved (register C65), so this should not be presented as an independent safety finding. Source: FDA 2026 (Fragrances in Cosmetics)

  • “FDA now requires fragrance allergens to be listed on cosmetic labels.”

    Why not: FDA's own current consumer page states the opposite: it says it lacks food-equivalent allergen-labeling authority for cosmetics, and never mentions MoCRA or a §609(b) rule; whether a rule exists elsewhere (Federal Register) was not checked here. Source: FDA 2026 (Fragrances in Cosmetics)

  • “The FDA defines what "fragrance-free" and "unscented" legally mean.”

    Why not: No such definition appears on the page; its only relevant statement is that "unscented" products may contain a masking fragrance, and "fragrance free" is used once as informal consumer advice, not a defined term. Source: FDA 2026 (Fragrances in Cosmetics)

  • “Essential oils and aromatherapy products are specially regulated or safety-tested by FDA.”

    Why not: FDA states there is no regulatory definition of "essential oils"; such products are cosmetics or drugs under the ordinary intended-use test, with no premarket approval either way. Source: FDA 2026 (Fragrances in Cosmetics)

The industry (69)
  • “Fragrance houses hide ingredients from the brands that sell them.”

    Why not: Paper never mentions fragrance; our inference. Source: Scruggs 2011, Environmental Science & Policy

  • “Most companies don't know what's in their products.”

    Why not: 20 hand-picked leaders; mentions not prevalence. Source: Scruggs 2011, Environmental Science & Policy

  • “Fragrance safety testing is unreliable, so fragrance ingredients are unsafe.”

    Why not: Mispredictions are bidirectional and mostly conservative; the paper evaluates methods, not products. Source: Lee 2024, Food and Chemical Toxicology Industry-funded

  • “Most fragrance ingredients are strong allergens.”

    Why not: Distribution is dominated by weak (25) and very weak (15) sensitizers, with 4 non-sensitizers. Source: Lee 2024, Food and Chemical Toxicology Industry-funded

  • “Industry safety limits for fragrance allergens are too low by 5 to 10 times.”

    Why not: Model prediction error, not a tested exposure limit; risk assessment adds uncertainty factors. Source: Natsch & Gerberick 2022, ALTEX Industry-funded

  • “This study shows fragrance products cause allergy.”

    Why not: Methods paper on 322 mostly non-fragrance chemicals; no product or patient data. Source: Natsch & Gerberick 2022, ALTEX Industry-funded

  • “Fragrance salicylates cause birth defects.”

    Why not: Neural tube defects were seen in hamsters and rats at maternally toxic doses of about 1,000-5,000 mg/kg, thousands of times the estimated cosmetic exposure; there is no human evidence. Source: RIFM Expert Panel / Belsito 2007, Food and Chemical Toxicology Industry-funded

  • “Fragrance salicylates cause cancer.”

    Why not: No modern bioassay exists; the old rat study's pituitary tumors (3 animals at 250 mg/kg/day) could not be analyzed for lack of detail. 'Not properly tested' is defensible; 'carcinogenic' is not. Source: RIFM Expert Panel / Belsito 2007, Food and Chemical Toxicology Industry-funded

  • “Using several salicylate-containing products puts you over the safety limit.”

    Why not: The aggregate margin is our worst-case arithmetic on summed high-end maxima, not a measured dose. Say the industry never added them up. Source: RIFM Expert Panel / Belsito 2007, Food and Chemical Toxicology Industry-funded

  • “Benzyl salicylate is a hormone disruptor.”

    Why not: Independent in vitro data now exist (Charles & Darbre 2009): benzyl salicylate is weakly, partially estrogenic in MCF7 cells (ER binding, ERE-CAT and pS2 induction, fulvestrant-sensitive proliferation), but only at concentrations (≈50 µM and up) at or above a evidence base-estimated realistic exposure ceiling (≈2.5–35 µM, from this review's own worst-case 100% dermal-absorption assumption). "Weakly estrogenic in a dish at very high concentration" is now defensible; "hormone disruptor", which implies a real-use effect, is still not shown. Source: RIFM Expert Panel / Belsito 2007, Food and Chemical Toxicology Industry-funded

  • “Perfume or scented products expose consumers to diacetyl at levels like those in fragrance factories.”

    Why not: The paper measured factory workers handling bulk neat chemicals; no consumer data. Source: Angelini 2016, PLoS ONE Industry-funded

  • “Fragrance-factory workers were shown to get lung disease from fragrance chemicals.”

    Why not: No health, symptom or lung-function data were collected; exceedances concern flavor diketones and acetaldehyde, while measured fragrance aromatics were in the ppb range. Source: Angelini 2016, PLoS ONE Industry-funded

  • “Science has proven lavender oil is a hormone disruptor.”

    Why not: It has not. This industry study is the strongest negative evidence in our evidence base and its designs are the regulatory standard: no estrogen or androgen receptor activity in guideline cell assays, and nothing in rat uterotrophic, Hershberger or one-generation reproductive screens up to a 1000 mg/kg/day limit dose. The honest line is 'plausible, biologically active in cells, not proven in people'. Source: Hareng 2024, Archives of Toxicology Industry-funded

  • “The study was paid for by BASF, so its results can be dismissed.”

    Why not: The conflict of interest is severe and must be disclosed, but the designs are OECD-guideline and GLP, the positive controls behaved as expected (17a-ethynylestradiol raised uterine weight ~7-fold; flutamide blocked testosterone propionate), and the paper is open access. Disclose the funder; do not use funding as a refutation. Source: Hareng 2024, Archives of Toxicology Industry-funded

  • “BASF's testing cleared lavender oil.”

    Why not: It cleared two constituents on two hormone pathways. Whole lavender oil, tea tree oil, alpha-terpineol, terpinen-4-ol and steroid-synthesis enzymes were not tested, and eight constituents reconstituted together only reproduce about half of the whole oil's activity. Source: Hareng 2024, Archives of Toxicology Industry-funded

  • “Linalool is proven safe.”

    Why not: Not for oxidized linalool, one of the commonest fragrance contact allergens, which was not tested here; and 'safe' was never the finding — the finding was no estrogen- or androgen-mediated activity in the specific assays run. Source: Hareng 2024, Archives of Toxicology Industry-funded

  • “The industry's own rat study showed lavender chemicals kill babies.”

    Why not: The pup deaths occurred only at 800 mg/kg/day, a dose that made the mother rats ill, and are most plausibly secondary to that maternal toxicity. The finding is worth citing as unresolved and needing the follow-up the authors themselves demand; it is not a consumer risk. Source: Hareng 2024, Archives of Toxicology Industry-funded

  • “Scented products release 24 cancer-causing air pollutants.”

    Why not: Potera's body text calls the 24 federally listed VOCs '24 carcinogenic hazardous air pollutants'; the primary's 24 include ethanol, acetone, pine compounds and camphor, and only 4 are EPA probable carcinogens (acetaldehyde, 1,4-dioxane, formaldehyde, methylene chloride). Use '11 of 25 products released at least one of 4 probable-carcinogen air pollutants'. Source: Potera 2011 (EHP news), Environmental Health Perspectives

  • “Green-labeled scented products emit exactly as many hazardous chemicals as regular ones.”

    Why not: The primary found no significant difference in 11 vs 14 products (p > 0.30), which rules out only a large difference; say 'no better in this small test'. Source: Potera 2011 (EHP news), Environmental Health Perspectives

  • “Dryer sheets give children seizures and air fresheners make adults pass out.”

    Why not: Anecdotes from letters and e-mails to a researcher, quoted in a news item; no documented cases or clinical data. Source: Potera 2011 (EHP news), Environmental Health Perspectives

  • “Fresh-scent household products set people up for a lifetime of chemical illness.”

    Why not: An expert's quoted hypothesis (TILT, Claudia Miller); no data in the item, and the TILT model is contested. Source: Potera 2011 (EHP news), Environmental Health Perspectives

  • “The fragrance industry never tests its chemicals.”

    Why not: RIFM runs an extensive testing and review program: monographs on ~1,100 ingredients by 2002, about 10% banned or restricted. The critique is what is tested (fresh chemical, skin route) and who checks it. Source: Bickers 2003 (RIFM Expert Panel), Regulatory Toxicology and Pharmacology Industry-funded

  • “RIFM's expert panel is paid by the fragrance companies and is not independent.”

    Why not: The paper shows RIFM is industry-funded and supports the panel, and requires members to be independent of the industry; there are no individual payment data. Say 'industry-convened and industry-funded, with no outside regulator'. Source: Bickers 2003 (RIFM Expert Panel), Regulatory Toxicology and Pharmacology Industry-funded

  • “Fragrance is unsafe to breathe because the industry never checked inhalation.”

    Why not: The paper shows the inhalation route was not assessed, not that it causes harm; measured indoor fragrance levels are mostly below irritation thresholds. Source: Bickers 2003 (RIFM Expert Panel), Regulatory Toxicology and Pharmacology Industry-funded

  • “Linalool is a strong skin allergen.”

    Why not: Fresh linalool is a very weak sensitizer; the allergen is the air-oxidized form (hydroperoxides), and patch-test rates come from dermatitis clinic patients. Source: Bickers 2003 (RIFM Expert Panel), Regulatory Toxicology and Pharmacology Industry-funded

  • “The industry admitted fragrance is dangerous to breathe.”

    Why not: Ford argued the opposite, and his exposure number is plausible; the fair point is that inhalation was dismissed without testing. Source: Ford 1994 (RIFM) Industry-funded

  • “Fragrance ingredients are untested.”

    Why not: About 1,300 had acute and skin tests by 1994; say which endpoints (inhalation, long-term) were not tested. Source: Ford 1994 (RIFM) Industry-funded

  • “Musk ambrette and AETT show that the musks in today's products damage nerves.”

    Why not: Those two were withdrawn in the 1980s; musk ketone and xylene were negative for neurotoxicity in the rat study. Source: Ford 1994 (RIFM) Industry-funded

  • “Fragrance-industry self-regulation never removes anything.”

    Why not: In this account AETT was withdrawn on rat data before publication and 82 materials were restricted; the critique is who decides and what endpoints are left out. Source: Ford 1994 (RIFM) Industry-funded

  • “The EU tested and banned 36 dangerous fragrance chemicals in 2000.”

    Why not: The committee adopted IFRA's list without new testing; 5 were banned for lack of use/safety data and 3 with no reason; 6 were negative in the sensitization test. Source: SCCNFP 2000

  • “These banned fragrance chemicals are in your perfume today.”

    Why not: They are banned from EU cosmetics (Annex II), and most had already been dropped by industry before 2000. Source: SCCNFP 2000

  • “25 of 25 volunteers sensitized means everyone who uses the ingredient becomes allergic.”

    Why not: The maximization test uses irritant pre-treatment, occlusion and ~10x the maximum use concentration; results vary widely between samples of the same material (0/30 to 18/25 for verbena oil) Source: SCCNFP 2000

  • “Musk ambrette was banned as a skin allergen, or all nitro musks were banned by the EU in 2000.”

    Why not: Musk ambrette was 0/25 in the sensitization test; its grounds were photosensitivity, neurotoxicity and slow excretion. Musk ketone and musk xylene are not on this list. Source: SCCNFP 2000

  • “This 2026 paper proves perfume mutagens are activated (or deactivated) by liver metabolism.”

    Why not: Metabolic (S9) activation was tested on cosmetics/skin-care creams, not on perfumes; the authors state directly that it was not performed for perfumes in this study. Source: Schmidtmann 2026, Analytical Chemistry

  • “Adding human liver enzymes to the test showed these products are safer than animal testing suggested.”

    Why not: The opposite was found: human liver enzymes produced stronger, not weaker, mutagenic signals for the same cosmetic extracts; the authors report no substantial detoxification with human S9. Source: Schmidtmann 2026, Analytical Chemistry

  • “This 2026 paper is independent confirmation of the earlier 42-perfume genotoxicity/hormone-disruption findings.”

    Why not: Same research group and platform, a different and much smaller (8 vs. 42) unnamed perfume set, a different bacterial endpoint (Ames, not SOS-Umu-C), and no hormone or antibacterial endpoints were retested. Source: Schmidtmann 2026, Analytical Chemistry

  • “Daily skin-care product use is 17,000 times a toxic dose, so it is dangerous in practice.”

    Why not: This is a plate-amount-to-daily-product-mass ratio with no absorption, distribution or metabolism term; the paper's own authors say this comparison 'is not a quantitative risk assessment.'. Source: Schmidtmann 2026, Analytical Chemistry

  • “The CIR found benzyl alcohol carcinogenic (or: the CIR proved it is completely safe from cancer).”

    Why not: NTP called the 2-year mouse study negative; EPA, reviewing the identical adrenal-adenoma data (3/48 high-dose vs 0/48 control), called it "equivocal evidence of carcinogenic activity rather than negative." CIR's report records both readings without resolving them; pick neither as a single verdict. Source: Nair 2001 (CIR Expert Panel), International Journal of Toxicology Industry-funded

  • “Benzyl alcohol is safe to inhale from perfumes and hairsprays because the CIR found it safe.”

    Why not: The report explicitly excludes inhalation from its safety conclusion, calling the available data insufficient, and that gap was never filled after a 1997 data request drew no response. Source: Nair 2001 (CIR Expert Panel), International Journal of Toxicology Industry-funded

  • “Benzyl alcohol caused the 1980s neonatal "gasping syndrome" deaths through cosmetic products.”

    Why not: Those deaths came from benzyl alcohol used as a preservative in injectable/IV fluids in hospitals (a different exposure route and population), not from cosmetics; don't merge the two routes. Source: Nair 2001 (CIR Expert Panel), International Journal of Toxicology Industry-funded

  • “The industry's own data prove benzyl alcohol and benzoic acid don't cause skin reactions.”

    Why not: The opposite: the industry panel's own cited studies found a reaction in the majority of a 200-volunteer panel at cosmetic-relevant concentrations (Table 7); the industry's safety argument rests on exposure pattern, not absence of the effect. Source: Nair 2001 (CIR Expert Panel), International Journal of Toxicology Industry-funded

  • “The replacement tests are worse than animal testing.”

    Why not: On this paper's own human comparison they are not: in vitro predicts human thresholds about as well as the mouse LLNA (R2 ~32-50% vs ~34-49%), and is better at flagging strong human sensitizers (19/27 vs 14/27) Source: Natsch 2015, Toxicological Sciences Industry-funded

  • “Fragrance safety limits are 6 to 18 times too weak.”

    Why not: These are prediction errors in a regression model, not tested exposure limits; risk assessment applies uncertainty factors on top and this paper tests no product or limit. Source: Natsch 2015, Toxicological Sciences Industry-funded

  • “Cinnamaldehyde and other fragrance allergens are more potent than industry models predict.”

    Why not: In this dataset they are not: cinnamic aldehyde, isoeugenol, citral and cinnamyl alcohol are all predicted within about 2-fold, and where wrong, the model is conservative (predicts higher potency than measured) Source: Natsch 2015, Toxicological Sciences Industry-funded

  • “The 62% accuracy figure for skin-allergy safety tests means the tests are 62% accurate against real human allergy.”

    Why not: That figure is against a composite metric that still leans on mouse LLNA data; against real human-only data the figure is 32-45%, not 62%. Source: Natsch 2023, ALTEX Industry-funded

  • “This study shows the safety tests are unreliable and fragrance products are dangerous.”

    Why not: The paper's message is that both the mouse test and its replacements have a similar, modest ceiling; it is a methods-validation paper with no product, exposure or patient data. Source: Natsch 2023, ALTEX Industry-funded

  • “Predictions for individual fragrance chemicals change substantially when human data replaces mouse data in these safety models.”

    Why not: 94% of 139 chemicals shift by less than 3.3-fold between the LLNA-trained and human-anchored models; practical point-of-departure numbers are fairly stable. Source: Natsch 2023, ALTEX Industry-funded

  • “Musk ambrette at fragrance-use levels damages human nerves.”

    Why not: The doses producing consistent effects in this study are 50-250x the industry's own estimated maximum human exposure; the authors themselves say the needed lower-dose study was never done. Source: Spencer 1984, Toxicology and Applied Pharmacology Industry-funded

  • “This proves today's synthetic musks (galaxolide, tonalide) are neurotoxic.”

    Why not: Musk ambrette is a discontinued nitro-musk; the polycyclic musks now in use have a different chemical structure and, per current our evidence, a different (non-neurotoxic) toxicological profile. Source: Spencer 1984, Toxicology and Applied Pharmacology Industry-funded

  • “Negative photosensitivity testing means a chemical is safe to wear in sunlight.”

    Why not: Musk ambrette passed controlled photosensitivity screening (Kligman 1966, 1972) but caused real photoallergic reactions in cologne users (Giovinazzo 1980) — screening tests can miss real-world hazards. Source: Spencer 1984, Toxicology and Applied Pharmacology Industry-funded

  • “A product being "IFRA-compliant" means it has been clinically proven safe for everyone.”

    Why not: The framework's own authors state QRA1/QRA2 have never been empirically or clinically validated, and the framework does not address elicitation in already-sensitized individuals at all. Source: Api 2020 (RIFM/IFRA), Regulatory Toxicology and Pharmacology Industry-funded

  • “QRA2 protects people who already have a fragrance allergy from reacting to compliant products.”

    Why not: QRA2's stated purpose (Section 2.2) explicitly excludes elicitation in already-sensitized subjects; its target is preventing new cases of sensitization only. Source: Api 2020 (RIFM/IFRA), Regulatory Toxicology and Pharmacology Industry-funded

  • “The industry's larger safety margins (30-300x Safety Assessment Factors) have been shown to cover the known ~2-3x error and ~62% R-squared ceiling of the newer non-animal skin-sensitization potency tests.”

    Why not: QRA2's own authors say explicitly that reviewing SAF suitability against NAM-derived NESIL uncertainty "remains to be seen" — this reassurance has not actually been established. Source: Api 2020 (RIFM/IFRA), Regulatory Toxicology and Pharmacology Industry-funded

  • “This industry report proves fragrance exposure in consumer products is safe.”

    Why not: It compares a modeled exposure estimate — built on industry-supplied, largely unpublished concentration and habits-and-practices survey data — to conservative screening thresholds. It is not a clinical or epidemiological safety study, and the industry's own numbers put about a quarter of ingredients above the systemic threshold and about half above the dermal-sensitization threshold. Source: Lee 2024 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “This study proves scented household and air-care products are harmless to breathe.”

    Why not: It reports low modeled inhalation exposure for most ingredients (99% below an industry-set inhalation threshold), not measured breathing-zone concentrations or a health-outcome study; 18 of about 3,200 modeled ingredients still exceed even that threshold, and whole-product mixture and secondary-chemistry effects are outside this per-ingredient model's scope. Source: Lee 2024 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “This RIFM study shows natural fragrance oils (essential oils) are more hazardous than synthetic fragrance chemicals.”

    Why not: The paper assigns natural complex substances a conservative 'reactive'/Cramer-Class-III default because their many components were not individually assessed, not because they were shown to be more reactive; the same paper states most, on a component basis, are likely safe — but supplies no component data to check that. Source: Lee 2024 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “This paper shows fragrance exposure from soaps, cosmetics or air fresheners is safe or unsafe.”

    Why not: This is a description of how an industry exposure-estimation model was built and expanded; it reports no toxicological, clinical or measured-exposure outcome data of its own. Source: Comiskey 2017 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “The fragrance industry started testing how much fragrance people actually breathe in 2017.”

    Why not: This paper adds a modeled inhalation exposure fraction derived from a pre-existing compartmental model run at single default parameter values, not new breathing-zone measurements of real people. Source: Comiskey 2017 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “Household cleaning and laundry products are now covered by the fragrance industry's aggregate exposure model.”

    Why not: The paper explicitly excludes household cleaning and laundry products and names their inclusion as future work; industry-wide coverage did not arrive until a 2024 paper (Lee et al.). Source: Comiskey 2017 (RIFM/Creme Global), Regulatory Toxicology and Pharmacology Industry-funded

  • “This study shows the fragrance industry's animal-based safety testing (the LLNA) is a validated, accurate predictor of human skin allergy risk.”

    Why not: The paper's own authors call the 76% concordance figure 'an alert for consideration, rather than… a general rule,' and document up to ~790-fold mispredictions in specific chemistry classes; a separate, independently confirmed finding shows the LLNA itself explains only ~43% of human sensitization variance by regression, no better than the non-animal replacement tests. Source: Api, Basketter & Lalko 2014, Cutaneous and Ocular Toxicology Industry-funded

  • “Because this study found hexyl salicylate and benzyl salicylate to be outlier chemicals, products containing them are especially risky for skin allergy.”

    Why not: The salicylate 'outlier' finding is that the mouse test OVER-predicts their potency relative to humans (the conservative, safer direction for a safety limit) — the opposite of a claim that they are especially dangerous. This paper is about assay-to-assay agreement on population thresholds, not about individual product risk or dose. Source: Api, Basketter & Lalko 2014, Cutaneous and Ocular Toxicology Industry-funded

  • “Fragrance mixtures containing citral, cinnamic aldehyde or phenylacetaldehyde are proven safe from sensitization as long as they include the traditional 'quenching' companion (d-limonene, α-pinene, mixed citrus terpenes or eugenol) at the originally tested ratio.”

    Why not: The founding 1976 evidence is a single unreplicated human test per mixture with no subject numbers reported; the same paper shows quenching failing at a different ratio of the same ingredients (cinnamic aldehyde:eugenol 2.5:1) and shows one of its three 'protective natural oil' examples (cinnamon bark oil) itself sensitizing. RIFM's own 2005 HRIPTs could not reproduce cinnamaldehyde quenching by eugenol or limonene, and the proposed citral quencher (air-oxidized d-limonene) is itself now one of the commonest fragrance allergens. Source: Opdyke 1976 (RIFM), via Ford 1994 Industry-funded

  • “This study shows the mouse skin-allergy test (LLNA) reliably predicts human allergic potency for fragrance chemicals in general.”

    Why not: The R-squared = 0.784 figure applies only within a domain that already excludes about 1 in 4 of the original 57-chemical dataset, using outlier chemistries identified from the very human data being predicted; the industry's own earlier paper on the same data found up to ~790-fold mismatches for the excluded chemicals. Source: Roberts & Api 2018, Regulatory Toxicology and Pharmacology Industry-funded

  • “This paper proves that a specific fragrance ingredient's current safety limit is set incorrectly.”

    Why not: The chemistry-based explanations for each outlier chemical are plausible but untested hypotheses (no new experiments), proposed by a RIFM-affiliated, Cefic LRI-funded research group whose safety-assessment framework depends on the LLNA remaining usable. Source: Roberts & Api 2018, Regulatory Toxicology and Pharmacology Industry-funded

  • “An independent U.S. EPA study of carpet emissions proves fragrance and cologne products are toxic to mice.”

    Why not: The 1995 EPA/ManTech study (Tepper et al.) tested two CPSC-complaint carpets only, never a fragrance product, and its actual finding was the opposite: no statistically significant carpet-related toxicity once individual-animal statistics were used. Source: Tepper et al. 1995, American Industrial Hygiene Association Journal

  • “Because an EPA study found no toxic effects from carpet emissions, fragrance products and other consumer products commonly called 'toxic' are safe.”

    Why not: This was an exploratory two-carpet screen with no correction for multiple comparisons, a limitation the authors themselves flag; it does not test fragrance products or any other product class and cannot be generalized beyond the two carpets studied. Source: Tepper et al. 1995, American Industrial Hygiene Association Journal

  • “Esterquats/fabric-softener quaternary ammonium compounds are proven safe by independent testing.”

    Why not: Every study behind HERA's conclusions is run and interpreted by the detergent/chemical industry itself (A.I.S.E./CEFIC); none is named, dated, or independently checkable from the published summary page. Source: HERA Project 2008 (A.I.S.E./CEFIC) Industry-funded

  • “Fabric softeners are safe because quaternary ammonium compounds (QACs) don't cause allergies or asthma.”

    Why not: HERA's page addresses only esterquats (the fabric-softening agent), a chemically distinct QAC subclass from the benzalkonium chloride/didecyldimethylammonium chloride disinfectant QACs our independent occupational-asthma literature documents as established respiratory sensitizers (Rosenman 2003, Weinberg 2017, Salonen 2024). Neither literature has tested the other subclass, so a blanket 'QACs are safe' or 'QACs cause asthma' claim is unsupported by what either source actually measured. Source: HERA Project 2008 (A.I.S.E./CEFIC) Industry-funded

  • “No one has ever studied whether fabric-softener or dryer-sheet use causes asthma.”

    Why not: DON'T CLAIM this as stated: no laundry-specific esterquat inhalation/asthma study was found (a real gap), but disinfectant-QAC occupational-asthma studies exist for a different QAC subclass and exposure setting — the accurate claim is 'no laundry-specific study', not 'no QAC-asthma study at all'. Source: HERA Project 2008 (A.I.S.E./CEFIC) Industry-funded

What you can do (18)
  • “Buying green or natural products cuts your chemical exposure.”

    Why not: Study used specific named-chemical labels; generic green claims fail in emission studies. Source: Harley 2016, Environmental Health Perspectives

  • “Swapping products lowers your health risk / cuts hormone disruption.”

    Why not: Urinary biomarkers only; no health outcome measured. Source: Harley 2016, Environmental Health Perspectives

  • “Fragrance-free products cut phthalate exposure by 27%.”

    Why not: Swap changed many products; fragrance not isolated. Source: Harley 2016, Environmental Health Perspectives

  • “Fragrance-free workplace policies have been shown to reduce symptoms (or shown not to work).”

    Why not: Only comparison is 32 vs 16 office occupants, no difference (all p>0.05), exploratory and underpowered; positive claim rests on unpublished IAQ data. Source: Roy 2026

  • “Fragrance sensitivity is all in the head.”

    Why not: The review argues a cognitive account of MCS, but the one primary double-blind perfume challenge in our evidence base found eye irritation with smell removed (Elberling 2006); olfactory thresholds do not test the trigeminal channel. Source: Dalton & Jaén 2010, Current Opinion in Allergy and Clinical Immunology Industry-funded

  • “Offices with high formaldehyde make workers sick.”

    Why not: The Finnish 176-office study cited found formaldehyde above the irritation level in >50% of buildings with no link to symptoms. Source: Dalton & Jaén 2010, Current Opinion in Allergy and Clinical Immunology Industry-funded

  • “Knowing about a risk is not enough: even among Germans who say fragrance makes them ill, 54.8% still use perfumed products to feel attractive and fewer than half (44.7%) read labels for fragrance information.”

    Why not: Self-report; the author's cognitive-dissonance/advertising interpretation is untested. Source: Klaschka 2020, Environmental Sciences Europe

  • “One in three Canadians reacts to fragrance.”

    Why not: No Canadian survey behind it; the ~1/3 figures are US/AU/UK/SE (Germany 19.9%); the only Canadian national figure is 9.4% self-reported MCS (preliminary CCHS 2025) Source: ASEQ-EHAQ 2020

  • “95% of perfume ingredients are petroleum-derived chemicals.”

    Why not: Only source is a 2008 Medical News Today item; no measured composition in our evidence base. Source: ASEQ-EHAQ 2020

  • “Air fresheners cause severe symptoms in babies.”

    Why not: Farrow 2003 (ALSPAC; abstract only) reports associations of air-freshener use with infant diarrhea and earache and of aerosols with diarrhea and vomiting, not severity or causation. Source: ASEQ-EHAQ 2020

  • “Hospitals have the highest rate of occupational asthma.”

    Why not: Cited to Pechter 2005, not in our evidence base and unverified; Weinberg 2017 shows fragrance-related work asthma clusters in offices, health care and schools, not that hospitals rank first overall. Source: ASEQ-EHAQ 2020

  • “Indoor air is 2–5 times more polluted than outdoor air.”

    Why not: TEAM class average for ~12 VOCs; ratios range from ~1 (benzene) to 26–59 (p-DCB); not a statement about overall air quality. Source: ASEQ-EHAQ 2020

  • “DEP is in all fragrance products.”

    Why not: The largest independent survey to date (Koniecki 2011, n=252) found DEP in 70% of fragrances, not 100%; the "100%" figure comes from two much smaller surveys (EWG 2002's original testing and Hubinger & Havery 2006's 5-product fragrance subsample). Source: Koniecki 2011, Environmental Research

  • “Phthalates in cosmetics are being phased out across the board.”

    Why not: Only DnBP in nail polish shows a clear downward trend across three independent surveys; DEP in fragrance shows no decline, and DEHP — already banned from Canadian cosmetics — still turns up at low levels, read as impurities rather than confirmation of removal. Source: Koniecki 2011, Environmental Research

  • “This study shows cosmetic phthalate exposure is harmful.”

    Why not: The paper only models external dose against oral (not dermal) guidance values developed for different exposure routes and endpoints; it explicitly declines to characterize risk and calls its own exposure estimates conservative and non-probabilistic. Source: Koniecki 2011, Environmental Research

  • “"Just read the ingredient label" is a simple, effective fix for allergic patients.”

    Why not: 46% of allergic patients found it difficult or extremely difficult, worst for less-educated patients; a curated, pre-checked product list or database may be more practical for many people than label reading. Source: Noiesen 2007, Contact Dermatitis

  • “People with fragrance allergy can easily avoid it by reading labels.”

    Why not: Even the best-off group in this study, patients allergic to fragrance only, still had 38% report difficulty; "easier than preservative-allergic patients" is not the same as "easy". Source: Noiesen 2007, Contact Dermatitis

  • “Smelling a product before buying protects fragrance-allergic people from reactions.”

    Why not: 44% of fragrance/balsam-of-Peru-allergic patients reported doing this, but the study did not test whether it prevents reactions, and some allergenic fragrance constituents (e.g. oxidized terpenes) are not necessarily detectable by smell at reactive doses. Source: Noiesen 2007, Contact Dermatitis

Other (17)
  • “Perfume causes autism / perfume use in pregnancy raises autism risk.”

    Why not: No human or epidemiological data; unreplicated speculative hypothesis. Source: Bagasra 2013, Medical Hypotheses

  • “All 91 perfumes tested were mutagenic.”

    Why not: Single unreplicated Ames test in Medical Hypotheses; bacterial mutagenicity is not human harm. Source: Bagasra 2013, Medical Hypotheses

  • “Perfume affects brain cells even at a one-in-a-billion dilution.”

    Why not: Biologically implausible (1:10^9 dilution); undermines credibility. Source: Bagasra 2013, Medical Hypotheses

  • “Synthetic fragrances cause autism, cancer and asthma.”

    Why not: Opinion piece, no original data. Source: Bagasra & Pace 2013, OA Autism

  • “884 of 2,983 fragrance chemicals are toxic according to NIOSH.”

    Why not: Cited secondhand without primary source; untraced. Source: Bagasra & Pace 2013, OA Autism

  • “Perfumes are toxic at femtomolar levels.”

    Why not: Rests on the authors' implausible dilution experiments. Source: Bagasra & Pace 2013, OA Autism

  • “Perfumes contain human pheromones that disrupt your hormones.”

    Why not: No human pheromone has been established (Wyatt 2015, cited by the review itself); androstadienone/estratetraenol studies measure ratings and choices in small lab samples, not endocrine or immune outcomes; the review's citations for these rows point to unrelated papers. Source: Babayan 2025, Functional Food Science

  • “Fragrance use is behind rising diabetes in India or thyroid disease and infertility in Armenia.”

    Why not: Asserted with no fragrance-use data or even an ecological correlation; the cited references are diabetes/thyroid epidemiology, family planning and DSD papers that do not mention fragrance. Source: Babayan 2025, Functional Food Science

  • “Limonene causes kidney cancer.”

    Why not: The renal tumors are an alpha2u-globulin mechanism specific to male rats and generally treated by regulators as not relevant to humans (verify against IARC/EPA); limonene's human hazard is its air-oxidation products (contact allergy, irritancy, ozone chemistry). Source: Babayan 2025, Functional Food Science

  • “Macrocyclic musks build up in breast milk and act as estrogens.”

    Why not: Our milk and adipose data cover polycyclic (HHCB, AHTN) and nitro (MK, MX) musks only; no source measures macrocyclics in human tissue. Source: Babayan 2025, Functional Food Science

  • “Perfume and air fresheners in restaurants contaminate your food with hormone disruptors.”

    Why not: Physically plausible (lipophilic musks into fatty foods) but never measured; the review offers it as an idea with no data and off-topic citations. Source: Babayan 2025, Functional Food Science

  • “A 2025 peer-reviewed review found fragrances cause infertility, heart disease and a weakened immune system.”

    Why not: Babayan 2025 is a narrative review in a journal not indexed in PubMed, accepted in 11 days, whose in-text citations do not map to its reference list; cite primaries instead. Source: Babayan 2025, Functional Food Science

  • “A third of the world's population (33%) is harmed by fragranced products.”

    Why not: 33% is one Australian self-report survey (Steinemann 2017), copied uncited by Athar 2020 and relabeled global. Use the four-country 32.2% and say it is self-reported symptoms, not diagnosis. Source: Athar 2020, Journal of Dermatology & Cosmetology

  • “Only 1-3% of allergic skin reactions (contact dermatitis) are caused by fragrance.”

    Why not: The SCCS 1-3% is the share of the general population with fragrance allergy, not the share of dermatitis cases; fragrance is a leading cause of cosmetic ACD. Source: Athar 2020, Journal of Dermatology & Cosmetology

  • “Fragrance-triggered asthma is an immune/allergic reaction.”

    Why not: Athar 2020 cites Elberling 2005 for this, but Elberling found no link with atopy and a link with bronchial hyper-reactivity and non-allergic asthma; the phenotype looks sensory-irritant. Source: Athar 2020, Journal of Dermatology & Cosmetology

  • “Zinc oxide and barium sulfate in cosmetics cause kidney and liver failure; lipstick aluminum causes anemia.”

    Why not: Unsourced in Athar 2020 and contrary to basic toxicology (zinc oxide is an approved UV filter; barium sulfate is an inert filler). Source: Athar 2020, Journal of Dermatology & Cosmetology

  • “Cite Athar 2020 (J Dermatol Cosmetol, MedCrave) as evidence that perfumes and cosmetics are harmful.”

    Why not: Very low-reliability mini-review from a publisher that appeared on Beall's list; conclusion copied uncited; most references miscited. A critic can discredit an article that cites it. Cite the primaries. Source: Athar 2020, Journal of Dermatology & Cosmetology

Information, not medical advice. See all the facts, graded. Found a problem with a claim? Email admin@ihateperfume.com.